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Probabilistic Reconstruction and Comparative Systems Biology of Microbial Metabolism 
Germán Plata 
With the number of sequenced microbial species soon to be in the tens of thousands, we are in a 
unique position to investigate microbial function, ecology, and evolution on a large scale. In this 
dissertation I first describe the use of hundreds of in silico models of bacterial metabolic 
networks to study the long-term the evolution of growth and gene-essentiality phenotypes. The 
results show that, over billions of years of evolution, the conservation of bacterial phenotypic 
properties drops by a similar fraction per unit time following an exponential decay. The analysis 
provides a framework to generate and test hypotheses related to the phenotypic evolution of 
different microbial groups and for comparative analyses based on phenotypic properties of 
species. Mapping of genome sequences to phenotypic predictions –such as used in the analysis 
just described– critically relies on accurate functional annotations. In this context, I next describe 
GLOBUS, a probabilistic method for genome-wide biochemical annotations. GLOBUS uses 
Gibbs sampling to calculate probabilities for each possible assignment of genes to metabolic 
functions based on sequence information and both local and global genomic context data. 
Several important functional predictions made by GLOBUS were experimentally validated in 
Bacillus subtilis and hundreds more were obtained across other species. Complementary to the 
automated annotation method, I also describe the manual reconstruction and constraints-based 
analysis of the metabolic network of the malaria parasite Plasmodium falciparum. After careful 
reconciliation of the model with available biochemical and phenotypic data, the high-quality 
reconstruction allowed the prediction and in vivo validation of a novel potential antimalarial 
target. The model was also used to contextualize different types of genome-scale data such as 
gene expression and metabolomics measurements. Finally, I present two projects related to 
population genetics aspects of sequence and genome evolution. The first project addresses the 
question of why highly expressed proteins evolve slowly, showing that, at least for Escherichia 
coli, this is more likely to be a consequence of selection for translational efficiency than selection 
to avoid misfolded protein toxicity. The second project investigates genetic robustness mediated 
by gene duplicates in the context of large natural microbial populations. The analysis shows that, 
under these conditions, the ability of duplicated yeast genes to effectively compensate for the 
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The document contains five main chapters (3 to 7) –each corresponding to a different research 
project– presented in approximately chronological order from most to least recent work. These 
projects are about two general topics: evolution at multiple levels of biological organization, and 
genotype to phenotype mapping in the context of microbial metabolic networks. Despite topic 
commonalities, the projects can be read independently of each other. In most cases I have kept 
the format with which they were presented to the corresponding scientific journals.  
The introduction (chapter 2) is a review on the current state of biochemical annotation 
methods in the context of the rapidly expanding catalog of fully sequenced microbial species. I 
discuss the importance of probabilistic integrative strategies for assigning functions to metabolic 
genes and emphasize the role of genome-scale metabolic reconstructions in allowing phenotypic 
predictions across thousands of newly sequenced genomes. 
In chapter 3, using metabolic network reconstructions for hundreds of species, I study 
the long-term evolution of bacterial phenotypes. The analysis shows that phenotypic similarity 
follows a clock-like exponential decay over billions of years of microbial evolution. Our 
observations provide a framework to analyze possible mechanisms governing the evolution of 
phenotypic properties and its variation across bacterial lineages and lifestyles.  
In chapter 4 I present work on a global probabilistic approach for biochemical 
annotations: GLOBUS [1]. The method uses Gibbs sampling to simultaneously assign 
probabilities to every possible gene-reaction assignment in a given genome. GLOBUS can 




functions of enzymes. I use GLOBUS to integrate global metabolic flux information with 
sequence and genome-context data in order to improve functional predictions. 
In chapter 5 I describe the reconstruction and flux analysis of the genome-scale 
metabolic model of Plasmodium falciparum, the causative agent of malaria. The article, 
published in Molecular Systems Biology [2], illustrates several applications of metabolic 
network models including the identification and experimental validation of a novel potential drug 
target.  
In chapter 6 I present computational and experimental work that explores the question of 
why highly expressed proteins evolve slowly. The article, published in Genome Biology [3], 
shows that at least for bacteria like E. coli the costs of producing gratuitous protein are a more 
important evolutionary constraint than those of misfolded protein toxicity. 
In chapter 7 I present work that explores the functional compensation between 
duplicated yeast genes.  I focus on the fitness consequences of duplicate gene deletions that are 
relevant for wild yeast populations. Surprisingly, the results show that close duplicates are, on 
average, no more likely than random singletons to provide significant backup for their paralogs. 












Chapter 2.  
 
NEXT GENERATION BIOCHEMICAL ANNOTATIONS FOR  
SYSTEMS MICROBIOLOGY 
 
As thousands of microbial genomes are sequenced every year, accurate annotation methods 
provide a path towards understanding the function, ecology, and evolution of microbes. 
Historically, gene functional assignments have relied on just a few sources of evidence and did 
not provide a quantitative measure of annotation confidence. This resulted in high rates of 
misannotations and contradictory results amongst databases. The explosive growth of genome-
scale data has given way to a new generation of annotation tools. Methods are developing that 
seek to integrate sequence, structure, phylogenetic, and expression data, among several others, 
into probabilistic functional annotations. Using a metabolic network context, accurate gene-
function assignments not only result in improved phenotypic predictions, but also allow the 
consideration of cell-level properties, measured by phenomics, metabolomics, or fluxomics data, 
as additional cues in the annotation process. 
2.1. From genomes to networks to phenotypes 
The vast majority of microbes in the planet cannot be cultured using standard techniques 
and their phenotypic properties are still unexplored. While it remains a challenge to estimate the 
total number of microbial species [4], the diversity of closely related strains within each 
taxonomic group ‒the pan-genome‒ may easily account for millions or even billions of 
phenotypically distinct prokaryotes [5-7]. Given the above, it is likely that most bacteria will 
never be studied in detail in the laboratory, and that most of the microbes that are indeed studied 
will be so mainly through their genome sequences or other types of high-throughput data. In 




biotechnology, genome annotations should be as precise as possible. This allows the 
identification of the genetic elements responsible for specific functions and, through the 
reconstruction of molecular network models, facilitates the prediction of a wide range of 
phenotypic traits. As illustrated in Figure 2.1, the process from genome sequences to predicted 
phenotypes is not necessarily linear. I show here how annotation strategies are being developed 
that integrate information at the gene and whole-cell levels, further improving the accuracy of 
metabolic models and their corresponding predictions. This review focusses on biochemical 
annotations as a central element of the genome-network-phenotype loop. I first describe the 
ongoing avalanche of genomic data and the concurrent evolution of annotation methods. Then, I 
review the role of annotations in the reconstruction of genome-scale metabolic models, 
emphasizing the possibility of obtaining phenotypic predictions across thousands of microbial 
species. Finally, I take look at the future of biochemical annotation methods and highlight 
















Figure 2.1. The genome to network to phenotype loop. Most species on earth live in complex 
communities and cannot currently be cultured under standard laboratory conditions. Genome 
annotations, coupled with reconstruction and modeling of molecular networks (e.g. metabolic 
networks), allow the prediction of phenotypes that can aid in our understanding of interactions 
and functional properties that are not observable by field measurements. Additionally, the 
network framework provides a context for using multiple types of evidence in the annotation 
process. 
 
2.2. Towards a comprehensive sampling of the earth’s microbiome 
With rapidly falling sequencing costs and doubling times of the number of bacterial 
genomes of around 20 months [8], the number of species with a sequenced genome is growing 
fast (Fig. 2.2a).  Currently there are at least 3,767 bacterial genome projects either completed or 




2013 [9]); it is likely that up to one to several hundred thousand genomes are sequenced within 
the next decade (Fig. 2.2a). Interestingly, while the first sequenced genomes were primarily 
selected because of prior knowledge of their medical, economic, or scientific value, attention is 
now turning towards poorly sampled phylogenetic groups and environments [10] (Fig. 2.2b). 
Sequencing of rare bacteria has become an important tool for the discovery of new cellular 
functions at specific ecological niches; for example, a combination of metagenomics and single 
cell sequencing revealed multiple genes and pathways for hydrocarbon degradation after a recent 
oil spill in the Gulf of Mexico [11]. Systematic sequencing of species across phylogenetic space 
can create taxonomic anchors for the classification of genes and species in metagenomic samples 
[12]. There is also a growing number of studies that sequence and compare the genomes of 
multiple strains rather than representative clones for a given microbial species (e. g. [13]). These 
diversity-driven studies provide tools to understand the evolution and functional diversification 
of microbes, as well as specific genetic features shared at different levels of phenotypic 
similarity. There are at least 857 metagenomic projects deposited in Genbank (June 2013 [14]), 
many of which include tens to hundreds of different samples. These data, coupled with a 
growing array of techniques for the molecular characterization of metagenomic samples (e.g. 
metatranscriptomics, metaproteomics, metametabolomics) are set to rapidly transform our view 
on microbial diversity and function in a community setting [15]. Making sense of this avalanche 





Figure 2.2 Exploring the world’s microbiome. (a) Cumulative number of completed bacterial 
genome projects over time (Source: GOLD [9]), the red line indicates a linear fit of the log-
transformed values. Dashed lines indicate projected times for ten thousand and one hundred 
thousand completed bacterial genomes. (b) The landscape of emerging technologies and 
exploration approaches to tackle the overwhelming diversity of existing microbes. 
 
2.3. The evolution of protein functional annotations 
Knowing the functions encoded in a particular genome or set of genomes can give clues 
as to the roles of genes, pathways, and whole molecular networks; these are essential steps 




such functional annotations, however, is not a trivial process. The functional characterization of 
genes relies on experimental evidence that is generally only available for a limited group of 
proteins and species. CharProtDB [16], a database of experimentally determined protein 
functions,  contained a little over sixteen thousand proteins from 1588 organisms when it was 
published in 2012. UniProt KB/Swiss-Prot [17], which also includes human-reviewed 
computational predictions of protein functions, had about half a million sequences from thirteen 
thousand organisms as of May 2013. By contrast, UniProt KB/TrEMBL [17], which is not 
reviewed, had over 35 million sequences from about half a million organisms, 73% of which 
were prokaryotes. There is a huge gap between the number of sequences that have to be 
algorithmically annotated, and those from which annotations will be transferred. This can lead in 
many cases to genome annotations with poor coverage, annotations that rely on weak evidence, 
or annotations to functions that are too general for a detailed analysis; for example, a pyruvate 
dehydrogenase (EC: 1.2.4.1) may be only annotated as an oxidoreductase (EC: 1.-.-.-).   
Sequence homology to proteins of known function, detected by programs like BLAST 
[18] or FASTA [19], constitutes a first and still popular approach to gene functional annotations. 
Transferring of functional assignments on the basis of sequence homology, however, is known to 
produce unreliable predictions when sequence identity is low (below 70%) [20]. This is an 
important problem as more of the species getting sequenced are not closely related to well-
characterized organisms, and they are unlikely to have high sequence similarity to known 
proteins [21]. An additional problem is that even when sequence identity is high, the prevalence 
of incorrect annotations across databases can lead to the spread of annotation errors [22, 23]. 




was shown to be increasing with time, and as high as 80% misannotation levels have been 
estimated for certain enzyme families across various automatic annotation repositories [24].  
The above shortcomings led to a second generation of functional annotation methods that 
use various computational tools and sources of evidence to improve annotation coverage and 
accuracy. For example, hidden Markov models (HMMs) and other sequence-based methods have 
been used for the identification of functional protein domains or motifs in uncharacterized genes 
[25]. Structural homology is another strategy that allows inferring functional properties when 
sequence homology is too low to reliably infer function [26]. Other strategies rest on the idea 
that genes already assigned a particular function can help to predict the function of other genes of 
the same species. For example, if most members of a biochemical pathway are identified in a 
given genome, there is a high likelihood that other genes will encode the remaining reactions 
[27]. Expert definition of pathways has been a popular approach in the characterization of novel 
genome sequences. BioCyc [28] and KEGG [29] generate organism-specific pathway databases 
under controlled chemical vocabularies which have been widely used in metabolic 
reconstructions. The RAST annotation system [30] further complements information from 
biological subsystems with the simultaneous assignment of gene functions across multiple 
genomes, taking advantage of sequence and pathway conservation across species. So-called 
genomic context correlations have also been widely used to improve annotation accuracy and to 
find genes responsible for orphan activities [31-33]. For example, the patterns of gene 
conservation across species have been used to calculate correlations between phylogenetic 
profiles in order to assign functions to genes that co-evolve with genes of known function [33]. 
Similar principles have been applied to other functional correlations such as chromosomal gene 




sequences and do not require the prior definition of metabolic pathways [1]. While each of these 
strategies can lead to improved functional predictions in their own context, integration of 
multiple data types under a unified framework has the potential to advance functional 
annotations beyond any single source of evidence. 
2.4. Data integration for next-generation annotation strategies 
Several partially independent evidence types should converge upon the real function of a 
gene.  As illustrated in Figure 2.3a, while high sequence identity between proteins can often be 
interpreted as evidence of equivalent molecular functions, complementary information can either 
support or contradict a particular assignment. This concept was recently used to predict 
annotation errors based on a combination of sequence identity and the strength of genomic 
context correlations between metabolic neighbors. The method, developed by Hsiao et al. [36], 
allowed the re-annotation of the leucine degradation pathway in the model gram positive 
bacterium Bacillus subtilis. Although this “policing” of biochemical annotations is useful to keep 
annotation databases in check, it does not necessarily point to the correct function of the 







Figure 2.3. Probabilistic metabolic annotations using multiple sources of evidence. (a) 
While sequence identity to previously annotated proteins is typically used to transfer functional 
annotations, additional information such as genome context correlations, structural similarity, or 
expression measurements can either increase (green) or decrease (red) our belief that an 
annotation is correct. When sequence identity is high these additional data can be used to spot 
potential misannotations; when it is low and it supports sequence-based predictions, it facilitates 
enzyme discovery. (b) In a genome-scale context, when multiple potential functions are found 
for each candidate gene, probabilistic annotations can be obtained through sampling from only 
those gene-to-reaction assignments that display high likelihood configurations of sequence 
identity and complementary context information [1]. 
 
Multiple algorithms have been used to combine evidence sources for functional 
assignments of metabolic as well as non-metabolic genes; these include Bayesian networks, 
support vector machines, decision trees, and functional linkage networks, among others (see 
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signaling networks) in that catalytic activities can be mapped to a well-defined network that is 
common across all species. Each enzyme is associated to a reaction or set of reactions such that 
links between metabolic activities can be precisely defined on the basis of shared metabolites 
[38]. The structure of the metabolic network provides a context to consider functional 
correlations between genes, and gene annotations can be optimized to maximize the consistency 
of such correlations in the network. For example, assignments can be made such that co-
expressed genes or genes that are clustered in bacterial chromosomes are responsible for 
consecutive metabolic reactions. Based on this idea, we recently used Gibbs sampling in 
GLOBUS [1] (Chapter 4) to simultaneously annotate all candidate metabolic genes of a species; 
the method assigns probabilities to each possible gene-reaction assignment based on the 
hypothesis that genes close in the metabolic network have strong functional associations with 
each other and have detectable sequence homology to known enzymes with the target functions 
(Fig. 2.3b). Importantly, several different types of context-based and homology-based 
information can be combined to derive such probabilistic predictions [1]. In the context of 
metagenomics data, sampling procedures were recently used to derive the probabilities for the 
presence of specific reactions in a bacterial community based on the enzymes detected in a 
metagenomics sample [39]. An important property of using a global network instead of pathway 
definitions to map gene-gene associations is generality; whereas not all pathways are conserved 
across organisms [40] and their boundaries are not always well defined, a global metabolic 
network represents all currently known biochemistry and is therefore able to represent every 
possible pathway architecture. The structure of the global network was recently combined with 





Binary annotations, which are common among several annotation repositories, can be 
misleading as not all functional assignments are equally good [42]. On the other hand, 
probabilistic approaches such as GLOBUS, not only provide a direct measure of error rates, but 
may result in higher accuracies compared to methods using a simple scoring cutoff. For example, 
a simple Bayesian approach that used sequence identity to predict the probability that a gene 
belongs to one of several functional classes was shown to outperform predictions based on direct 
functional transfer from the top BLAST hit [43]. In summary, a next generation of biochemical 
annotation methods is developing that is able to accommodate diverse types of data in a network 
context, and also provides confidence scores that differentiate reliable from unreliable 
predictions. 
2.5. Converting annotations to phenotypes across thousands of genomes 
While gene annotations, by themselves, give rise to important functional hypotheses 
about microbial systems, they are also the foundation for the reconstruction of network models 
used for system-level phenotypic predictions (Fig. 2.1). Although several methods exist to 
simulate metabolic network behavior (reviewed in [44]), constraints-based analysis has become 
one of the main tools to perform this step. This is mainly because this type of analysis does not 
require detailed knowledge of enzyme kinetics or metabolite concentrations, which are typically 
not available on a genome-wide scale even for the best studied model microorganisms. 
Constraints-based methods like Flux Balance Analysis (FBA) [45], rely on identifying metabolic 
fluxes that optimize one or several objectives (e.g. synthesis of biomass precursors) while 
keeping metabolite concentrations at steady-state given the metabolic networks’ stoichiometric 
matrix [45].  Additional constraints can be applied to limit flux capacity and reaction 




predict gene essentiality [46], viable media for growth [47], genetic interventions for metabolite 
overproduction [48], and potential cross-species interactions [49], among several other 
phenotypes. A thorough review of constraints based analysis methods and their applications can 
be found in [50].  
Enzyme annotations are the main source of information for the reconstruction of genome-
scale metabolic models used in FBA, however, the corresponding lists of reactions are often not 
enough to obtain a (gapless) model amenable for constraints-based analysis. For instance, 
spontaneous reactions or missing enzyme annotations may be needed to allow the synthesis of 
every molecule in the network. Historically, filling of those missing reactions has been done 
through the assembly of pathways and individual gene annotations coupled with manual curation 
supported by organism-specific literature [51]. Because many of the microbial species now 
sequenced and those to come are unlikely to have a vast body of published biochemical 
knowledge, network models must be produced based on high confidence annotations, universal 
sets of reactions and pathways, and experimental data, if available. Given the exponential growth 
of sequence databases, attention is now rising towards the problem of automating metabolic 





Figure 2.4. Strategies for model auto-completion following gene annotation. (a) The initial 
assembly of reactions catalyzed by annotated enzymes may contain gaps that prevent production 
or consumption of specific metabolites (blocked metabolites, red crosses). (b) The GapFill 
algorithm [52] uses mixed integer linear programming (MILP) to find the least number of 
reactions from a reaction repository that allow flux to proceed through blocked metabolites. (c) 
An alternative strategy, starts with a flux-balanced model of all known reactions, and iteratively 
removes reactions that are not needed to maintain a gapless network or have weak correlations 
with already annotated genes; the reactions that are most frequently used across iterations are 
used to reconstruct the final model [53]. 
 
In 2010, Henry et al. [54] built into a single pipeline (Model SEED) the steps for 
annotation, assembly, and refinement of microbial metabolic models. The study demonstrated 
that a draft metabolic reconstruction can be produced for any sequenced species with currently 
available computational tools, and that at least several phenotypes predicted by such models do 
not display much lower accuracy relative to manually curated reconstructions. As access to 
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additional sources of experimental data and novel annotation strategies are developed, the range 
and correctness of predictable phenotypes by these models is likely to increase. Figure 2.4 
describes two different strategies used for model auto-completion following genome annotation. 
Model SEED [54] and MetaFlux [55], for example, use predicted reactions in individual 
metabolic subsystems and mixed integer linear programming (MILP) to find the least number of 
additional reactions from a universal biochemical database needed to produce a gapless model 
[52], i.e. one in which all metabolites in the optimized objective can be synthesized at steady-
state (Fig. 2.4b). A different strategy, implemented in MIRAGE [53], starts with a stoichiometric 
model that includes all reactions from a universal reaction database. The method then uses a 
pruning procedure that keeps high-confidence annotations and reactions likely to be present 
based on functional genomic correlations while maintaining a consistent flux-balanced model 
(Fig. 2.4c). 
Although network reconstructions generated by computational pipelines have yet to 
achieve the accuracy attained by manually curated networks, they significantly reduce the time 
and effort required to obtain a working model, making constraints-based analysis easily available 
for almost any sequenced species. These tools also facilitate cross-species comparisons by using 
standard rules to name reactions and metabolites. Because the same effort goes into building 
each model, this leads to predictions that can often be directly compared without extensive 
model reconciliation [56]. The Model SEED pipeline was recently applied to the reconstruction 
of metabolic models for 37 species of Actinomycetes allowing the analysis of gene and reaction 
conservation and essentiality across this important group of bacteria [57]. Despite their 
shortcomings, automated network reconstructions will play an important role in characterizing 




depend on both the quality of the annotations and the methods that transform them into 
predictive models. 
2.6. Comparing the phenotypic potential of microbial species  
In the context of an expanding catalog of sequenced genomes, it is perhaps the ability to 
do comparative biology that will benefit the most from novel annotation and model 
reconstruction strategies. It has been argued that genome-scale metabolic reconstructions can be 
used in prokaryotic systematics through the prediction of metabolic features (phenotypes) that 
could serve as evolutionary markers [58](Fig. 2.5a). As an example, the comparison of 
metabolic networks across Pseudomonas species served to reveal evolutionary events and strain-
specific metabolic features associated with pathogenic and non-pathogenic lifestyles [59]. In the 
same vein, automated annotation and reconstruction methods can provide relatively uniform 
models for comparative drug target discovery. The ability to predict the essentiality of genes and 
reactions has long been one of the main applications of genome-scale metabolic reconstructions 
[60], as shown in Chapter 5, such efforts can readily suggest potential drug targets against 
pathogenic microbes. As more genomes become available, the comparative analysis of species 
genetic vulnerabilities can be used to detect novel narrow-spectrum drug targets that may help 
reduce the rate of resistance transfer among species [61] (Fig. 2.5b). Notably, as I show in 
Chapter 3, metabolic gene essentiality is typically conserved for about 50 to 70% of essential 
genes depending on the evolutionary distance between species, which provides ample ground for 
the comparative drug-target identification approach. A third example of comparative systems 
analysis is related to microbial cell factories.  Several different methods have been proposed to 
facilitate rational strain design for metabolite overproduction [44]; among these efforts, attention 




of specific byproducts (Fig. 2.5c). For instance, Zakrzewski et al. [62] used 38 genome-scale 
actinobacterial metabolic models to predict the efficiency of each species in producing 15 
different biotechnologically relevant compounds; the study suggested that a large number of 
secondary metabolite biosynthesis genes does not necessarily correlate with higher production 
efficiencies. Such strategies will continue to become more relevant as microbial species from 
diverse environments and their biosynthetic properties continue to be characterized.  
Finally, because individual species do not live in isolation, as the number of high quality 
genomic and metagenomic annotations increases it should be possible to predict cross-species 
metabolic interactions and their joint phenotypes (Fig. 2.5d). Metabolic models were used in the 
past to study the association between sulfate-reducing bacteria and methanogens, producing 
accurate predictions for growth in co-culture [63]. Constraints-based models were also used to 
study general principles facilitating cooperative interactions between species [49]. Modeling 
frameworks that consider individual and community-level fitness criteria to simulate community 
behavior have been developed [64]; these tools, along with deeper or targeted sequencing of 
microbial communities [11] will provide means for the characterization of ecological features at 





Figure 2.5. Applications of genome-scale metabolic reconstructions for a growing catalog of 
sequenced genomes. (a) Accurate metabolic annotations allow the utilization of the presence 
and absence of metabolic pathways and phenotypes to support taxonomic classifications and to 
track evolutionary events leading to phenotypic differences among bacteria [58]. (b) 
Comparative analysis can also be used to reveal differences in gene and reaction essentiality 
between species, which can be used to identify organism-specific drug-targets for narrow-
spectrum antibiotic development [61]. (c) Different strains may respond differently to genetic 
perturbations aimed at metabolite overproduction; systems analysis allows in silico screening to 
identify the most suitable strains for specific bioengineering tasks [62]. (d) As metagenomics, 
metatranscriptomics, and targeted single-cell sequencing become more prominent, systems 
analysis can be used to model and understand cross-species interactions and community function 
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2.7. The road ahead for functional annotations  
Currently, our ability to understand microbial diversity is largely determined by the 
information that can be extracted from genome sequences and other types of high-throughput 
data. Biochemical annotations can uncover microbes’ metabolic potential and allow tracing 
species properties to the activity of particular genes. Functional annotations are also the 
fundamental blocks for the reconstruction of molecular networks used for system-level 
phenotypic predictions and comparative studies. As metagenomics and single-cell studies extend 
genomic coverage into unexplored portions of the microbial world [10], annotations will more 
prominently rely on weak sequence homology to proteins of known function. This situation, 
together with a substantial prevalence of annotation errors in public databases [24, 36], and poor 
agreement between published annotations even for such well-studied species as E. coli [41], calls 
for annotation methods that do not rely on sequence identity alone and are able to deal with 
annotation uncertainty. I have argued that a new generation of methods for biochemical 
annotation should possess several important characteristics: i) allow diverse types of functional 
cues to be included in the annotation process and produce valid predictions even if certain kinds 
of data are missing. ii) Annotations should be probabilistic or at least provide a quantitative 
measure of annotation confidence that tells apart reliable and unreliable predictions. iii) Once 
made, functional predictions should be traceable to the evidence sources supporting a particular 
assignment; for instance by keeping track of the context-based and homology-based scores that 
were combined by the annotation method. iv) The next generation of biochemical annotation 
methods should be network oriented; this not only provides a common context for comparing 




which to consider biochemical functions that is complementary to subsystems or pathways that 
are not necessarily well conserved.  
Considering biochemical annotations in the context of the genome-network-phenotype 
loop illustrated in Figure 2.1 suggests that the processes of data acquisition, gene annotation, 
and model reconstruction and simulation are tightly connected and should not be considered in 
isolation. This opens the possibility of using high-level information such as flux distributions, or 
phenotypic and metabolomics measurements for the accurate identification of gene functions. In 
Section 4.4, using GLOBUS, I demonstrate how these high-order considerations have a 
significant effect on annotation coverage and accuracy. As exploration of the earth’s microbiome 
continues to move forward, I envision flexible computational tools that weight-in virtually any 
available data to provide a genome or metagenome-wide probabilistic landscape of predicted 
metabolic functions and phenotypes. Unbiased whole-network functional annotations and model 
reconstructions will be essential for comparative studies within species and across phylogenetic 






























































LONG TERM PHENOTYPIC EVOLUTION OF MICROBIAL SPECIES 
 
For many decades the comparative analysis of protein sequences and structures has been used to 
understand fundamental principles of molecular evolution [65-67]. In contrast, relatively little is 
known about the long-term evolution of phenotypic and genetic properties. This represents an 
important gap in our understanding of evolution, as exactly these proprieties play key roles in 
natural selection and adaptation to diverse environments. Here we present a comparative analysis 
of hundreds of genome-scale metabolic models to investigate the long-term phenotypic evolution 
of bacteria. The analysis reveals that, in spite of lineage-specific differences, the average long-
term phenotypic divergence of bacterial species can be described by a clock-like exponential 
decay spanning billions of years. The observed trend, with approximately similar fractions of 
phenotypic properties changing per unit time, was validated through experimental profiling of 40 
bacterial species across 62 growth conditions. Although fast phenotypic evolution is frequently 
observed between strains in the same species, a transition from high to low phenotypic similarity 
happens primarily at the genus level. A complementary analysis of gene knockout phenotypes 
suggests that gene essentiality diverges substantially slower than the ability to use different 
nutrients, with a relatively high conservation across lineages. Synthetic lethality, on the other 
hand, diverges much faster.  
3.1. Introduction 
 Prokaryotes are the main agents of biogeochemical transformations and play essential 
roles in the life and health of all multicellular organisms [68]. Despite their recognized 
importance, we still know little about where bacteria live and what roles they play in their natural 




central to characterizing microbial diversity. For more than half a century, the comparative 
analysis of protein sequences and structures has been an essential resource to elucidate the 
mechanisms, constraints, and rates of protein evolution [70, 71]. More recently, the explosive 
growth of genome sequencing (see Section 2.2) made it possible to extend comparative analysis 
to complete genomes and the structures of several molecular networks[72-75]. In stark contrast, 
comparative studies of microbial phenotypic properties remain sparse; these analyses are 
necessary to address several fundamental questions in microbial ecology and evolution 
including: What is the typical variation of phenotypic properties in bacteria? How fast or slow do 
different phenotypic properties change? What processes or evolutionary models can explain 
observed trends of phenotypic evolution? And how does phenotypic variation relate to bacterial 
taxonomy and genetic distance between species? 
Although a large-scale comparative analysis of microbial phenotypes –such as the ability 
to grow on different nutrients or withstand genetic perturbations– is currently challenging due to 
a relative paucity of experimental data, we rationalized that thoroughly validated computational 
methods can be used to investigate the phenotypic evolution of diverse bacterial species. 
Constraints-based analyses of metabolic networks have been successful in predicting various 
phenotypic properties of microbial species. Flux balance analysis (FBA), in particular, has been 
used to accurately predict gene and nutrient essentiality [2, 76, 77], microbial growth rates [78], 
metabolic flux distributions [79, 80], and evolutionary adaptations to environmental and genetic 
perturbations [81-83]. An important advantage of FBA methods is that they generally do not 
require kinetic parameters and rely on stoichiometric models that can be inferred from complete 
genome sequences. The accuracy of FBA methods has been independently demonstrated for 




environments [84]. Recently, sophisticated methods have been developed for the automated 
reconstruction, optimization, and gap filling of flux-balanced stoichiometric models [1, 52, 54, 
55, 85, 86]. Here we take advantage of these methods and use flux balance analysis to investigate 
the long-term evolution of microbial growth and gene-knockout phenotypic properties. 
3.2. Results 
3.2.1. Species considered for in silico phenotyping 
 
Figure 3.1. Phylogenetic tree showing 100 families of 322 bacterial species used in this 
study. The numbers of selected species per family are shown in parentheses. Different colors 
correspond to different classes of bacteria. The tree was built using the neighbor joining 

















We selected for our analysis 322 phylogenetically diverse bacteria (Fig. 3.1) for which 
genome-scale metabolic models were produced using the approach developed by Henry et al. 
[54] (See Methods). To quantify the evolutionary distance between bacterial species we used the 
divergence between their 16S rRNA sequences; 1% 16S RNA distance approximately 
corresponds to 50 million years of divergence since a common ancestor [88, 89].  
3.2.2. Long-term evolution of growth phenotypes 
To investigate the long-term evolution of growth phenotypes we considered 62 carbon 
sources that are commonly used by microbes for growth and energy production [90]. 
Specifically, for each of the considered species we used FBA to determine a subset of the 
compounds that could be used for biomass synthesis or generation of ATP –two of the essential 
metabolic objectives for bacterial growth [91]. This analysis resulted in binary phenotypic 
vectors that describe the ability of each microbial species to utilize each of the considered 
compounds (see Methods). The evolution of these phenotypic vectors, measured as the change in 
phenotypic similarity as a function of species divergence, is shown Figure 3.2A,B; the density 
plots in the figures were calculated based on pairwise comparisons of all considered species. 
Notably, this analysis demonstrates that the long-term evolution of growth phenotypes, averaged 
across species, can be approximated well by an exponential decay: the red lines in the figures 
show a running average of the density plots and the black lines show the exponential fits to the 
data (see Methods). A similar trend was also observed for phenotypic evolution with respect to 
compounds that can be utilized as a nitrogen source (see Supplementary fig. 3.1), and when the 
analysis was repeated testing a larger set of compounds as possible carbon sources 
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Figure 3.2. Evolution of growth phenotypes across bacterial species. The figures show the 
point density for all pairwise comparisons between 322 metabolic models at a given genetic 
distance. A. Similarity of carbon sources that can be used for biomass synthesis as a function of 
the genetic distance between species. The black line indicates an exponential fit of the data; the 
red line shows a 5% genetic distance moving average of the data. B. Similarity of carbon sources 
that can be used for ATP synthesis as a function of the genetic distance between species. C. 
Experimental validation of patterns of phenotypic divergence between bacteria. 40 species were 
tested for their ability to use 62 different carbon sources for growth using phenotypic 
microarrays. Each point in the figure indicates a pair of species. An exponential fit of the 
experimental data is shown in blue, the fits from A and B are shown in red and green, 
respectively. The orange line indicates a 5% genetic distance window moving average of the 





The observed exponential trends suggest that over long evolutionary distances 
approximately similar fractions of phenotypic properties are changing per unit time, as microbial 
species diverge and adapt to different environmental niches. Although the observed phenotypic 
evolution has been continuing for billions of years, for species separated by more than one 
billion years of evolution (~0.2 divergence in Figure 3.2) the divergence of growth phenotypes 
is approaching saturation. The average phenotypic similarity for biomass production (Fig. 3.2A) 
at these long evolutionary distances is ~25%, which  is close to the value expected by chance 
given the relative frequency with which each of the considered compounds is used across models 
(Supplementary fig. 3.3). About half of the carbon sources shared at long evolutionary distances 
corresponds to metabolites that are used by more than 90% of the species (Supplementary table 
3.1). Frequently used compounds include sugars such as D-glucose, D-fructose, D-mannose, and 
D-maltose, which are typical substrates of glycolysis, and organic acids such as L-lactate, L-
glutamate and L-malate. 
Notably, before the evolution of growth phenotypes settles into the aforementioned 
average trend (distances <0.01 in Fig. 3.2), we observe an initial burst, .i.e. significantly higher 
rate, of phenotypic evolution. This results in an average phenotypic similarity at close genetic 
distances of about 75%. Such a rapid phenotypic evolution is a common hallmark of speciation 
and other important evolutionary transitions representing diversification to adapt to new habitats 
or host species [92-94]; it also reflects the underlying genomic plasticity of bacterial pan-
genomes [6], which is a result of homologous recombination, mutation and horizontal gene 





3.2.3. Experimental validation of observed trends 
To experimentally validate the predicted patterns of long-term phenotypic evolution, we 
selected 40 diverse microbial species (Supplementary fig. 3.4) for phenotyping using Biolog 
Phenotype MicroArrays (PMs) [90]. PM technology is based on the reduction of a tetrazolium 
dye which allows quantifying the metabolic activity of microbes across different growth 
conditions [97]. PM-based phenotyping has been previously used for bacterial strain 
identification, characterization of metabolic properties of diverse microbes, and the curation of 
genome-scale metabolic reconstructions, among several other applications [98, 99]. We used 
PMs to determine the ability of each of the selected bacteria to utilize the 62 different carbon 
sources used in the FBA simulations. As shown in Figure 3.2C we found a very good agreement 
between the average trends of phenotypic change as a function of genetic distance based on the 
experimental data and the computational predictions. The correspondence was further supported 
by a strong correlation (Pearson’s r=0.75, p-value=3x10
-9
) between the experimental and 
predicted similarity values for the 10 species present in both the computational and experimental 
analyses (Supplementary fig. 3.5). 
3.2.4. Possible drivers of phenotypic divergence 
There are several known examples of rapid bacterial evolution for species undergoing 
massive gene loss [100, 101]. Therefore, we investigated the extent to which phenotypic variance 
across bacteria can be explained by the size difference between species’ metabolic networks 
(Fig. 3.3A). At close genetic distances the fraction of phenotypic variance explained by size 
differences for all microbial species is about 20% (Fig. 3.3A, gray bars). This fraction decreases 




considered (Fig. 3.3A, red bars), the fraction of explained phenotypic variance increases to about 
30% at close distances. Host-associated bacteria that acquire a symbiotic lifestyle frequently 
loose multiple biosynthetic pathways while adjusting their metabolism to the environments and 
nutrients available in their hosts [102-104]. 
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Figure 3.3. Drivers of fast and slow phenotypic change. A. Fraction of phenotypic variance 
explained by the relative size difference of metabolic networks at different genetic distances. 
Size differences are based on the number of reactions in each species’ metabolic model; absolute 
differences were divided by the average number of reactions in each species pair. Error bars 
represent the R2 standard error. Values correspond to the square of the Pearson correlation 
coefficient between size difference and phenotypic similarity (biomass) at each bin. 
Supplementary figure 3.6 shows the results for the similarity of carbons sources used for ATP 
production. B. Fold-change in the fraction of reaction differences for various metabolic subsets 
as a function of the genetic distance between species. Fold-change is calculated relative to the 
fraction of reaction differences between metabolic networks for the first bin. The lines 
correspond to a moving average across genetic distances (window=0.2, step=0.05).  
 
Other than massive gene losses, phenotypic change can also be explained by the types of 
reactions that are changed between metabolic networks. In agreement with previous studies [40, 
105], we found that at close genetic distances (<0.05, Supplementary table 3.2) there is a 
significant overrepresentation of reaction differences related to secondary metabolism and 




metabolism are underrepresented. As the genetic distance between species increases (Fig. 3.3B) 
the fraction of differences in central metabolic processes goes up while the fraction in peripheral 
pathways becomes less prominent.  
3.2.5. Phenotypic similarity in the context of bacterial taxonomy 
We next investigated the diversity of metabolic phenotypes within different levels of 
conventional taxonomic classification (Fig. 3.4). The figure shows the distribution of phenotypic 
similarities –based on carbon source usage for growth– for pairs of bacteria related at different 
taxonomic ranks. Bacteria from the same species show mostly similar phenotypic properties; 
nevertheless, as apparent from the long left tail of the distribution, some organisms can show 
substantial phenotypic differences even at this taxonomic level. The relatively high average 
phenotypic similarity at the species level indicates that currently used criteria to define microbial 
species [106], usually correctly delineate clusters of phenotypically related organisms. Notably, 
at the genus level the distribution is very broad and multimodal, with some bacteria displaying 
high levels of phenotypic similarity, and some others showing differences that are more typical 
of the higher ranks. Beyond the genus, for species related at the levels of family, order, class, and 
phylum there is in general little change in average phenotypic similarity, which remains low at 
about 30-40%. Comparison with experimental data at each taxonomic rank shows good 





Figure 3.4. Phenotypic similarity distribution at different taxonomic ranks. The figure 
shows the frequency distribution of carbon source similarities for pairs of species related at a 
given taxonomic level. The stars indicate the average values for available experimental data; the 
dark gray line connects the mean values at each taxonomic level.  
 
3.2.6. Using metabolic phenotypes as classification markers 
Although it is generally accepted that bacterial species should be soundly predictive of 
the phenotypic potential of a strain [107], common species definition criteria (e.g. based on 
DNA-DNA hybridization or 16S rRNA gene sequence identity [106]) have been criticized for 
resulting in too much phenotypic variation within a named species [107]. Indeed, despite being 
more phenotypically similar than strains related at broader taxonomic ranks (Fig. 3.4), strains in 
the same species still differ by an average 20-25% of the carbon sources they can use for growth. 
The frequency distributions in Figure 3.4 are very wide (range ~80%), and all of them overlap 
with each other to some extent; this suggests that multiple pairs of strains could be more or less 




Although several methods have been proposed to build phylogenetic trees based on genomic data 
[108], the flux analysis approach can provide complementary information by directly considering 
a variety of phenotypic properties to determine associations between bacteria. 
 
Figure 3.5. Phenotypic tree of 322 phylogenetically diverse bacterial species. The tree is 
based on the Jaccard distances of binary vectors representing the ability of species to use 
different carbon sources for growth. 443 carbon containing compounds were tested as possible 
carbon sources.   
In Figure 3.5, using the neighbor joining algorithm [87], we show a ‘phenotypic tree’ for 
the 322 bacteria considered in this study. The tree is based on the Jaccard distance (1 minus 
phenotypic similarity) between carbon source utilization vectors; each node in the tree 
corresponds to one of the 322 strains and colors correspond to different classes of bacteria 
(similar to Fig. 3.2). Notably, while phenotypic proximity generally groups bacteria belonging to 



























different groups are closer to each other than they are to more phylogenetically related strains. A 
closer inspection of these cases revealed multiple ecological similarities between widely 
diverged bacteria. For example, we identified a tight cluster of phylogenetically distant species –
Aquifex aeolicus (Aquificae), Thiomicrospira crunogena (Gammaproteobacteria) and 
Sulfurimonas denitrificans (Epsilonproteobacteria)– which are all sulfur-oxidizing, thermophilic 
bacteria. We also found a higher than expected phenotypic similarity between bacteria in the 
genera Mycoplasma (Mollicutes) and Chlamydia/Chlamydiophila (Chlamydiia), all displaying 
and obligate intracellular lifestyle. On the same vein, Mycobacterium tuberculosis 
(Actinobacteria) and Legionella pneumophilla (Gammaproteobacteria), both of which are known 
to infect human macrophages, were found together in the phenotypic tree. Another interesting 
association was that of Clostridium difficile and C. botulinum (Clostridia) with species that also 
find their habitat in the human gastrointestinal tract such as Enterococcus faecalis and 
Lactobacillus plantarum (Bacilli).  
Our analysis identified multiple species of Burkholderia (Betaproteobacteria) and 
Pseudomonas (Gammaproteobacteria) which despite being related only at the phylum level show 
a relatively high level of phenotypic similarity (~60%). Interestingly, Burkholderia species were 
initially classified as part of the genus Pseudomonas, but they were later re-classified based on 
several genetic and biochemical characteristics [109]. Importantly, these two groups of species 
share several interesting biological properties such as their occurrence as human and plant 
pathogens [110], and their reported co-existence in specific microbial consortia in environments 
such as the rizosphere and waste water sludge [111, 112]. These observations suggest that in 
silico profiling of bacterial metabolic properties could, in some cases, support a more phenotype-




The above results suggest that ‘phenotypic trees’ can be used as a tool to generate and 
evaluate hypotheses about microbial ecology. First, unrelated species that are close in phenotypic 
space potentially share common lifestyles and biochemical characteristics. Experimentally 
measured phenotypes, e.g. through phenotypic microarrays, and careful curation of the metabolic 
models can further validate these commonalities. Second, flux analyses of bacterial strains 
sequenced from a single location or microbial consortia could reveal the extent to which different 
environments select for bacteria with specific characteristics. In particular, the presented 
approach could be used to measure phenotypic distances between bacteria within a particular 
environment, and contrast these distances with the expected similarity based on their 
taxonomic/genetic proximity. As the quality of automated reconstructions improves, and 
sequencing of single cells directly from the environment [11] continues to expand, in silico 
phenotyping will play an important role in microbial ecological theory. 
3.2.7. Evolution of gene essentiality and epistasis 
To complement our analysis of metabolic growth phenotypes, we used FBA to 
investigate the long-term evolution of genetic phenotypes. Specifically, we considered the 
evolution of metabolic gene essentiality and gene-pair synthetic lethality (i.e. the evolution of 
genetic interactions) between bacterial species. To test these genetic phenotypes we determined 
the ability of each species to synthesize biomass on rich media, i.e. when all nutrients were 
available to the models, after in silico removal of model reactions corresponding to the metabolic 
genes considered (see Methods). The analysis demonstrated that the long-term evolution of gene 
essentiality can also be well described by an exponential decay (Fig. 3.5A, red line – moving 
average, black line –exponential fit). Nevertheless, the average evolution of reaction essentiality 




compared to the evolution of metabolic growth phenotypes (Fig. 3.2). The results suggest that 
even at long evolutionary distances, for an average pair of microbial species, about half of the 
conserved essential genes in one species remain essential in the other. Notably, the 
computationally predicted trend is consistent with available experimental data (Fig. 3.5A, black 
dots) for microbial species with high-quality genome-wide gene deletion screens.  
In stark contrast to gene essentiality, our analysis revealed a very fast divergence of 
genetic interactions between metabolic genes (Fig. 3.5B).  Even at close evolutionary distances 
synthetic lethality is conserved only for about 30% of metabolic gene pairs. As bacterial species 
diverge, synthetic lethality quickly drops further to about 5%. This demonstrates that synthetic 
lethality similarity is much more sensitive to changes of microbial genotypes than gene 
essentiality and growth-related phenotypic similarities. Only several comprehensive attempts 
have been made to experimentally assess the conservation of genetic interactions. Comparison of 
fitness data from budding and fission yeast revealed a similarity of ~26% [113]. On the other 
hand, only 5% of the orthologs of epistatic gene pairs in yeast were also found to be epistatic in 
Caenorhabditis elegans [114]. Although these data were obtained from eukaryotes, the 
experimental results (Fig. 3.5B, black dots) are generally consistent by the bacterial simulations, 















































































Figure 3.6. Similarity of metabolic gene essentiality and synthetic lethality across bacterial 
species. A. Density plot for the similarity of gene essentiality as a function of the genetic 
distance between species. Black lines indicate exponential fits of the data, red lines represent a 
5% genetic distance moving average. Black dots indicate experimentally derived results from 
metabolic gene knockout experiments based on all pairwise comparisons between Escherichia 
coli [115], Bacillus subtilis [116], Streptococcus sanguinis [117], Salmonella enterica [118] and 
Caulobacter crescentus [119]. B. Density plot for the similarity of gene-pair synthetic lethality 
as a function of species’ genetic distance. Black and red lines are as in A. The black dots 
represent experimentally determined values of synthetic lethality conservation between budding 
and fission yeast [113], and between budding yeast and C. elegans [114]. 
 
3.3. Discussion 
Analysis of phenotypic evolution, such as the morphological variation of beaks in 
Darwin’s finches [120], provided the original impetus and context for understanding natural 
selection. Understanding of phenotypic diversity within and between species continues to be an 
important area of biological research [50, 121-123]. Because the evolutionary significance and 
physiological role of different phenotypic traits change over time, it is often difficult to establish 
a clear mapping between genotypes and phenotypes for metazoans, in particular across long 




different nutrient sources, although clearly not the only important phenotype, always remains an 
essential determinant of bacterial fitness and lifestyle. Flux analyses of metabolic networks 
provide a relatively straightforward connection between genotype and phenotype. Using these 
tools and properties of microbial metabolism we were able to trace phenotypic change across 
four billions years of bacterial evolution. Notably, the observed clock-like behavior of 
phenotypic divergence is reminiscent of the molecular clock in protein evolution [65, 71]. 
Similar to protein evolution, it is likely that the long-term trends for phenotypic divergence are 
due both to bacterial adaptation to diverse environmental niches and neutral changes [93, 124-
126]. The relative contribution of adaptive and neutral changes is likely to be different in each 
particular linage and evolutionary context. Our analysis shows that growth phenotypes, gene 
essentiality, and synthetic lethality diverge with different rates and respond differently to 
changes in bacterial genotypes. It is likely that other phenotypic properties, such as the ability to 
produce different compounds or withstand specific environmental perturbations, will also show 
distinct evolutionary patterns. Similar analyses performed on defined subsets of bacteria can be 
used to predict ecological relationships between species and provide clues about the evolutionary 
forces acting on different lineages. As genome sequencing is currently expanding at an 
unprecedented rate [8] and metabolic reconstruction methods are continuously improving  
(Chapter 2), it will be possible to construct in the near future a detailed map of phenotypic 













3.4.1. Model selection  
We obtained 322 genome-scale metabolic network models using the method of Henry et 
al. [54], including 123 models discussed in their original publication. The remaining 199 models 
were selected such that the reconstruction strategy used less than 20% reactions not supported by 
gene annotations to produce flux-balanced models of the corresponding species. We decided to 
ignore all genomes in the order Enterobacteriales for two reasons; first, there were significantly 
more genomes for this group than other sets of bacteria, which would significantly bias the all-
against-all results. Second, gene annotation for these species displays a higher coverage than 
most other bacteria due to the close phylogenetic proximity to the well-studied model bacteria E. 
coli, which would produce numerous metabolic differences more often related to the 
completeness of the models than the underlying biology [56].  
3.4.2. Flux balance analysis 
Flux balance analysis finds feasible values of metabolic reaction fluxes subject to 
reaction stoichiometry constraints and the assumption of steady state of metabolites. These 
values are typically selected to maximize a specific objective such as biomass or ATP 
production. Additional constraints can be used to assign upper and lower bounds to fluxes going 
through specific reactions or reaction combinations  [45]. In order to simulate the ability of 
species to use different carbon sources for growth or energy (ATP) production, we first 
simulated a carbon limited growth condition. To do this, a constraint was added such that the 
total number of carbon atoms going through the full set of metabolite uptake reactions was below 




constraint. For each compound tested, we ran FBA using the same conditions, but allowing a 
larger flux through the uptake reaction of the corresponding compound. If the resulting biomass 
or ATP produced was higher than the original value, we concluded that such compound could be 
used by the bacterium. The 62 compounds that we tested correspond to carbon sources typically 
assayed in Biolog [90] experiments that could be mapped to compounds in the metabolic 
reconstructions. An analogous procedure was used to test for nitrogen source phenotypic 
similarity.  
To test for gene essentiality, based on the gene-reaction associations encoded in each 
model, we set the maximum flux through the reactions that depended on each gene to zero, and 
solved FBA for maximal biomass production. If biomass could not be produced, the 
corresponding genes were labeled as essential. A pair of non-essential genes was considered to 
be synthetic lethal if simultaneous deletion of the pair of genes resulted in zero biomass 
production as predicted by FBA. These simulations were made on an in silico rich medium, 
meaning that fluxes were allowed through every transport reaction present in the metabolic 
networks. 
All FBA problems were solved using the COBRA toolbox [127]. 
3.4.3. Measuring phenotypic similarity 
 For a set of features, i.e. essential genes, epistatic gene pairs, or carbon sources that can 
support growth, similarity between two species was measured using Jaccard’s similarity index 
[128], which is defined as the size of the intersection divided by the size of the union between 
two sets. For example, if A represents the set of carbon sources that can be used by species a, 
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Importantly, to assess the similarity of gene essentiality and gene pair synthetic lethality 
we only considered genes shared between metabolic networks. Orthologous genes were 
identified as bi-directional BLASTP [18] hits with an e-value cutoff of (0.05).  
3.4.4. Validation with Biolog phenotypic arrays 
 40 species spanning a wide range of phylogenetic distances (Supplementary fig. 3.4) 
were tested against a panel of 62 carbon sources using Biolog phenotypic microarrays [90]. The 
Biolog system uses a colorimetric technique to provide a quantitative measure of microbial 
respiration in the presence of specific compounds. Results for each species were normalized to a 
scale of 0 to 100; we considered any value above 5 to be positive for growth on a given carbon 
source and any value below to be negative. Similar results were obtained at other cutoff values.  
3.4.5. Exponential decay fits  
Pairwise comparisons of phenotypic similarity (y) as a function of genetic distance (x) 
were fitted using the following formula: 
          
In the above equation, a represents the saturation level at long distances, a+b represent the 
phenotypic similarity at zero genetic distance, and c measures the decay rate, with lower (more 






3.6. Supplementary figures and tables 









































Supplementary figure 3.1. Evolution of phenotypic similarity based on the fraction of shared 
nitrogen sources that can be used for growth. The graph shows the point density at a given 
genetic distance for pairwise comparisons between 322 species. The red line is a 5% genetic 
distance moving average, and the black line is an exponential fit of the data. Results are based on 
the utilization of 74 nitrogen sources typically tested in phenotypic microarrays. 





























   62 carbon sources
 145 carbon sources
 443 carbon sources
 
Supplementary figure 3.2. Evolution of phenotypic similarity for different sets of carbon 
sources. Thin lines are a moving average of the data (window size 1%, step size 0.2%) and thick 
lines are an exponential fit. The set of 145 carbon sources includes the 62 compounds used in our 
main analysis as well as 83 other carbon sources typically tested in phenotypic microarrays. The 
set of 443 carbon sources includes all possible compounds containing carbon that were present 




































 322 model prediction
 Random expectation
 
Supplementary figure 3.3. Null expectation of phenotypic similarity. The figure shows the 
average phenotypic similarity for all pairwise comparisons between 322 species as a function of 
genetic distance (black), and the average similarity when the same number of compounds used 
by each species is chosen at random according to the frequency with which those compounds are 
used across the 322 models (red).  
 
Supplementary figure 3.4. Phylogenetic tree for the 40 species used for experimental 
validation. Different colors indicate different classes of bacteria. The tree is based on the 16S 
rRNA distance between species. Asterisks mark the species that were present in the set of 322 




































Predicted carbon source similarity
 
Suplementary figure 3.5. Correlation between predicted and measured phenotypic similarity. 
Data is for all pairwise comparisons between the 10 species in common between the set of 322 
models used for computational predictions and the set of 40 used for validation. Pearson’s 
r=0.75, p-value=3x10
-9 
Spearman’s r: 0.66, p-value=7x10
-7
. 















































Supplementary figure 3.6. Phenotypic variance explained by size differences as a function of 
genetic distance. Values correspond to the square of the Pearson correlation coefficient between 
size difference and phenotypic similarity at each bin. Phenotypic similarity is for the fraction of 







Supplementary table 3.1. Frequency of metabolite usage as a carbon source across 322 species 
(ranked by frequency) as predicted by FBA. 
Metabolite name Number of models Metabolite name Number of models 
L-Glutamic Acid 222 D-Sorbitol 63 
a-D-Glucose 210 D-Gluconic Acid 58 
D-Fructose 198 D-Galacturonic Acid 58 
L-Malic Acid 173 Mucic Acid 55 
L-Lactic Acid 171 D-Saccharic Acid 55 
Maltose 158 D-Galactose 48 
Glycerol 142 D-Raffinose 30 
L-Serine 133 Dextrin 29 
L-Arginine 132 N-Acetyl-b-D-Mannosamine 28 
L-Aspartic Acid 127 g-Amino-Butyric Acid 27 
D-Mannose 122 L-Rhamnose 27 
Citric Acid 118 Salicin 26 
N-Acetyl-D-Glucosamine 114 D-Glucose-6-Phosphate 24 
D-Trehalose 104 Propionic Acid 16 
Sucrose 94 D-Melibiose 16 
L-Histidine 93 D-Aspartic Acid 16 
Inosine 92 Quinic Acid 15 
a-Keto-Glutaric Acid 89 L-Fucose 13 
L-Alanine 81 m-Inositol 13 
Formic Acid 80 Stachyose 9 
D-Glucuronic Acid 79 N-Acetyl-Neuraminic Acid 8 
a-D-Lactose 75 D-Arabitol 7 
D-Serine 74 Acetic Acid 7 
Acetoacetic Acid 74 N-Acetyl-D-Galactosamine 6 
D-Cellobiose 71 D-Fructose-6-Phosphate 5 
D-Mannitol 68 a-Keto-Butyric Acid 4 
D-Malic Acid 64   
 
Supplementary table 3.2. Overrepresentation of functional categories for reaction differences 
between species at close genetic distances (genetic distance < 0.05), relative to random species 
pairs.  
Functional category Sense Fraction of differences: 
Close species/Random pairs 
P-value* 
Nucleotide Underrepresented 0.69 5E-34 
Central carbon Underrepresented 0.73 1E-26 
Vitamin / cofactor Underrepresented 0.86 2E-06 
Aminoacid Underrepresented 0.92 2E-04 
Lipid / cell wall Underrepresented 0.94 6E-04 
Other carbon -- 1.04 3E+00 
Other nitrogen -- 1.05 8E+00 
Other Overrepresented 1.25 3E-40 
Transport Overrepresented 1.32 7E-24 
Secondary metabolism Overrepresented 1.53 7E-51 


















































Chapter 4.  
 
GLOBAL PROBABILISTIC ANNOTATION OF METABOLIC NETWORKS ENABLES 
ENZYME DISCOVERY  
 
This chapter is based on “Plata, G., Fuhrer, T., Hsiao, T., Sauer, U., Vitkup, D. Global 
Probabilistic Annotation of Metabolic Networks Enables Enzyme Discovery. Nat. Chem. 
Biol. (10):848-54, (2012)” 
 
Annotation of organism-specific metabolic networks is one of the main challenges of systems 
biology. Importantly, owing to inherent uncertainty of computational annotations, predictions of 
biochemical function need to be treated probabilistically. We present a global probabilistic 
approach to annotate genome-scale metabolic networks that integrates sequence homology and 
context-based correlations under a single principled framework. The developed method for 
global biochemical reconstruction using sampling (GLOBUS) not only provides annotation 
probabilities for each functional assignment but also suggests likely alternative functions. 
GLOBUS is based on statistical Gibbs sampling of probable metabolic annotations and is able to 
make accurate functional assignments even in cases of remote sequence identity to known 
enzymes. We apply GLOBUS to genomes of Bacillus subtilis and Staphylococcus aureus and 
validate the method predictions by experimentally demonstrating the 6-phosphogluconolactonase 
activity of YkgB and the role of the Sps pathway for rhamnose biosynthesis in B. subtilis. 
 
4.1. Introduction 
Advances in DNA sequencing technologies and high-throughput experiments provide a 




perspective seeks to understand how the interaction between multiple genomic components 
determines cellular physiology. Genome-scale metabolic networks serve as an important 
platform for such systems analyses and have been very successful in predicting various emergent 
properties of biological systems. They also have great potential for guiding metabolic 
engineering [129] and aiding drug target discovery [130]. Unfortunately, accurate manual 
annotations of organism-specific metabolic networks are laborious and can take up to a year for a 
typical microbial genome. Efforts have been made to automate the reconstruction process, 
particularly the initial steps of genome annotation and network assembly [85, 86, 131, 132]. 
The annotation process usually relies on sequence homology methods, in which the 
function of a metabolic gene is assigned based on sequence similarity to known enzymes [133]. 
Although homology methods have been successful overall, annotations established based solely 
on weak sequence identity are often unreliable due to frequent functional divergence between 
distant homologues. It was demonstrated that a sequence identity above 60% is usually required 
to accurately transfer a precise enzyme function, i.e. all four digits of an Enzyme Commission 
(EC) number [20]. Consequently, homology-based methods fail to assign functions to a 
substantial fraction of genes in completely sequenced genomes [134] and have been known to 
produce multiple imprecise or incorrect annotations [24, 36, 135]. 
The metabolic network reconstruction for a given genome is usually performed based on 
a functional annotation of all metabolic genes. Functional databases such as BRENDA [136], 
GeneCards [137], KEGG [131], MetaCyc [138] or Swiss-Prot [139] are useful resources for 
establishing initial associations between metabolic genes and corresponding biochemical 
reactions. Draft metabolic models are typically reconstructed by assembling annotated 




are annotated individually rather than being considered together in a proper network context. 
Therefore, some successful computational approaches utilize pre-defined or manually curated 
metabolic pathways [28] and subsystems [30] to annotate network reactions. Naturally, the 
accuracy of such methods depends both on the quality of the initial annotation and the 
evolutionary conservation of reference pathways. 
Context based methods such as phylogenetic profiles [140], protein fusions [35], gene co-
expression [141], and chromosomal gene neighborhood [34, 142] capture conserved functional 
relationships and often provide information complementary to sequence homology [143]. The 
effectiveness of these methods has been shown by determining members of protein complexes, 
functional modules, and molecular pathways [144, 145]. Multiple studies have also demonstrated 
that context associations combined with local network structure can be used to identify genes 
responsible for orphan metabolic activities and to improve existing annotations of metabolic 
genes [31, 33, 146]. Therefore, it is natural to combine sequence homology and context 
functional descriptors using a unified probabilistic framework.  
Although powerful probabilistic approaches, such as Bayesian and Boolean networks 
[147], have been applied to reconstruction of regulatory and signaling networks based on high-
throughput data [148], global probabilistic methods to annotate metabolic networks have not 
been developed. Here, we present such a global probabilistic approach that integrates sequence 
homology and context associations to annotate genome-scale metabolic networks. The method 
for Global Biochemical reconstruction Using Sampling (GLOBUS) not only provides annotation 
probabilities for each gene and each metabolic activity, but also suggests possible alternative 




evaluate the accuracy of the reconstructed networks, and experimentally validate three B. subtilis 
predictions that have important functional consequences. 
4.2. Results 
4.2.1. Strategy of a global probabilistic reconstruction 
The conceptual outline of GLOBUS is shown in Figure 4.1. First, we built a generic 
metabolic network containing all possible metabolic activities characterized in the Enzyme 
Commission (EC) system (http://www.chem.qmul.ac.uk/iubmb/enzyme/). Nodes of this EC 
network represent known enzymatic activities (Fig. 4.1a), and network edges are established by 
metabolites shared between the activities either as substrates or products [38]. The usage of the 
global EC network allowed us to consider gene function in a proper network context without 
predefining metabolic pathways. With the EC network as a scaffold, the global metabolic 
reconstruction for a given organism is equivalent to assigning metabolic genes to their correct 
network locations (Fig. 4.1b). In this way, organism-specific networks will occupy a subset of all 
possible locations (activities) in the global EC network. 
A gene assigned to its correct network location usually has at least remote sequence 
identity to enzymes known to catalyze the corresponding activity. In addition, a correctly 
assigned gene often has good context correlations with its network neighbors. As we 
demonstrated previously, the genes with high mutual context correlations tend to be located 
closer in metabolic networks [33]. For example, in Supplementary figure 4.1 we show that the 
higher a context correlation between a pair of Saccharomyces cerevisiae genes, the more likely 




In GLOBUS we used sequence homology and context correlations to evaluate a given 
global assignment of multiple metabolic genes into a set of network locations using a Markov-
like fitness function. The contribution of each gene to the fitness function depends on the 
sequence identity to the assigned location and the context correlations with the genes assigned to 
neighboring network positions. The overall GLOBUS fitness function E(g1, g2, …., gn) (see 
Methods), which is calculated based on a given assignment of metabolic genes (g1, g2, …., gn), 
consists of the following terms: 
 (          )                                                                                             
where fs are various homology-based and context-based functional descriptors, and bs are 
corresponding positive coefficients representing weights of each descriptor in the fitness 
function. For homology descriptors we used two separate terms: 1.) the highest sequence identity 
to a Swiss-Prot [149] protein annotated to catalyze the corresponding activity in other species 
(annotations marked as based exclusively on computational methods were excluded), and 2.) a 
binary (0 or 1) descriptor indicating if a protein ortholog in another species is annotated to 
catalyze the activity (see Methods). For context-based descriptors we used three types of gene-
gene correlations: phylogenetic profiles (which quantify the co-occurrence of gene orthologs 
across species, see Methods), chromosomal gene clustering across sequenced genomes, and 
mRNA co-expression. For each context descriptor, we considered the maximum correlation Z-
score (see Methods) between the gene under consideration and genes assigned to neighboring 
network locations. In addition, we also considered a context term describing the co-occurrence 
across sequenced genomes of various metabolic activities according to annotations available in 




Using the described fitness function the global probability for a particular assignment of 
multiple genes into their network locations is given by P(g1, g2, …., gn) based on the relationship 










    
, where E(g1, g2, …., gn) is the aforementioned fitness function, and Z is a normalizing partition 
function, which is necessary to insure that probabilities of all possible metabolic assignments 
sum to one. Using the defined probabilities we sampled from all possible assignments 
proportionally to their likelihood using Gibbs sampling [151]. Gibbs sampling is a version of 
Markov Chain Monte Carlo (MCMC) [152] and has been successfully used in many 
computational biology applications, such as finding transcription factor binding sites in a set of 
DNA sequences [153]. The efficiency of the Gibbs sampling in GLOBUS is due to the fact that 
although there is a combinatorially large number of possible metabolic assignments, the vast 
majority of them have very low probabilities. Gibbs sampling allows to efficiently sample the 





Figure 4.1. Overview of the GLOBUS method. (a) A generic Enzyme Commission (EC) 
network is defined where nodes represent all known biochemical activities and edges represent 
connections between the activities established by shared metabolites. (b) For a genome of 
interest, the potential network locations of each gene are assigned based on sequence homology 
to known enzymes. (c) Each gene is initially assigned randomly to one of its possible locations. 
A fitness function is defined such that assignments to locations with high sequence identity and 
good context correlations with neighboring genes correspond to higher values of the fitness 
function (higher probability). (d) Gibbs sampling is used to sample all possible assignments of 
genes to their candidate network locations. At each step of a Gibbs chain a random gene is 
selected and re-assigned to one of the possible locations (arrows). The marginal probabilities for 
assigning every gene to each candidate network location are derived from converged Gibbs 
chains. 
A step in a Gibbs chain was simulated by: 1.) selecting a random gene assigned to a 
particular network location, 2.) determining the probabilities for all possible locations of the 
selected gene, including the present location, and 3.) re-assigning the gene to a location 
according to the calculated probabilities (Fig. 4.1c-f). In the sampling we only considered the 
locations with at least remote sequence identity to the corresponding gene. In addition to possible 




the move to the out-of-the-network node was also considered. The energy contribution to the 
fitness function for all genes located in the out-of-the-network node was the same. The energy in 
the out-of-the-network node is a parameter of the simulation (see below), it ensures that genes 
with little sequence identity or context correlation to any network location have a low probability 
of being assigned to an EC number. Importantly, we empirically established the absence of 
ergodicity problems in Gibbs sampling of microbial genomes. In other words, the annotation 
probabilities converged to essentially the same values for chains started from different random 
assignments; after about 20,000 iterations the maximum probability difference across all genes 
was < 1%. Based on the convergent Gibbs chains we obtained the marginal probabilities for each 
metabolic assignment, consistent with the global fitness function. 
4.2.2. Optimization of the fitness function parameters 
The GLOBUS fitness function contains several important adjustable parameters bs, that 
represent relative weights of several sequence and context correlations. The values of these 
parameters significantly affect the sampling and the resulting gene annotation probabilities. To 
learn the parameters we applied a maximal likelihood approach using a well-annotated metabolic 
model of S. cerevisiae (iLL672 [154]). Specifically, following the approach commonly used in 
MRF [150], we optimized the fitness function parameters to maximally increase the product of 
the probabilities for correct gene assignments in the yeast network. Multiple simulated annealing 
[155] runs were used to the search the parameter space for maximal likelihood values. 
Importantly, in searching for the parameters over-fitting was not an issue as many hundreds of 
known metabolic annotations (485 yeast genes with EC numbers in the iLL672 model) dominate 
the number of optimized parameters (7 parameters in total). As a result of the maximum 




probability of 0.617, and an overall prediction accuracy of 80.5%, i.e. the overlap with the 
iLL672 model when genes were assigned to their most probable locations. Using more recent 
metabolic models of S. cerevisiae (iMM904 [156]) or  B. subtilis (iBsu1103 [157]) for 
optimization resulted in similar parameter values and similar GLOBUS probabilities 
(Supplementary fig. 4.2). Thus, we used the parameters optimized with the iLL672 model for 
GLOBUS metabolic annotations in other species. 
4.2.3. GLOBUS precision-recall performance  
 To understand the utility of GLOBUS for metabolic network annotations we applied it to 
the genomes of a gram-positive model bacterium, B. subtilis, and a medically important 
bacterium, S. aureus. The genomes of these bacteria contain 1244 (B. subtilis) and 854 (S. 
aureus) genes with at least remote sequence identity to known enzymes in other species. Several 
curated metabolic models are also available for these species: iYO844 [158] and iBsu1103 [157] 
for B. subtilis and iSB619 [159] for S. aureus. The parameters optimized using the yeast model 
(see above) were used in Gibbs sampling of all possible metabolic assignments in the two 
bacteria. The GLOBUS annotation probabilities were generated and precision-recall curves 
calculated (Fig. 4.2a) based on comparison with the corresponding curated models. For 
comparison we also show in the figure the precision-recall curves calculated based only on 
sequence identity to enzymes in other species; similar results were obtained using either BLAST 
or PSI-BLAST [18] (Supplementary fig. 4.3). The precision-recall calculations demonstrate that 
GLOBUS significantly outperforms homology in the areas of high recall and high precision. 
Further analysis (Fig. 4.2b,c) demonstrates that the main source of the superior GLOBUS 




enzymes. In Figure 4.2b we show the recall (at 70% precision) for gene annotations in B. 
subtilis and S. aureus as a function of sequence identity to known enzymes. GLOBUS recovers 
significantly more correct assignments compared to homology (10, P < 4x10-4 for B. subtilis and 
14%, P < 5x10-5 for S. aureus using 
2
 test), especially for cases with less than 40% sequence 
identity. In Figure 2c we show that at the same level of recall (90%) GLOBUS achieves 
significantly higher precision (9-11% more). The difference in precision is again highest for 
genes with low sequence identity to known enzymes (Supplementary fig. 4.4).  
To investigate the contribution of individual context correlations to the GLOBUS 
performance, we optimized the coefficients of the fitness function without each context 
descriptor. We then compared the precision and recall values for predictions using all context 
correlations and predictions obtained without individual correlations (see Supplementary fig. 
4.5). This analysis showed that all correlations contribute to the method accuracy and that – 
similar to the complete fitness function - the effects of the individual context correlations are 



































































































Sequence identity (%)  
Figure 4.2. GLOBUS precision-recall performance. Using available metabolic models 
(iBsu1103 [157] for B. subtilis and iSB619 [159] for S. aureus) we compared predictions by 
GLOBUS to predictions made using sequence homology; predictions for B. subtilis are on the 
left, and predictions for S. aureus are on the right. (a) Precision–recall curves for GLOBUS 
(black lines) were calculated by ranking genes using assignment probabilities. Precision-recall 
curves for homology (red) were calculated by ranking genes using sequence identity. (b) Recall 
of known metabolic genes (at 70% precision) as a function of sequence identity to the closest 
enzymes from other species with the annotated functions. GLOBUS recovers significantly more 
enzymes with remote sequence identity (<40%). (c) Prediction precision (at 90% recall) for 
known metabolic genes as a function of sequence identity to the closest enzyme from other 





We investigated the potential utility of GLOBUS for refining existing metabolic 
reconstructions by comparing two curated models of B. subtilis [157, 158] (older iYO844, newer 
iBsu1103) and two models of S. cerevisiae [154, 156] (older iLL672, newer iMM904). 
Specifically, we considered all annotations with non-zero GLOBUS probabilities that were not 
included in the older metabolic models. We then subdivided these non-zero GLOBUS 
annotations into those that were included in the newer models for each species and those that 
were not included in the newer models. This analysis showed (see Supplementary fig. 4.6) that 
for both species, and across different sequence identity bins, higher GLOBUS probabilities 
corresponded to higher likelihoods of being included in the newer metabolic models. 
 
4.2.4. Specific metabolic predictions and biochemical validation in B. subtilis 
GLOBUS results indicate that in many cases context correlations provide crucial 
functional evidence determining correct annotations, especially when sequence identity is small. 
One example is the B. subtilis gene hemD, known to be responsible for the uroporphyrinogen-III 
synthase activity [160] (EC 4.2.1.75). The sequence identity of hemD to the closest Swiss-Prot 
sequence performing its correct function is only ~24%; however, GLOBUS assigned a high 
probability (P=0.86) to the correct EC number because of the excellent context associations with 
its neighboring enzymes at this location: the gene clustering Z-score (defined as the number of 
standard deviations from the mean based on all gene-gene context scores, see Methods) is 21.2, 
the co-expression Z-score is 5.64. Context correlations are also helpful in selecting between 
potential functions with comparable sequence identity. For instance, the B. subtilis 8-amino-7-
oxononanoate synthase bioF [161] has ~39% sequence identity to both its correct function (EC 




assignment (P=0.64 vs. 0.02) despite the equivalent sequence identity due to high clustering and 
co-expression Z-scores (16.6 and 4.3, respectively) in the correct location compared to the 
alternative location (1.1 and 2.4). 
 In Table 4.1 (B. subtilis) and Table 4.2 (S. aureus) we list GLOBUS predictions without 
experimental validation that have high annotation probabilities despite low sequence identity to 
enzymes responsible for corresponding functions in other species. The annotations in the tables 
are ordered by averaging the prediction ranks sorted by decreasing annotation probability and the 
prediction ranks sorted by decreasing sequence identity distance to known enzymes. For each 
prediction in the table we also show the average Z-score for the three context correlations in the 
corresponding network location. 
From the predictions listed in Table 1 we selected the genes spsI, spsJ, and ykgB for 
experimental validation. The first two genes were selected because they were predicted to 
catalyze the first two steps in a rhamnose biosynthesis pathway (Supplementary fig. 4.7); the 
other two genes from the pathway (spsK and spsL, in Table 1) were also predicted by GLOBUS. 
Rhamnose is a main sugar component of the B. subtilis exosporium [162]. The sps genes are 
transcribed from a σ
K
-controlled promoter [163] at late stages of B. subtilis sporulation when the 
outer components of the spore coat are being assembled. The gene ykgB was selected because 
GLOBUS predicted (with probability P=0.51) that this gene catalyzes the long elusive 6-
phosphogluconolactonase activity of the B. subtilis pentose phosphate (PP) pathway. 
Importantly, despite a central role of PP pathway in the B. subtilis metabolism, this enzymatic 





Table 4.1. Prediction of gene function in B. subtilis. In the table we show predictions without 
experimental validation that have GLOBUS-assigned probabilities above 0.5 and protein 
sequence identity to known enzymes below 50%. Shaded rows represent activities validated in 
this study. The annotations in the table are ordered by averaging the prediction ranks sorted by 
decreasing annotation probability and the prediction ranks sorted by decreasing sequence identity 
distance to known enzymes. The last column shows the average Z-score of phylogenetic 
correlations, gene clustering and gene co-expression when all sequences are assigned to their 
most probable locations. The Z-score for each type of data was calculated using the maximum 
context correlation between a gene and its immediate network neighbors (see Methods). 
Gene 
EC 






murF 6.3.2.10 UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine 
ligase 
0.98 32.8 9.0 
spsL 5.1.3.13 dTDP-4-dehydrorhamnose-3,5-epimerase 0.95 33.1 8.4 
ycgM 1.5.99.8 proline dehydrogenase 0.76 25.6 3.6 
yfnG 4.2.1.45 CDP-glucose-4,6-dehydratase 0.76 27.5 11.0 
birA 6.3.4.15 biotin-[acetyl-CoA-carboxylase] ligase 0.77 31.7 2.3 
gcvPB 1.4.4.2 glycine dehydrogenase (decarboxylating) 0.97 41.5 12.3 
yloI 4.1.1.36 phosphopantothenoylcysteine decarboxylase 0.99 44.5 2.6 
fruK 2.7.1.56 1-phosphofructokinase 0.88 40.4 10.9 
spsK 1.1.1.133 dTDP-4-dehydrorhamnose reductase 0.87 39.6 8.4 
murB 1.1.1.158 UDP-N-acetylmuramate dehydrogenase 0.97 43 5.2 
folK 2.7.6.3 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
diphosphokinase 
0.99 45.3 8.0 
sul 2.5.1.15 hydropteroate synthase 0.99 47 8.2 
yitJ 2.1.1.13 methionine synthase 0.54 30.6 2.1 
ybbF 2.7.1.69 protein-Npi-phosphohistidine-sugar phosphotransferase 0.85 40.5 11.3 
 
yloI 6.3.2.5 phosphopantothenate-cysteine ligase 0.97 44.5 2.9 
ykgB 3.1.1.31 6-phosphogluconolactonase 0.51 30.4 2.6 
pheA 4.2.1.51 prephenate dehydratase 0.69 36.1 6.7 
purK 4.1.1.21 phosphoribosylaminoimidazole carboxylase 0.89 43.5 13.3 
spsI 2.7.7.24 glucose-1-phosphate thymidylyltransferase 0.93 44.4 11.6 
ysnA 3.6.1.15 nucleoside-triphosphatase 0.56 33.3 7.7 
ywbC 4.4.1.5 lactoylglutathione lyase 0.6 35.2 3.6 
pucE 1.2.3.14 abscisic-aldehyde oxidase 0.62 35.8 1.0 
ydhR 2.7.1.4 fructokinase 0.77 41.5 5.3 
yfnH 2.7.7.33 glucose-1-phosphate cytidylyltransferase 0.88 43.2 11.0 
ybbD 3.2.1.52 beta-N-acetylhexosaminidase 0.52 33.1 3.1 
yngE 6.4.1.4 methylcrotonoyl-CoA carboxylase 0.64 36.2 8.6 
kbl 2.3.1.29 glycine C-acetyltransferase 0.97 49 9.4 
spsJ 4.2.1.46 dTDP-glucose-4,6-dehydratase 0.97 48 12.0 
tenI 2.5.1.3 thiamine-phosphate diphosphorylase 0.7 40.6 6.6 







Table 4.2 Prediction of gene function in S. aureus. In the table we show predictions without 
experimental validation that have GLOBUS-assigned probabilities above 0.5 and protein 
sequence identity to known enzymes below 50%. The annotations in the table are ordered by 
averaging the prediction ranks sorted by decreasing annotation probability and the prediction 
ranks sorted by decreasing identity distance to known enzymes. The last column shows the 
average Z-score of phylogenetic correlations as described in Table 4.1. 
Gene 
EC 






bioD 6.3.3.3 dethiobiotin synthase 0.99 31.2 7.9 
hisG 2.4.2.17 ATP phosphoribosyltransferase 0.99 39.6 6.3 
murE 6.3.2.13 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-
diaminopimelate ligase 
0.96 39 7.0 
thrB 2.7.1.39 ho oserine kinase 1.00 42.4 7.0 
mvaA 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 0.95 40.1 5.9 
hemD 4.2.1.75 uroporphyrinogen-III synthase 0.76 27.4 6.4 
SA2374 1.3.3.1 dihydroorotate oxidase 0.84 37.8 2.2 
murF 6.3.2.10 UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine 
ligase 
1.00 46 7.2 
mvaK1 2.7.1.36 mevalonate kinase 0.73 35.1 6.7 
ribB 2.5.1.9 riboflavin synthase 0.91 43.3 8.3 
ribC 2.7.1.26 riboflavin kinase 0.96 45.5 2.3 
lysC 2.7.2.4 aspartate kinase 0.86 41.6 5.4 
scrB 3.2.1.26 beta-fructofuranosidase 0.82 40.5 5.9 
folA 1.5.1.3 dihydrofolate reductase 0.89 42.8 9.6 
SA1288 6.3.4.15 biotin-[acetyl-CoA-carboxylase] ligase 0.56 33.1 2.0 
aroK 2.7.1.71 shikimate kinase 0.66 34.9 2.0 
coaW 2.7.1.33 pantothenate kinase 0.71 36.6 2.1 
nagA 3.5.1.25 N-acetylglucosamine-6-phosphate deacetylase 0.95 45.5 8.1 
ansA 3.5.1.1 asparaginase 0.66 36 2.2 
SA2317 4.3.1.17 L-Serine ammonia-lyase 0.90 43.9 2.8 
bioA 2.6.1.62 adenosylmethionine-8-amino-7-oxononanoate 
transaminase 
0.97 48.2 9.3 
asd 1.2.1.11 aspartate-semialdehyde dehydrogenase 0.98 48.9 5.8 
gcvPB 1.4.4.2 glycine dehydrogenase (decarboxylating) 0.81 42.3 9.2 
thiD 2.7.4.7 phosphomethylpyrimidine kinase 0.89 44 8.9 
hemY 1.3.3.4 protoporphyrinogen oxidase 0.94 47 4.1 
trpG 4.1.3.27 anthranilate synthase 0.68 40.6 6.6 
SA2006 4.1.1.5 acetolactate decarboxylase 0.90 46.6 4.9 
alr1 5.1.1.1 alanine racemase 0.82 43.6 3.3 
SA0511 1.1.1.103 L-threonine 3-dehydrogenase 0.78 43.5 2.2 






Figure 4.3. In vitro biochemical assays for characterizing activities of SpsI and SpsJ using 
high-precision mass spectrometry. (a) Reaction diagram. (b) Peak plots show intensities with 
masses corresponding to the products dTDP-glucose and dTDP-4-dehydro-6-deoxy-glucose of 
the reactions catalyzed by SpsI and SpsJ (black arrows, detailed in c). Observed masses deviate 
by less than 0.001 atomic mass units (amu) from the corresponding reference masses. Spectra 
were recorded from two independent assays. (c,d) Bar plots show dependency of dTDP-glucose 
(c) and dTDP-4-dehydro-6-deoxy-glucose (d) accumulation on protein concentration of SpsI and 
SpsJ, respectively. As negative control (NC), the protein free filtrate of 6.99 µM spsI or 203.01 
µM SpsJ solution was used. Error bars represent standard deviations from two independent 
assays.  
 
The three proteins selected for experimental validation were over-expressed in E. coli and 
purified by His-Tag affinity and anion exchange chromatography. The correct identity of the 
purified proteins was confirmed by in-gel tryptic digestion and subsequent peptide analysis using 
mass spectrometry. In vitro enzymatic assays for SpsI and SpsJ were performed using a 
published method [164]. Predicted SpsI substrates (dTTP and α-D-glucose-1-phosphate; Fig. 
3.1a) were observed in negative ionization mode high-precision mass-spectra profiles at 259.022 
m/z and 480.981 m/z (M-H
+
) respectively. Intensities of both dTTP and α-D-glucose-1-
phosphate decreased only when SpsI was present in the assays, indicating that the enzyme uses 




product (dTDP-glucose) accumulated at 563.068 m/z (M-H
+
) only in the presence of SpsI (Fig. 
4.3b,c). The product of SpsJ (dTDP-4-dehydro-6-deoxy-glucose) was observed at 545.058 m/z 
(M-H
+
) only in the presence of both SpsI and SpsJ (Fig. 4.3b,d), suggesting that SpsJ indeed 
converts dTDP-glucose into dTDP-4-dehydro-6-deoxy-glucose (Fig. 4.3a). Product 
accumulation as well as substrate consumption showed a clear dependence on the protein 
concentrations within a wide range around the estimated in vivo concentration of glucose-1-
phosphate thymidylyltransferase  (~1 µM for RfbA in Escherichia coli [165]). 
 
Figure 4.4 In vitro biochemical assays for characterizing 6-phospho-gluconolactonase 
activity of YkgB. (a) Reaction diagram for 6-phosphogluconolactonase. (b) Time courses of 
lactone degradation at different YkgB concentrations were recorded online by direct flow 
injection analysis. Different symbols represent replicate assays. (c) Bar plot shows relative 
intensity increase comparing final and initial intensities as a function of YkgB concentration. As 
negative control (NC), the protein free filtrate of 223.2 µM YkgB solution was used. Error bars 




Similarly to SpsI and SpsJ, the YkgB activity (Fig. 4.4a) was followed by observing the 
6-phospho-gluconolactone degradation with online flow injection into a high-precision mass-
spectrometer operating in the negative ionization mode. The intensity at the mass of 257.007 m/z 
(M-H
+
), corresponding to 6-phospho-gluconolactone, decreased with rates faster than the rate of 
spontaneous background hydrolysis only when YkgB was present in the assays (Fig. 4.4b). The 
6-phospho-gluconolactone degradation rate also exhibited a clear dependence on the protein 
concentration (Fig. 4c) within a wide range around the estimated in vivo 6-
phosphogluconolactonase concentration (~1.5 µM for YbhE in Escherichia coli [165]). 
Similarly, the production rate of 6-phosphogluconic acid was significantly higher than the 
background when YkgB was present in the assays (Supplementary fig. 4.9). Notably, available 
expression and proteomic data show that the ykgB gene is transcribed during several 
environmental conditions [166, 167], such as heat and phenol stress. This suggests that YkgB - 
similar to lactonases in other species [168] - is likely to play a role in removing toxic byproducts 
of the PP pathway. 
4.2.5. GLOBUS automation and probabilistic predictions for multiple species 
 Our probabilistic annotation method can be applied to any sequenced microbial genome. 
Other than gene co-expression, which may be hard to come by for species with no or too few 
expression studies, phylogenetic correlations and gene chromosomal clustering, as well as the 
remaining functional descriptors can be easily calculated based on pre-defined open reading 
frames (see Methods). Using high-quality annotations from Swiss-Prot [17] and enzyme 
definitions from ExPASy [169] and KEGG [29] it is possible to automatically update the generic 
EC network and sequence database used to detect homology. Furthermore, data on gene order 




scale to produce the information required to solve the energy function equation during Gibbs 
sampling (Fig. 4.5). To demonstrate the scalability of GLOBUS, we have applied it to 45 diverse 
prokaryotic species producing thousands of probabilistic gene annotations within a couple of 
days. Based on these tests, using GLOBUS to annotate all (~4,000) currently sequenced genomes 
could be achieved within 3-6 months.  
We have set up a prototype database at http://vitkuplab.c2b2.columbia.edu/globus/ with 
probabilistic predictions for 10 species of medical importance. As illustrated in Figure 4.5, these 
predictions are based on our automated annotation pipeline and are linked to the underlying 
functional descriptor scores that resulted in the observed probabilities. These scores are 
important for manually reviewing annotations, for example, during the reconstruction of 
genome-scale metabolic models. Additionally, all predictions can be downloaded in bulk format 
to be used in downstream computational methods (see for example Section 4.4), and links to 
external resources such as BRENDA [136] are provided. The quantitative results are also linked 
to visualization tools [170], allowing the inspection/comparison of the annotated enzymatic 





Figure 4.5. GLOBUS database implementation. Probabilistic annotations can be obtained for 
any sequenced microbial genome based on public and subscription based (optional) data 
repositories. A prototype database (http://vitkuplab.c2b2.columbia.edu/globus/) was built to 
display GLOBUS results and the underlying functional descriptor scores. Links to BRENDA 
[136] and iPATH [170] for visualization are also provided.  
 
4.3. Discussion 
Owing to the inherent uncertainty of computational annotations, predictions of 
biochemical function need to be treated probabilistically. Currently, most publicly available 
biochemical databases do not provide quantitative probabilities or confidence measures for 
existing annotations. This makes it hard for the users of these valuable resources to distinguish 
between confident assignments and mere guesses. As the application and impact of genome-
scale metabolic networks rapidly expands [76], a probabilistic treatment of annotations is 






















assignments, provides a principled framework for such global probabilistic annotations. The 
method assigns annotation probabilities to each gene, as well as suggests likely alternative 
functions. 
We demonstrate that context correlations can significantly improve the accuracy of 
biochemical predictions, especially when annotations are based on distant sequence identity. 
Over half of potential metabolic genes, even in such well-studied model organisms as S. 
cerevisiae and B. subtilis, have remote sequence identity (<40%) to known enzymes 
(Supplementary fig. 4.4). Application of GLOBUS to less-studied organisms should be 
straightforward, as context-based correlations, with the exception of gene co-expression, can be 
calculated directly from genomic sequences; the decrease in the overall accuracy without gene 
co-expression is relatively small (<1%). The accuracy of other context correlations should only 
improve with the rapid growth of fully sequenced genomes. 
Probabilistic predictions generated by GLOBUS can be directly used to annotate 
sequences and genomes. GLOBUS annotations can be also used by various gap identification 
and gap filling approaches [31, 33, 52, 54, 146] to produce simulation-ready flux balanced 
networks [76]. In addition, recent advances in metabolomics, proteomics, and fluxomics offer 
complementary opportunities to expand and refine biochemical annotations and network 
reconstructions [171, 172]. The flexibility of the GLOBUS framework makes it easy to integrate 
metabolomics and proteomics data. For example, as genes are moved through the network to 
sample possible assignments, available data for corresponding proteins and metabolites can be 
included in the global fitness function. Additional functional descriptors, for example based on 




framework. Such probabilistic integration of diverse biochemical data will be crucial for 
exploiting the ongoing avalanche of genomic sequencing. 
4.4. Appendix: Using system-level properties as evidence for gene annotations  
 As described in Chapter 2, one of the main applications of biochemical annotations is 
the reconstruction of stoichiometric models suited for constraints-based analysis. The 
reconstruction process involves the mapping of annotated enzymatic activities to mass-balanced 
reactions that, represented  as a stoichiometric matrix, enable the search for steady state flux 
distributions [51]. Typically, a pre-defined set of biomass precursors plays an important role in 
the reconstruction process: based on literature reports or computational predictions, reactions are 
included in the models such that all biomass precursors can be synthesized at steady state [2]. 
Given that all species possess the ability to obtain basic bio-molecules such as proteins, nucleic 
acids, lipids, and co-factors, we rationalized that prior knowledge of the reactions needed for 
these biosynthetic processes could be considered in GLOBUS to further improve functional 
assignments (Fig. 4.6). In particular, if a reaction is likely to be present in a given metabolic 
network, a global assignment of genes to EC numbers that has genes assigned to said reaction is 





Figure 4.6. Identification of necessary reactions based on GLOBUS and flux analysis. 
System-level properties of metabolic networks, such as the ability to synthesize biomass 
precursors, can be used to find reactions that are likely to be in a metabolic network based on an 
initial annotation. The identified reactions can then be used to improve GLOBUS predictions by 
narrowing the set of possible locations with a high-probability. These reactions can be obtained 
from a universal stoichiometric network using an optimization approach such as mixed integer 
linear programming (MILP). 
In order to test this approach, a new term representing the presence of a reaction in the 
metabolic network was added to the GLOBUS energy function. Similar to previous sections, a 
weight was learned for this new variable using simulated annealing and the yeast iLL672 model. 
Every node in the EC network was labeled according to its presence (1) or absence (0) in the 
iLL672 model, and the energy function was defined in such way that a higher probability (lower 
energy) was obtained when genes were assigned to reactions marked as present. Using the 
parameters obtained after training on the yeast model, GLOBUS was ran on the B. subtilis 
genome using the EC numbers present in the iBsu1003 model [157] as input. As shown in 
Figure 4.7a, there was a significant boost in precision and recall when prior knowledge of 




as 30% known EC numbers were ignored or 30% random functions were considered (Fig. 4.7a, 
orange and green lines). 
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Figure 4.7. Improving GLOBUS performance through system-level information. (a) 
Precision-recall curves for GLOBUS (red), GLOBUS considering known reactions in the B. 
subtilis metabolic network (black), and GLOBUS considering known reactions with different 
levels of false positives and false negatives. (b) Precision-recall curves for GLOBUS (black) and 
GLOBUS using reactions required for the synthesis of biomass precursors (red) identified using 
MILP in three different genomes (B. subtilis, N. meningitidis and S. aureus). (c) Recall at a given 
level of precision (blue lines in panel b) for different bins of sequence identity to known enzymes 
across three different species. Error bars represent the SEM.  
 
Because it is unlikely that one would know all reactions present in a given species 




likely to be present in a query metabolic network.  For this, 10,625 mass-balanced reactions from 
the ModelSEED were used to build a universal stoichiometric model, and EC numbers in the 
generic EC network were mapped to those reactions. For a given species, GLOBUS probabilities 
were transferred to reactions in this stoichiometric network and mixed integer linear 
programming (MILP) was used to find the least number of low or zero-probability reactions that 
would allow the synthesis of all biomass components defined for such species (see Methods, 
Section 4.5.7). These reactions were then used as an additional input for GLOBUS using the 
newly defined energy function and the parameters obtained after training with known yeast 
reactions (Fig. 4.6).  As shown in Figure 4.7b for three different species (B. subtilis, Neisseria 
meningitidis and S. aureus), considering the reactions identified this way produces a substantial 
(~10%) improvement in precision and recall of metabolic annotations. Interestingly, looking at 
recall values for genes with different levels of sequence identity to known enzymes (Fig. 4.7c), 
there is a similar improvement at every sequence identity bin using the new method. This 
suggests that GLOBUS can effectively combine local context information, which is most useful 
in cases of remote sequence identity (Fig. 4.2), and the new global context term related to the 
ability of genome-scale metabolic networks to synthesize essential and organism-specific 
biomass components.   
While biomass synthesis (growth) is a phenotypic characteristic shared by all organisms, 
the described approach could be used to incorporate more specific phenotypic properties such as 
the ability to utilize various nutrients (measured by phenotypic microarrays [90]), or the ability 
to produce specific metabolites detected by untargeted mass-spectrometry. Both of these tasks 
can be achieved through a reformulation of the optimization problem described. On the other 




stoichiometric network provides useful information for deciding –through manual inspection, or 
optimization procedures– what reactions to include or leave out in the reconstruction of genome-
scale metabolic models (see Supplementary fig. 4.6). In summary, integrative probabilistic 
methods such as GLOBUS can be used to integrate into a single process the annotation and in 
silico systems analysis of sequenced genomes (Fig 2.1). 
4.5. Methods  
4.5.1. Construction of the generic EC network 
In the construction of the EC (Enzyme Commission) network we considered 3284 EC 
numbers (http://www.chem.qmul.ac.uk/iubmb/enzyme/) responsible for biochemical activities 
involving small compounds as substrates and products; activities such as “RNA polymerase” or 
“protein kinase” were excluded. In the global EC network, nodes represent EC numbers and 
edges represent connections established by metabolites shared by reactions. Following a 
common procedure [38], linkages through the top 30 most highly connected metabolites and 
cofactors were not considered (Supplementary table 4.1). 
4.5.2. Identification of potential metabolic genes and potential metabolic functions 
The program BLAST [18] (with E-value cutoff of 5*10
-2
) was used for homology 
searches against enzymes in Swiss-Prot [149], excluding sequences that were: 1.) from genomes 
of closely related species (species in the same taxonomic genus) or 2.) likely annotated based 
exclusively on computational methods, i.e., annotations with keywords probable, like, by 
similarity, hypothetical, or putative. Although many remaining annotations in Swiss-Prot are also 
derived using computational methods, they are usually curated, ensuring that the misannotation 




To account for multi-functional enzymes, when non-overlapping regions of a query gene 
could be mapped to different enzymatic functions - indicating domains responsible for distinct 
metabolic activities - the mapped regions of the query gene were allowed to be assigned 
independently to different network locations. 
4.5.3. The functional descriptors considered in the GLOBUS fitness function 
The fitness (energy) function over all metabolic genes, E(g1, g2, …., gn), was defined to 
reflect the hypotheses that a particular global assignment of genes into their network locations 
will be more probable if genes have significant homologies to the assigned locations, and also 
exhibit strong context correlations with their network neighbors. Accordingly, in GLOBUS 
calculations we used the following fitness function for genes included in the network: 
 (          )                                                                                             
where, b(s) are positive coefficients representing weights of each functional feature, and f(s) are 
various functional features described below. 
4.5.3.1. Sequence homology. f homology  
The term, f homology, represents the descriptor of sequence homology. The higher the 
sequence identity between a protein and enzymes in other species known to catalyze the assigned 
activity, the more likely is the assignment to be correct [20, 173]. As the sequence homology 
descriptor we used the logarithm of the conditional probability that the gene performs the 
assigned function, given the highest sequence identity to a Swiss-Prot [149] protein annotated to 
catalyze the target activity: 
          ∑    (                      |                                                         )
 





The conditional probabilities were estimated using the well-curated yeast iLL672 
metabolic model [154] (Supplementary fig. 4.1d).  
4.5.3.2. Orthology. f orthology  
An additional binary descriptor related to sequence homology was the possible gene 
orthology to a gene from another species annotated with the target activity. The orthology 
descriptor was based on bi-directional best hits by SSEARCH [174]; in these calculations we 
used the bi-directional best hits in the KEGG SSDB database [131] 
(http://www.genome.jp/kegg/ssdb/). For each gene, the orthology term was either 1, if at least 
one possible ortholog was annotated in Swiss-Prot to perform the target activity, or 0, if no 
orthologs with the target activity could be identified. Again we excluded annotations based 
exclusively on computational methods, and treated separately non-overlapping regions with 
homology to different activities (see above). 
4.5.3.3. Gene-gene context correlations. f context 
Gene pairs that share similar biological functions tend to be either present or absent 
together in genomes of sequenced species (phylogenetic correlation), tend to be co-localized on 
chromosomes across multiple genomes (gene chromosomal clustering), and tend to be co-
regulated. These context-based correlations were initially developed to infer gene functions and 
provide complementary information to sequence homology data [143, 175]. Multiple studies 
have also demonstrated that genes located close to each other in a metabolic network tend to 
have significantly stronger context associations [38, 176]. Previously, we and others used context 
associations in combination with local structure of the metabolic network to identify genes 




In GLOBUS we used the context correlations by first transforming them into Z-scores 
[178] using the distribution of correlations between all pairs of candidate metabolic genes, and 
then estimating the conditional probability that two genes are direct network neighbors given 
their context association Z-score. The conditional probabilities were derived based on the 
iLL672 yeast metabolic model (Supplementary fig. 1a-c). In the GLOBUS fitness function for 
each assigned gene we considered the maximum log probability among all network neighbors of 
the gene: 
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4.5.3.3.1. Phylogenetic correlation 
Phylogenetic correlation [140, 179] measures the co-occurrence (co-presence) of 
homologues for a pair of genes across genomes. Phylogenetic profiles were constructed using 
protein BLAST searches against a collection of 70 diverged genomes [33]. We used the binary 
phylogenetic profiles, i.e. 70-dimensional binary vectors representing the presence or absence of 
homologues in the target genomes. Pearson’s correlation between the profile vectors was 








, where N is the total number of target genomes. For genes X and Y, x is the number of genomes 
in which any homologue of X is present, y is the number of genomes in which any homologue of 




4.5.3.3.2. Gene chromosomal clustering 
For a pair of genes, chromosomal gene clustering [34, 142, 180] measures the degree of 
co-localization of their orthologues across a set of genomes. We considered gene order statistics 
instead of the exact nucleotide positions of genes, i.e. we defined a gene order distance d(X,Y) as 
the minimum number of genes separating genes X and Y. Under the null hypothesis that genes 
are distributed randomly within a genome, P(dγ(X, Y)) is the probability of observing gene order 
distance equal or less than dγ(X, Y) between a pair of genes X and Y in a genome γ. P(dγ(X, Y)) 
can be calculated directly as the fraction of gene pairs in genome γ that are separated by gene 
order distance dγ(X, Y) or smaller. Assuming gene order distances are independent across a set of 
108 evolutionary divergent organisms Γ, and given that X and Y are orthologues of genes A and 
B from the target genome, we calculated the clustering of genes A and B: 
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For a given set of genomes, this clustering measure can be biased by the variable 
phylogenetic proximity between different organisms. Therefore we deliberately filtered the 
genome set to eliminate species closely related to the target genome using a mutual information 
threshold of 0.9 for ortholog occurrences [31]. Orthology mapping required for the chromosomal 
clustering calculations was established using best bi-directional hits in the KEGG SSDB dataset 
[131] (http://www.genome.jp/kegg/ssdb/). 
4.5.3.3.3. Co-expression 
Numerous studies [141, 181] demonstrated that genes with similar mRNA expression 




GLOBUS were calculated as Spearman’s rank correlation between expression profiles obtained 
from the Rosetta “compendium” dataset [182] for S. cerevisiae and the GEO database [183] for 
B. subtilis and S. aureus. In all calculations Log10 intensity ratio values were used. 
4.5.3.4. EC co-occurrences. fECco-ocurrence 
In addition to gene phylogenetic profiles, we used in GLOBUS a functional descriptor 
based on likely co-occurrence between different metabolic activities (EC numbers) across 
species. This descriptor measures the correlation between the occurrences of different metabolic 
activities across species without considering specific genes assigned to the activities. To 
calculate the correlation between different metabolic activities (EC numbers) we used a 70-
dimentional binary vector for each EC number representing its presence or absence in a set of 70 
genomes (see section 4.5.3.3.1) according to the KEGG database [131] 
(http://www.genome.jp/kegg). For every pair of EC numbers the Pearson’s correlation between 
their profile vectors was calculated (see section 4.5.3.3.1).  
In the GLOBUS fitness function for each assigned gene we considered the EC co-
occurrence descriptor equal to the average correlation between the EC activity of the assigned 
gene and the EC activities for all its network neighbors. The most relevant information about 
homology usually comes from annotated enzymes with the highest sequence identity to a protein 
under consideration. On the other hand, the EC co-occurrence reflects common presence and 
absence of metabolic activities across multiple KEGG genomes. Thus, this term quantifies 






4.5.4. Calculating the marginal probability using Gibbs sampler 
The marginal probability, P(gi), represents the probability that a gene is responsible for a 
metabolic activity (EC number) consistent with all possible assignments of other genes into the 
network. Formally, given all parameters of the GLOBUS fitness function, b homology, b orthology, b 
context, and b EC co-occurrence, P(gi) can be calculated by summation: 
  








1 1 1  
, where Z is a normalizing partition function. Suppose that there are n metabolic genes in the 
genome and each metabolic gene has m potential network assignments, obtaining P(gi) then 
requires summing over m
n
 possible terms. Because a typical genome contains many hundreds to 
thousands of metabolic genes, this summation is computationally intractable. Nevertheless, the 
success of the GLOBUS approach is due to the fact that the vast majority of all possible gene 
assignments have very low probabilities. Consequently, it is possible to recover correct marginal 
probabilities for each gene using an efficient sampling of high probability configurations 
(assignments). 
To sample probable gene assignment we applied a widely used algorithm, the Gibbs 
sampler [151, 184, 185]. The Gibbs sampler is a special case of Markov Chain Monte Carlo 
(MCMC) and the Metropolis-Hasting algorithm [152, 186]. The Gibbs sampler allows obtaining 
marginal probabilities using sampling based on conditional probabilities. Starting with a random 







obtained iteratively by selecting a random gene i and re-assigning to a location gi according to 
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represents the location of gene i at step k of the Gibbs chain G. If at each iteration the 
location of every gene was recorded; it can be proven that the distribution of Gi converges to 
P(gi) as the number of iterations t → ∞. 















   
 
Since in each iteration the denominator of the above equation and Z (the partition 
function) are constant, the conditional probability can be derived from the fitness function, E(g1, 
g2, …., gn): 
 














 A schematic illustration of a Gibbs sampler chain generating iterative gene assignments is 
shown in Supplementary figure 4.10.  
4.5.5. Computational requirements and statistical analysis 
The calculations were performed using the 3GHz Intel Xeon processor with 256MB of 
RAM. GLOBUS run times depended both on the number of iterations and the number of genes 




over all genes took about 10 minutes to complete. The run time increased linearly with the 
number of iterations and the number of genes. Importantly, 20,000-50,000 iterations (20-50 
minutes) were required to achieve 1% convergence of annotation probabilities, i.e. a 
convergence where not a single annotation probability varied by >1% between independent 
sampling runs. 
P values used to compare precision-recall performances for GLOBUS and sequence 
identity were calculated using the one tailed
2
 test, n=332 to 717 annotations.  
4.5.6. Experimental validation of biochemical predictions 
Different amounts of purified SpsI or SpsJ were incubated at 37 °C in 1 mL of 10 mM 
potassium phosphate buffer pH 7.4, 2.5 mM MgCl2, 1 mM glucose-1-phosphate, 1 mM dTTP 
and 1 U pyrophosphatase[164]. The enzyme reaction samples were assayed after 4 hours by 
flow-injection into a time of flight mass spectrometer (6520 Series QTOF, Agilent Technologies) 
operated in the negative ionization mode. High-precision mass spectra were recorded from 50-
1000 m/z and analyzed as described previously [187]. Acquired masses were deviating less than 
0.001 atomic mass units (amu) from the reference masses 259.022, 480.982, 545.058, and 
563.068 for α-D-glucose-1-phosphate, dTTP, dTDP-glucose, and dTDP-4-dehydro-6-deoxy-
glucose, respectively. 
Purified YkgB was assayed in 1 mL 5 mM potassium phosphate buffer pH 7, 2.5 mM 
MgCl2, and freshly prepared 6-phospho-gluconolactone. The lactone was prepared freshly from 
6-phospho-gluconic acid by lyophilization, and its degradation due to the YkgB activity was 




above. Acquired masses were deviating less than 0.001 atomic mass units (amu) from the 
reference masses 257.007 and 275.017 for 6-phospho-gluconolactone and 6-phosphogluconic  
4.5.7. MILP problem description 
 A universal stoichiometric reaction network was built from the set of reactions in the 
ModelSeed database (http://seed-viewer.theseed.org/). Unbalanced reactions and reactions of 
compounds with unspecified numbers of monomers were discarded; transport and exchange 
reactions were added based on the set of bacterial genome-scale metabolic models described in 
Chapter 3. For a particular species a template biomass composition was selected as described by 
Henry et al. [54], making sure that the universal network was able to produce all biomass 
components; i.e. that flux balance analysis (FBA [45]) predicted a positive flux through a 
biomass reaction with all considered precursors as reactants. Having defined a biomass reaction, 
flux variability analysis (FVA [188]) was used in order to remove reactions that could not carry 
flux under any condition while still producing biomass.  
 For a given genome GLOBUS probabilities were obtained as described (Section 4.2.1). 
The probability of each EC number in the generic EC network was estimated as the maximum 
probability among all genes assigned to the EC number. EC probabilities were assigned to the 
corresponding reactions based on the ModelSeed reaction definitions. When more than one EC 
number was associated to a particular reaction, the highest EC probability was used as the 
reaction probability. Reactions that were not associated with an EC number, reactions associated 
with EC numbers with zero probability, and reactions with a probability below 0.05 were all 




In order to identify a set of likely reactions, a subset of reactions from the universal 
stoichiometric network was selected at random with likelihood proportional to the reaction 
probabilities. Starting with these reactions and using the previously defined biomass composition 
we solved the following optimization problem using mixed integer linear programming (MILP): 
         ∑ (  (              ))  
 
   
  
              
       
           
           
The solution identifies the least number of low probability reactions i not included in the 
initial subset that allow flux through the biomass reaction (vbiomass) larger than a small constant k. 
Zi is a binary variable indicating the presence or absence of every reaction not present in the 
initial reaction set in the solution. The first condition ensures that the solution is at steady state; S 
represents the network’s stoichiometric matrix and v is a vector containing all metabolic fluxes. 
The second condition sets upper bounds (ubi) to fluxes in v when reversible reactions are 
represented as pairs of forward and backward reactions. 
 A binary vector of the reactions carrying flux in the MILP solution was used in GLOBUS 
with a modified objective function:  
 (          )                                                                                             
                            
, where the additional term flikely-rxn had a value of 1 when genes were assigned to EC numbers 





4.6. Supplementary figures and tables 








































































































































































































Supplementary figure 4.1. Conditional probabilities used in the GLOBUS fitness function. The 
context correlations used in GLOBUS (a-c) were first transformed into Z-scores[178] using the 
distribution of correlations for all pairs of candidate metabolic genes. Then we estimated the 
conditional probability that two genes are direct network neighbors given their context 
association Z-score. The greater the context correlation Z-score, the more likely the two genes 
are network neighbors. The conditional probabilities were estimated based on the iLL672 yeast 
metabolic model[154]. (a) The conditional probabilities for phylogenetic profiles, (b) The 
conditional probabilities for chromosomal gene clustering, (c) The conditional probabilities for 
mRNA co-expression. (d) As a sequence homology term in GLOBUS we used the conditional 
probability that a gene performs the assigned function, given the highest sequence identity to a 
Swiss-Prot[149] protein annotated to catalyze the target activity. The conditional probabilities for 
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Supplementary figure 4.2. Training GLOBUS parameters using different models. (a) 
Maximum likelihood values of the context weight coefficients derived using the iLL672[154] 
and iMM904[156] S. cerevisiae models and the iBsu1103 [157] model for B. subtilis. SEQ: 
sequence identity; PC: phylogenetic correlation; GC: gene clustering; EX: co-expression; ORT: 
Orthology; EC: EC co-occurrence; OUT: not in the network (b) The correlation of probabilities 
with values higher than 0.1 in S. aureus based on GLOBUS parameters obtained by training with 
the two different yeast models (Pearson’s r=0.94, median probability difference = 0.04, 
maximum probability difference = 0.33). (c) The correlation of probabilities with values higher 
than 0.1 in S. aureus based on GLOBUS parameters obtained by training with the yeast iLL672 
and the iBsu1103 metabolic models (Pearson’s r=0.96, median probability difference = 0.05, 
























 GLOBUS with Psi-Blast
 Sequence identity with Psi-Blast
 
Supplementary figure 4.3. Comparison of the precision-recall relationships obtained using 
homology information established by BLAST and PSI-BLAST. Using PSI-BLAST, instead of 
regular BLAST, does not improve the performance significantly because additional sequences 
with low identity (detected by PSI-BLAST) only rarely have the target function. 







































Supplementary figure 4.4. Fractions of potential metabolic genes in S. cerevisiae (green) and B. 
subtilis (grey) are shown as a function of sequence identity to annotated enzymes in other 
species. Over half of metabolic genes have relatively small sequence identity (<40%) to known 




































a Fitness function term ignored:
 



































b Fitness fiunction term ignored:
 
Supplementary figure 4.5. Contribution of individual context correlations to the GLOBUS 
performance. Different columns in the figure represent precision/recall values - across sequence 
identity bins - achieved by GLOBUS without using individual context correlations. The 
corresponding GLOBUS parameters were determined by simulated annealing optimizations 
performed without using each of the context correlations. The results show that at the same level 
of precision (70%) (a) and recall (90%) (b), there is a marked reduction in performance; such 
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Supplementary figure 4.6. Potential utility of GLOBUS in refining manually curated metabolic 
models. (a) Annotations with non-zero GLOBUS probabilities that were not included in the older 
iYO844[158] B. subtilis model were subdivided into those included (black) and those that were 
not included (red) in the newer iBsu1103 model. Results show that, for different bins of 
sequence identity, higher GLOBUS probabilities correspond to higher likelihoods that 
annotations were included in the newer model. (b) Similar result is observed for yeast. 
Annotations with non-zero GLOBUS probabilities that were not included in the older 
iLL672[154] S. cerevisiae model were subdivided into those included (black) or not included 




















































































































Supplementary figure 4.7. GLOBUS predictions for sps genes in B. subtilis. (a) Genomic 
positions of the sps genes, as well as gene mapping (dashed arrows) to the dTDP-L-rhamnose 
biosynthesis pathway. The expression of sps genes is controlled by the σ
K
 transcription 






Supplementary figure 4.8. Substrate consumption at different spsI concentrations. Mass 
spectrometry intensities of α-D-glucose-1-phosphate (left panel) and dTTP (right panel) are 
shown as a function of the SpsI concentration. As negative control (n.c.), the protein free filtrate 




Supplementary figure 4.9. Product accumulation at different YkgB concentrations. Mass 
spectrometry intensities of 6-Phosphogluconic acid (left panel) and its relative intensity increase 
(right panel) comparing final and initial intensities are shown as a function of the YkgB 
concentration. As negative control (n.c.), the protein free filtrate of 232 µM YkgB solution was 













Supplementary figure 4.10. Illustration of Gibbs sampler used to derive marginal probabilities, 
P(gi), in GLOBUS. A marginal probability for a gene assignment reflects the likelihood of the 
gene to catalyze the corresponding activity consistent with, i.e. integrated or summed over, all 
possible assignment of other genes in the network. Probabilities were calculated directly from the 
Gibbs chain counts. 
Supplementary table 4.1. Highly connected metabolites that were not used in establishing 
connections between metabolic activities (EC numbers). 
Metabolite Number of 
connected EC 
numbers 
Metabolite Number of 
connected EC 
numbers 
H2O 1224 Reduced acceptor 115 
H+ 703 AMP 111 
NADP+ 435 Pyruvate 109 
NADPH 433 S-Adenosyl-L-homocysteine 107 
NAD+ 422 Acetyl-CoA 103 
NADH 412 H2O2 102 
Oxygen 379 L-Glutamate 100 
ATP 375 2-Oxoglutarate 96 
Orthophosphate 306 UDP-glucose 76 
ADP 294 Acetate 73 
CO2 254 D-Glucose 56 
CoA 230 Carboxylate 48 
Pyrophosphate 185 Succinate 43 
NH3 183 Oxaloacetate 41 
UDP 150 Glycine 41 
S-Adenosyl-L-methionine 115   










































RECONSTRUCTION AND FLUX BALANCE ANALYSIS OF THE Plasmodium falciparum 
METABOLIC NETWORK 
 
This chapter is based on “Plata, G., Hsiao, T., Olszewski, K., Llinás, M., Vitkup, D. 
Reconstruction and Flux-balance Analysis of the Plasmodium falciparum Metabolic 
Network. Mol. Syst. Biol. 6:408 (2010)” 
 
Genome-scale metabolic reconstructions can serve as important tools for hypothesis generation 
and high-throughput data integration. Here we present a metabolic network reconstruction and 
flux-balance analysis of Plasmodium falciparum, the primary agent of malaria. The 
compartmentalized metabolic network accounts for 1001 reactions and 616 metabolites. 
Enzyme-gene associations were established for 366 genes and 75% of all enzymatic reactions. 
Compared with other microbes, the P. falciparum metabolic network contains a relatively high 
number of essential genes, suggesting little redundancy of the parasite metabolism. The model 
was able to reproduce phenotypes of experimental gene knockout and drug inhibition assays with 
up to 90% accuracy. Moreover, using constraints based on gene expression data, the model 
predicted the direction of concentration changes for external metabolites with 70% accuracy. 
Using flux-balance analysis, we identified 40 enzymatic drug targets (i.e. in silico essential 
genes) with no or very low sequence identity to human proteins. To demonstrate that the model 
can be used to make clinically relevant predictions, we experimentally tested one of the 
identified drug targets, nicotinate mononucleotide adenylyltransferase, using a recently 






Malaria is an ancient disease which can be dated back to 2800 B.C. [189] and remains 
one of the most severe public health challenges worldwide. Currently, about half of the Earth’s 
population is at risk from this infectious disease according to the World Health Organization 
[190]. Malaria inflicts acute illness on hundreds of millions of people worldwide and leads to at 
least one million deaths annually [190, 191]. It ranks as a leading cause of death and disease in 
many developing countries, where the most affected groups are young children and pregnant 
women [190]. The disease is transmitted to humans by the female Anopheles mosquito and is 
caused by at least five species of Plasmodium parasites. The lifecycle of the parasite is highly 
complex and includes various hosts and tissue types. During a blood meal, sporozoites are 
transmitted from the mosquito to humans and initiate infection in the liver where they reproduce 
prolifically but are asymptomatic. In the next stage of infection the parasites are released from 
the liver cyst into the bloodstream in the form of merozoites, where they invade red blood cells 
and reproduce asexually [192]. The destruction of red blood cells coupled with the significant 
load imposed on the host metabolism is ultimately responsible for the major clinical symptoms 
of malaria, which are often fatal [193]. 
Although several anti-malarial drugs are currently available, most of them are losing 
efficacy due to acquired drug resistance in the most lethal causative agent, Plasmodium 
falciparum [194, 195]. The loss of drug efficiency in resistant strains poses a great threat to 
malaria control and has been linked to increases in worldwide malaria mortality [196]. There is 
an urgent need for new anti-malarial drugs coupled with better administration strategies. 




is essential for identification of new drug targets, especially given the difficulties associated with 
in vivo drug testing [197]. 
Various systems biology approaches have been applied to improve our understanding of 
P. falciparum physiology and to facilitate drug development [198]. The sequencing of the P. 
falciparum genome has provided researchers with a complete collection of parasite proteins and 
likely regulatory interactions [199, 200]. Several large scale transcriptome [201-204], proteome 
[205-207] and metabolome [208] analyses have been conducted in order to dissect functional 
interactions and define essential biological pathways. In addition to experimental studies, several 
databases have been developed to integrate functional knowledge of the parasite and its 
metabolism. For example, PlasmoCyc is an integrated database that links genomic data, protein 
annotation, enzymatic reactions, and pathway information [209]; the Malaria Parasite Metabolic 
Pathway Database, on the other hand, is a manually curated resource which assembles annotated 
enzymes into likely metabolic pathways [210]. 
A stoichiometric representation of metabolism can be effectively used to study functional 
properties of biochemical networks using a growing number of computational methods [211]. 
For example, flux balance analysis (FBA) considers steady state distributions of metabolic fluxes 
satisfying a set of biophysical constrains, such as bounds and mass balance of fluxes [45]. Given 
the applied constraints, a likely distribution of fluxes in the network can be obtained by 
maximizing an appropriate objective function (e.g. biomass production) [78] or applying 
minimal perturbation principles [79, 80]. The analysis of flux-balanced genome-scale metabolic 
networks is useful not only for the discovery of essential genes and potential drug targets, but 
also as a tool to better understand species-specific biology [76, 171]. For example, among other 




[212], explore metabolic weaknesses in bacterial pathogens [213], integrate gene expression and 
other types of data [214], and investigate objective functions important under different growth 
conditions [215]. Given the complex life cycle of Plasmodium, a flux-balanced model of this 
organism is of direct relevance to the ongoing search to identify new therapeutic drug targets. 
In this study we reconstructed the genome-scale flux balanced metabolic network of P. 
falciparum and used it to perform a systems level analysis of the parasite’s metabolism. Based on 
in silico gene deletions we identified potential new anti-malarial drug targets with low sequence 
identity to human proteins. One of these targets, nicotinate mononucleotide adenylyltransferase, 
was experimentally tested in a growth inhibition assay using a recently discovered small 
molecule inhibitor. We also illustrate, using a previously published methodology, how the 
reconstructed metabolic model can be used to integrate flux analysis with expression data to 
more accurately simulate the physiology of this complex eukaryotic pathogen. 
5.2. Results 
5.2.1. Scale of the reconstructed flux-balanced metabolic network 
 The reconstructed flux-balanced model is based on gene-reaction associations reported in 
public domain databases as well as on a careful literature analysis. We used well-curated 
microbial metabolic models and enzyme databases to determine the stoichiometry of most 
reactions. To produce a functional reconstruction we also searched the literature for missing 
steps necessary for the model to produce a set of required biomass components (see Methods). 
The model accounts for 366 genes, corresponding to 7% of all genes identified in P. falciparum. 
Compared to 61 metabolic models of various organisms compiled by Feist et al. [216], our 




models with small gene numbers include many parasitic/symbiotic species, such as Mycoplasma 
genitalium, Buchnera aphidicola, Haemophilus influenzae and Helicobacter pylori. The P. 
falciparum network also includes 616 metabolites and 1001 reactions, 657 of which are 
metabolic transformations (Table 5.1). In addition, there are 231 reactions corresponding to 
transport between different cellular compartments and 111 input–output exchange reactions that 
allow extracellular metabolites to enter and end products to be excreted from the network.  
Table 5.1. Characteristics of the reconstructed metabolic network of P. falciparum. 
Reactions 1001 Metabolites 616 
   Cytosolic reactions 503    Cytosolic metabolites 537  
   Mitochondrial reactions 47    Mitochondrial metabolites 83 
   Apicoplast reactions 105    Apicoplast metabolites 135 
   Transport reactions 231    Extracellular metabolites 159 
      Cytosolic transport reactions 130 Genes 366 
      Mitochondrial transport reactions 50   
      Apicoplast transport reactions 48   
   Exchange reactions 111   
 
The metabolic reconstruction includes four distinct compartments: parasite cytosol, 
mitochondria, apicoplast (a non-photosynthetic plastid), and the extracellular space (representing 
the host cell cytosol and host serum). The majority of all reactions (50%) occur in the cytosol. 
The apicoplast accounts for 10% of all reactions, such as the synthesis of isopentenyl 
diphosphate, fatty acids, and heme [217]. A special reaction is included in the model to account 
for the biomass components and essential metabolites needed for growth (Table S1). 
Supplementary file 1 provides a complete list of all network reactions and metabolite 
abbreviations. 
Excluding metabolite-exchange reactions, 74% of the reactions in the model are directly 




the iND750 yeast model (70%) [218] and the iAC560 model for Leishmania major (63%) [212]. 
The remaining reactions include spontaneous transformations that can proceed without 
enzymatic catalysis and reactions required for the proper functioning of the metabolic model. 
Intracellular and inter-compartmental transport reactions, most of which are not currently 
associated with any gene, account for about 6% and 15% of all reactions in the model, 
respectively (Figure 5.1A). Most of the transporter proteins in Plasmodium spp. are currently 
uncharacterized. However, it is well-established that the parasite significantly modifies the 
permeability of the host cell membrane [219, 220] and several metabolic processes occur across 
different organelles. For instance, such metabolic pathways as heme biosynthesis and antioxidant 
defense have been shown to involve both host and parasite enzymes localized to multiple intra-
cellular compartments [221, 222]. Given the importance of metabolite exchange, many transport 
reactions were included in the model, although the identities of the corresponding genes remain 
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Figure 5.1. Annotation of reactions in the genome-scale metabolic model of P. falciparum. 
A. Number of orphan (non-gene associated) reactions in P. falciparum grouped by metabolic 
processes. B. Reactions grouped by Enzyme Commission (EC) classifications. C. Reactions 
grouped by metabolic processes in P. falciparum and S. cerevisiae [218]. 
 
Transferases and hydrolases comprise the largest fraction of enzymatic reactions in the 
network (Fig. 5.1B). In terms of specific metabolic processes (Fig. 5.1C), most reactions in the 
network are related to lipid metabolism, followed by transport and exchange reactions. In 
comparison with S. cerevisiae, a free living eukaryote of similar genome size, the most 
significant metabolic difference is the fraction of reactions involved in amino acid metabolism 




responsible for amino acid pathways; in contrast, this fraction is only 7% in P. falciparum. 
Amino acid biosynthesis pathways are absent in P. falciparum metabolism due to the unique 
ability of the parasite to catabolize the erythrocyte hemoglobin [223] and to scavenge free amino 
acids from the host serum (human stages) or hemolymph (mosquito stages). 
5.2.2. Analysis of in silico single and double gene deletions 
 We simulated gene deletions using flux balance analysis (FBA) of the reconstructed 
metabolic network. Even though sugars other than glucose do not support P. falciparum growth 
in culture [224], in performing the in silico deletions we initially allowed all exchange reactions 
to carry non-zero metabolic fluxes, thereby permitting the potential import and utilization of 
other hexoses. Purines, such as inosine and adenosine, which are not normally included for in 
vitro culture but can be imported in vivo [225], were also made available to the network. We note 
that genes identified as essential when all exchange reactions are allowed will also be essential 
under more specific (constrained) conditions. The phenotypic effects of in silico deletions were 
classified into four groups: lethal (L), growth reducing (GR, growth between 0% and 95% of the 
wild type network), slight growth reducing (SGR, growth between 95% and 100%), and with no 
effect (NE). About 15% of all single gene deletions (Table 5.2) were lethal, approximately 1% 









Table 5.2.Total number of single and non-trivial double deletion phenotypes.  
Predicted phenotype
a




Double deletion  
(# non-trivial pairs) 
Double 
deletions (%) 
No Effect (NE) 295 80.60 43160 + 4974 (trivial GR,SGR) 99.85 
Lethal (L) 55 15.02 16 0.03 
Growth Reducing (GR) 3 0.82 48 0.10 
Slight Growth Reducing (SGR) 13 3.55 7 0.01 
TOTAL 366 100.0  48205 100.0 
 
a 
Single and double gene deletion predictions were classified into lethal, growth reducing (growth 
between 0% and 95% of wild type), slight growth reducing (growth between 95% and 100%), and no 
effect. 
 
Out of 366 genes in the P. falciparum metabolic network, 55 genes were predicted to be 
essential for growth (Supplementary table 5.2). To assess the accuracy of these predictions we 
compiled a list of experimentally validated gene-knockouts and phenotypes resulting from 
targeted inhibitions of enzymatic activities with drugs (Table 5.3). In the computational analysis 
we assumed that the drug treatments resulted in a complete inhibition of targeted enzymatic 
activities. In this way, the available drug phenotypes were simulated with computational 
deletions of the corresponding genes. In total, 14 metabolic gene knockouts and 25 drug 
inhibition phenotypes for genes were retrieved from the literature for P. falciparum and P. 
berghei, a murine malaria parasite commonly used in experimental studies [226, 227]. 
The FBA analysis was able to achieve 100% accuracy for predictions of both essential 
and non-essential gene knockouts (14 cases in total). In contrast, about 70% accuracy was 
achieved for phenotypes resulting from drug inhibitions of metabolic enzymes. Interestingly, all 
mispredicted drug phenotypes (8 cases) involved genes for which the computational analysis 
predicted a non-zero growth phenotype, while corresponding drugs were lethal to the parasite in 




experimental drug inhibitions can be explained by considering functions that are not explicitly 
represented in our model. These included the degradation of spontaneously forming toxic 
metabolites (e.g. methylglyoxal), and the synthesis of metabolites that are involved in the 
progression between the intraerythrocytic stages (e.g. sphingolipid-ceramide) [228]. The 
remaining discrepancies (5 cases) can be resolved by taking into account specific literature-based 
evidence (Table 5.3, green rows), i.e. by considering nutrient availabilities and directionality of 
exchange reactions. Interestingly, in one case the source of discrepancy between the model and 
experiments was clearly related to off-target drug effects. Specifically, the inhibitor of enoyl-
Acyl carrier reductase (FabI), triclosan, has been shown to kill P. falciparum in vitro and in vivo 
(Surolia and Surolia 2001) despite the fact that its presumed target, PfFabI, can be deleted with 
no apparent blood-stage phenotype [229-231]; this deletion phenotype is correctly predicted by 
our model. 






Sp Exp Pred Biological Process Reference 
PFL2510w Chitinase 3.2.1.14 Pber NLb NL Aminosugars metabolism [232] 
PFI0320w Arginase 3.5.3.1 Pber NLc NL 










Pber NLd NL Fatty acid synthesis [231] 4.2.1.60 
4.2.1.61 
PFF0730c 
Enoyl-acyl carrier reductase 
(FABI) 
1.3.1.9 Pber NLd NL Fatty acid synthesis  [229, 231]  
PFF1275c 
3-oxoacyl-acyl-carrier protein 
synthase I/II (FABB/F) 
2.3.1.41 Pber NLd NL Fatty acid synthesis [231] 










PF13_0269 Glycerol kinase 2.7.1.30 Pfal NL NL Glycolysis [236] 
PF14_0425* Fructose-bisphosphate aldolase 4.1.2.13 Pfal NLe,q  NLc Glycolysis [237] 








1.1.1.267 Pfal L L Isoprenoids metabolism [239] 
PF14_0788 Adenylyl cyclase 4.6.1.1 Pber NL NL Isoprenoids metabolism [240] 
PF10_0322* 
Ornithine decarboxylase 4.1.1.17 
Pfal Lf Lf 











Methionine and polyamine 
metabolism 
[244] 











2.4.2.8 Pfal L L Purine metabolism [246] 
PF13_0287* Adenylosuccinate synthase 6.3.4.4 Pfal L L 
Purine metabolism, 
Asparagine and aspartate 
metabolism 
[247] 
PFB0295w* Adenylosuccinate lyase 4.3.2.2 Pfal L L Purine metabolism [248] 




PFF0160c* Dihydroorotate dihydrogenase 2.4.2.8 Pfal L L Purine metabolism [250] 
PF10_0289* Adenosine deaminase 3.5.4.4 Pfal Li  Li 
Purine metabolism  






2.4.2.1 Pfal Lj Lj 
Purine metabolism 

















PF11_0410* Carbonic anhydrase 4.2.1.1 Pfal L L 
Pyrimidine metabolism 
Fatty acid synthesis 
Pyruvate metabolism 
[254] 













Lactoylglutathione lyase 4.4.1.5 Pfal L NLo Pyruvate metabolism [257] 
PFF0230c* 






















2.5.1.19 Pfal L L Shikimate biosynthesis [262] 
PFF1105c* Chorismate synthase 4.2.3.5 Pfal L L Shikimate biosynthesis [263] 
PFL1870c* Sphingomyelinase 3.1.4.12 Pfal L NLp 
Sphingomyelin and ceramide 
metabolism 
[228] 
PF11_0295* Farnesyl diphosphate synthase 
2.5.1.10 
Pfal L L Terpenoid metabolism [264] 
2.5.1.1 




2.3.1.43 Pber NLl NL Utilization of phospholipids [266] 
a 
Genes are grouped and sorted by biological process. Yellow rows indicate cases for which the model is 
unable to reproduce the experimental phenotype. Green rows highlight cases for which predictions 
coincide with experiments after specific experimental conditions are included in the simulation. *Drug 
targets with experimental evidence, mostly as compiled by [209]. L: Lethal, NL: Non-Lethal. Pber: P. 
berghei, Pfal: P. falciparum.  
b 
reduced mosquito stage viability.  
c 
slightly reduced growth.  
d 
liver stage not viable.   
e 
reduced parasitemia.  
f 
lethal in the absence of putrescine.  
g 
lethal in the absence of spermidine.  
h 
mosquito stage not viable.  
i 
lethal in the absence of inosine and hypoxanthine.  
j 
lethal in the absence of hypoxanthine.  
k 
lower gametocyte production.  
l 
reduced liver stage viability.  
m 
lethal when pyruvate export is not allowed in the model.  
n 
this activity is required to maintain a low dUTP/dTTP ratio to prevent DNA damage. This is not 
reflected in the biomass function and cannot be predicted by FBA.  
o 
this activity is required for detoxification of methylglyoxal, which is forms spontaneously and must 
eventually converted to lactate and excreted. This cannot be predicted by FBA.  
p 
slight growth reducing, sphingomyelinase is required for progression from the trophozoite to schizont 
stage, this is not captured by our objective function. 
q
 incomplete inhibition 
 
For 15 metabolic genes identified in our analysis as essential, knockout experiments or 
drug inhibition assays in P. falciparum/P. berghei are already available in the literature (see 
Tables III, S2). The remaining predictions include 24 genes coding for proteins with relatively 
low sequence identity (20%-40%) to human transcripts (Supplementary fig. 5.1, see Methods), 
and 16 genes with no significant sequence identity to any human protein (BLAST E-value > 10
-
2
). This last group comprises six genes associated with isoprenoid metabolism, three genes 




(Table 5.4). Nine of the genes with no homology to human proteins are homologous to plant 
proteins; this is consistent with the essential functions of apicoplast-associated genes in the 
Apicomplexa [267]. These forty enzymes are of immediate interest as potential drug targets, as 
low homology to human proteins suggests that side effects for drugs targeting these enzymes 
may be minimized or avoided. Interestingly, five of the 16 enzymes with no detectable homology 
correspond to enzymatic activities (EC numbers) that are unlikely to be present in human 
metabolism according to the KEGG [131], HumanCyc [268] and UniProt [17] databases. Among 
the predicted essential genes with low but significant sequence identity to human transcripts, 
only aminodeoxychorismate lyase/synthetase (2.6.1.85, 4.1.3.38, PFI1100w) is associated with 
EC numbers not reported in human metabolism. In addition to genes predicted as essential, 9 
internal metabolic reactions with no associated network genes (orphan reactions) were also 
predicted to be essential for growth. Four of these reactions are associated with the shikimate 
biosynthetic pathway; three with ubiquinone metabolism, one with nicotinamide, and one with 
porphyrin metabolism (Supplementary table 5.3). 
One metabolic pathway of significant interest in the parasite is the mitochondrial 
tricarboxylic acid (TCA) cycle. In most free-living microbes this pathway fully oxidizes 
available carbon sources to carbon dioxide, in the process generating high-energy phosphate 
bonds (ATP/GTP). Within the Plasmodium species, however, the nature and function of the TCA 
cycle remains unclear [269]. In the malaria parasites the sole pyruvate dehydrogenase complex, 
which normally provides the key link between glycolysis and TCA metabolism, localizes not to 
the mitochondrion but to the apicoplast. In that compartment it is likely to be used primarily to 
generate acetyl-CoA for lipogenesis [270]. Incorporating this fact into our model, we find that 




complex. This enzyme converts 2-oxoglutarate into succinyl-CoA, which is required for heme 
biosynthesis. Intriguingly, metabolic labeling experiments indicate that TCA cycle of the parasite 
also reduces 2-oxoglutarate to malate, generating acetyl-CoA from citrate cleavage (Olszewski 
and Llinas, unpublished). A non-zero flux through this reaction is observed in our model when 
additional constraints are applied to mitochondrial transport reactions. 
Table 5.4. Predicted essential genes with no homologs in the human genome
a
.  
Gene name Enzyme name EC Biological Process 
MAL8P1_81 Phosphopantothenoylcysteine decarboxylase 4.1.1.36 CoA biosynthesis 
PF07_0018 Pantetheine-phosphate adenylyltransferase 2.7.7.3 CoA biosynthesis 
PFF1490w 
Methenyltetrahydrofolate cyclohydrolase 








1.17.7.1b Isoprenoid metabolism 












2.7.1.148b Isoprenoid metabolism 
PF13_0159 Nicotinate-nucleotide adenylyltransferase 2.7.7.18 
Nicotinate and nicotinamide 
metabolism  
PF14_0697 Dihydroorotase 3.5.2.3 Pyrimidine metabolism 
PFE0630c Orotate phosphoribosyltransferase 2.4.2.10 Pyrimidine metabolism 
MAL13P1_221 Aspartate carbamoyltransferase 2.1.3.2 
Pyrimidine metabolism, asparagine 
and aspartate metabolism 
MAL13P1_292 Riboflavin kinase 2.7.1.26 Riboflavin metabolism 
PF11_0059 Pantothenate transporter -- Transport 
PF11_0169 
Pyridoxine/pyridoxal 5-phosphate biosynthesis 
enzyme 
-- Vitamin B6 metabolism 
 
a
 In bold: nicotinate-nucleotide adenylyltransferase, which was selected for experimental validation. 
b







We also extended the computational analysis of essential Plasmodium genes to pairs of 
genes that are not essential on their own, but are lethal if deleted simultaneously, i.e. synthetic 
lethal enzyme pairs with non-trivial genetic interactions [271] (see Table 5.2). In total, deletion 
of 16 gene pairs gave rise to such synthetic lethality in the unconstrained model. The enzymes 
that were essential upon double deletions participate in glycolysis, metabolism of nucleotides, 
lipids, porphyrin, the pentose phosphate cycle, and transport of NO2 and phosphate 
(Supplementary table 5.4). 
The analysis of essential genes in the S. cerevisiae metabolic network iND750 [218] can 
be used to put the results of the P. falciparum in silico deletions into an appropriate context. To 
make the proper comparison, we only considered deletions of genes carrying non-zero metabolic 
fluxes in wild type models of both networks; the focus on non-zero fluxes is necessary to prevent 
the difference in network sizes (S. cerevisiae 750 genes/1266 reactions, P. falciparum 366 
genes/1001 reactions) from biasing the results. When both networks were allowed to 
simultaneously use all carbon sources the fraction of essential genes associated with non-zero 
fluxes in P. falciparum was 37%, while in S. cerevisiae it was 5% (Fisher’s exact test  P-value 
<10
-10
). The fraction of essential genes was also significantly higher in the parasite when single 
carbon sources were used in both models. For example, when glucose was used as the sole 
source of carbon, 50% of genes were essential in the parasite versus 26% in yeast (P-value =10
-
6
). To understand whether the significantly higher fraction of essential genes in P. falciparum 
arises exclusively from a smaller number of isoenzymes in that network (111 in P. falciparum 
versus 276 in S. cerevisiae) or if it is also related to the inherent differences in the networks’ 
architecture, we performed deletions of all isoenzymes associated with metabolic reactions, 




the reactions with non-zero fluxes were essential in P. falciparum, compared to only 6% in S. 
cerevisiae (P-value <10
-10
). In a glucose minimal media, 62% of the reactions are essential in the 
parasite and 47% in yeast (P-value <10
-10
). These results demonstrate that a significantly smaller 
genetic robustness of the parasite’s network arises, at least in part, due to a paucity of alternative 
metabolic pathways [272]. The lower redundancy of the P. falciparum network is likely to be a 
consequence of the adaptation to the relatively homeostatic and nutrient-rich environments of the 
hosts in which it proliferates [200]. 
5.2.3 Resolution of disagreements between in silico predictions and experimental data 
 While the presented metabolic model achieves a high accuracy in predicting phenotypes 
of the experimental knockouts and drug inhibiton assays, it is the disagreement between the 
model and experiments that often leads to model improvement [51]. Thus, it is important to 
discuss the inconsistencies between modeling and experimental results which were corrected in 
the process of model construction. In four cases the disagreements between the predicted gene 
essentiality and experimental results reported in the literature were resolved through additional 
flux constraints. The adjustments included purine nucleoside phosphorylase (PFE0660c), 
adenosine deaminase (PF10_0289), ornithine decarboxylase (PF10_0322) and lactate 
dehydrogenase (PF13_0141/PF13_0144). The additional constraints applied to the network were 
based either on specific experimental conditions or known details of Plasmodium spp. 
physiology (Table III, Green rows). For example, lactate is believed to be the main byproduct of 
glucose metabolism in P. falciparum [273], and lactate dehydrogenase is an essential enzyme 
that regenerates NAD
+
 from NADH [274]. In contrast, in our initial model pyruvate was 
exported as the primary glycolysis byproduct and NAD
+
 was regenerated through the 




of extensive pyruvate export in Plasmodium, a constraint was added to the corresponding 
pyruvate exchange reaction. As a result, we observed reduction of pyruvate to lactate, followed 
by lactate export. In the adjusted model lactate dehydrogenase carried a non-zero flux and was 
correctly predicted to be essential for growth. In the other three cases, constraints on exchange 
fluxes were added to reproduce the composition of the media used in drug inhibition 
experiments. Specifically, purine nucleoside phosphorylase has been shown to be essential if 
hypoxanthine is not available in the environment [252], while adenosine deaminase is essential 
in the absence of both inosine and hypoxanthine [251]. When the fluxes through the inosine and 
hypoxantine exchange reactions were set to zero, the experimentally observed knockout 
phenotypes were reproduced. Similarly, ornithine decarboxylase was correctly predicted to be 
essential without putrescine in the growth media [241]. 
In two cases, the inability of our initial model to reproduce experimental results was due 
to reactions involving metabolic dead-ends; i.e. metabolites that are either only produced or only 
consumed in the network [275]. In the first case the model was not able to synthesize spermidine. 
The synthesis of spermidine from putrescine by spermidine synthase was accompanied by the 
production of 5-methylthioadenosine (MTA) [244], which was a metabolic dead end in the initial 
model. Consequently, the spermidine synthesis caused MTA to accumulate, violating the steady 
state assumption of the constraint-based approach. However, while it is known that in 
Plasmodium spp. MTA is first converted to 5-methylthioinosine by adenosine deaminase and 
then recycled into methionine and hypoxanthine [276], not all enzymes involved in these 
reactions have been fully characterized. We addressed this problem by including in the model the 
PfADA and PfPNP activities, responsible for the hypoxanthine synthesis from MTA [276], and 




PO4, to methionine in order to represent the methionine salvage pathway. The second case was 
related to the folate biosynthesis pathway. In this pathway, the reaction catalyzed by 6-
pyruvoyltetrahydropterin synthase (4.2.3.12), in addition to the folate biosynthesis intermediate 
6-hydroxymethyl-7,8-dihydropterin, is known to produce a small amount of 6-pyruvoyl-5,6,7,8-
tetrahydropterin (6PTHP) [277]. Initially, both products were included in the model and, because 
6PTHP represented another metabolic dead end, the cell was not able to synthesize folate. We 
resolved this problem by including in the model separate reactions for each of the two alternative 
products. 
The total number of remaining dead end metabolites in the final model (266) is 
comparable to that of other recently published genome-scale metabolic networks; for example 
the iBsu1103 model for Bacillus subtilis (270 dead-end metabolites,[157]), the iAC560 model of 
L. major (261,[212]), or the iND750 S. cerevisiae model (194, [218]). The remaining dead-ends 
in the Plasmodium network include 109 metabolites that are consumed but are not currently 
produced or imported in the model, 80 metabolites that are produced but not consumed, and 79 
metabolites, associated with reversible reactions, that can be either exclusively consumed or 
produced. Because protein synthesis is not explicitly included in the metabolic model, a 
significant number (42) of the remaining dead end compounds correspond to tRNAs; this 
compares to 68 dead end tRNAs in the iND750 yeast network. Among the other functional 
categories associated with a large number of the metabolic dead ends are lipid metabolism 
(45%), transport reactions (15%), the metabolism of carbohydrates (5%), amino acids (8%), and 
nucleotides (5%). More precise measurements of the P. falciparum biomass composition, for 
example a detailed lipid composition of the parasite membrane [278, 279], can be used in the 




5.2.4. Validation of the predicted drug target nicotinate nucleotide adenylyltransferase 
The most urgent motivation for flux-balance reconstruction of the pathogen metabolism 
is to facilitate drug development. To illustrate the potential of the model to make clinically 
relevant predictions, we experimentally tested a predicted target for which candidate drugs have 
been reported in other microbial species. The ideal drug target will be an essential enzyme with 
no homolog in the human genome and in a pathway not currently targeted by any 
pharmaceutical. Based on these criteria we selected for validation nicotinate mononucleotide 
adenylyltransferase (NMNAT, PlasmoDB ID PF13_0159, EC 2.7.7.18) (Table 5.4). This 
enzyme, a member of the plasmodial nicotinamide adenine dinucleotide (NAD) synthesis and 
recycling pathway, catalyzes the conversion of nicotinic acid mononucleotide to nicotinic acid 
adenine dinucleotide (Fig. 5.2A). NMNAT has recently been the focus of novel antimicrobial 
agent development due to structural and metabolic differences between the enzyme in microbial 
and human cells [280]. As NAD(P) is one of the most promiscuous redox molecules in 
metabolism, as well as a cofactor for important histone regulatory proteins such as sirtuins [281], 
inhibition of NAD(P) synthesis and recycling should have a profound impact on parasite 
metabolism. However, to the best of our knowledge, this pathway has not been previously 





Figure 5.2. Small-molecule inhibition of the parasite nicotinate mononucleotide 
adenylyltransferase (NMNAT). A.  Schematic of the P. falciparum NAD(P) synthesis and 
recycling pathway determined from the genome sequence. Nicotinamide (NM) and nicotinic acid 
(NA) can be scavenged from the host.  Compound 1_03 is an inhibitor targeting NMNAT. B. 
Compound 1_03 causes growth arrest of intraerythrocytic P. falciparum. Cultures were 
resuspended in niacin-free medium containing 0 or 100 μM of compound 1_03 at early ring stage 
and observed for 66 hours (see Methods).  Untreated parasites undergo normal development and 
reinvasion, while drug-treated parasites arrest at the trophozoite (“troph”) stage and do not 
reinvade. Abbreviations: NM, nicotinamide; NA, nicotinic acid; NaMN, nicotinate 
mononucleotide; NaAD, nicotinate adenine dinucleotide; NAD(P)
+
, nicotinamide adenine 
dinucleotide (phosphate), reduced; NMase, nicotinamidase; NPRT, nicotinate 
phosphoribosyltransferase; NMNAT, nicotinate mononucleotide adenylyltransferase; NADS, 




Recently, Sorci et al. used a combination of in silico structure modeling and enzyme 
inhibition assays to identify several classes of small molecules that inhibit bacterial (E. coli and 
B. subtilis) but not human NMNAT [282]. Several of these drug candidates were able to inhibit 
bacterial growth in culture. We tested two of the designed candidate compounds (1_03 and 
3_02), representing two different chemotypes, for their ability to inhibit P. falciparum growth 
using both the SYBR Green I fluorescence assay [283] to measure DNA synthesis and 
microscopic examination of morphological effects. The two compounds were tested at a range of 
concentrations for growth inhibitory effects in nicotinamide-free culture medium so as not to 
rescue any metabolic blocks induced by the drugs. Nicotinamide removal has been previously 
shown not to affect normal growth in culture [284], which we confirmed before running our 
growth assay experiments (data not shown). While the compound 3_02 did not significantly 
affect parasite’s growth at moderate concentrations (MIC50 > 100 μM), the compound 1_03 (N'-
[(E)-anthracen-9-ylmethylideneamino]-N-(4-bromophenyl)pentanediamide) exerted an 
inhibitory effect in a growth assay (MIC50 = 50 μM, Supplementary fig. 5.2) comparable to that 
previously observed for bacteria (MIC50 > 80 μM for E. coli, MIC50 = 10 μM for B. subtilis). At 
100 μM the compound 1_03 completely blocked host cell escape and reinvasion by arresting 
parasites in the trophozoite growth stage (Fig. 5.2B). Importantly, the human NMNAT isoforms 
are insensitive to the compound at least up to the concentrations used in our assay [282]. This 
suggests that the parasite NMNAT enzyme and, more generally, the NAD(P) synthesis pathway 
are indeed potentially effective and druggable targets. The experimental results also highlight the 






5.2.5. Prediction of metabolite concentration changes based on expression data 
Genome-scale metabolic networks can be used not only to predict the effects of gene 
deletions, but also as a tool for integration of diverse genomic and physiological data [76, 171]. 
For example, information on nutrient availability, uptake rates, and maximal rates of internal 
reactions can be used to further constrain the space of feasible metabolic fluxes. To illustrate the 
ability of the model to combine genomic data we investigated whether available gene expression 
datasets can be used to predict shifts in concentrations of external metabolites caused by the P. 
falciparum exchange fluxes at different developmental stages. Investigation of the exchange 
fluxes is essential for understanding perturbations caused by parasitic infections in the metabolic 
state of their host tissues, and, consequently, main mechanisms of pathogenesis. Because the 
flux-balance analysis operates in the space of the fluxes and not in the space of metabolic 
concentrations, the model cannot be directly used to predict absolute concentration changes. 
Nevertheless, it is possible to use the model to investigate the direction of concentration changes 
for external metabolites, following the simple logic that an increase in the uptake rate or decrease 
in the excretion (output) rate should lead to a drop in the concentration of the corresponding 
external metabolite; similarly, an uptake rate decrease or excretion rate increase should increase 
the metabolite concentrations. 
Although gene expression level does not perfectly correlate with the flux through the 
associated enzyme [285, 286], the recent study by Colin et al. [214] demonstrated that mRNA 
abundance data, if used as additional constraints on maximal reaction fluxes, can significantly 
improve stoichiometric model predictions. For instance, if the expression level of a particular 
enzyme is low, it is unlikely that the enzyme will be used by the metabolic network to carry a 




accurate view of the in vivo metabolic state. To test this, we used DNA microarray results 
collected from synchronized cultures of the P. falciparum 3D7 strain during the red blood cell 
phase of the parasite’s lifecycle [204, 208]. The expression data were collected at the ring, 
trophozoite, and schizont developmental stages (see Methods). Following Coljin et al., the 
maximum flux allowed through enzymes was constrained proportionally to the relative 
expression level of the corresponding genes [214]. 
We compared the accuracy of our predictions to the experimentally measured metabolic 
changes in Plasmodium-infected red blood cells [208]. In Figure 5.3 we show the predicted and 
experimentally measured changes, indicating either an increase or decrease in metabolic 
concentrations for the transition from the ring to trophozoite and from trophozoite to schizont 
stages. The predicted shifts in metabolic concentrations agree with the experimental results in 
70% of the measurements (Binomial P-value =9*10
-4
). In addition, we found a significant 
correlation between the magnitudes of the change in metabolite concentrations and the predicted 
flux values (Pearson’s correlation: 0.34, P-value =6*10
-3







Figure 5.3. Comparison between the predicted and experimentally measured shifts in 
metabolite concentrations in infected red blood cells. UP/DOWN indicates direction of 
experimentally measured changes in metabolic concentrations in infected versus uninfected cells. 
Blue color indicates agreement between experiment and predictions, while yellow indicates 
disagreement. In most cases (70%, P-value =9*10
-4
) the shifts in metabolic concentrations from 
one stage to the next can be predicted based on changes in the P. falciparum metabolic exchange 
fluxes. The in silico predictions of exchange fluxes were made based on the expression-
constrained flux-balance analysis [214]. Briefly, for genes with available mRNA expression data, 
the maximum flux through the associated metabolic reactions was constrained proportionally to 




 The presented flux-balanced model can serve as a valuable tool for quantitative 




The results of in silico gene deletions demonstrate that the model achieves high accuracy in 
reproducing available experimental measurements. In addition, our analysis suggests several 
dozen essential metabolic targets for therapeutic intervention. Although several studies which 
assemble and analyze plasmodial metabolic pathways have been performed previously [209, 
210, 287, 288], our contribution is important because the genome-scale model can be used to 
investigate and predict genetic perturbations from a network-level perspective. 
Interestingly, our results suggest a limited degree of robustness in the P. falciparum 
network, which should lead to a relatively high success rate for inhibitors of metabolic genes. It 
is possible that the small robustness of the reconstructed model, for example in comparison with 
the yeast metabolic network, is due primarily to unannotated P. falciparum genes without 
significant homology to known enzymes in other organisms. To investigate this possibility 
further we used the available collection of single metabolic gene knockouts/inhibitions in P. 
falciparum or P. berghei (Table 5.3) and all metabolic gene knockouts in S. cerevisiae [289]. 
We calculated the fraction of orthologs for essential metabolic knockouts in the parasite which 
are also essential in yeast, and, vice versa, the fraction of orthologs for essential metabolic 
knockouts in yeast which are essential in the parasite (see Supplementary table 5.5). 
Interestingly, while the majority of orthologs for essential metabolic genes in P. falciparum are 
not essential in S. cerevisiae, about half of the essential metabolic genes in yeast are also 
essential in the parasite (Supplementary table 5.5, Fisher’s exact test P=0.04). This result 
independently supports the conclusion of the flux balance simulations about the relatively small 
robustness of the P. falciparum network. 
 We anticipate several immediate extensions of our work. First, the presented network can 




interactions can be incorporated into the model [290]. Accurate measurements of gene 
expression [202], key protein-DNA regulatory interactions [291], and post-translational 
modifications [292] in the parasite will be especially important for modeling the dynamic 
behavior of the network under varying environmental conditions. Second, it will be important to 
model exchanges and interactions between the metabolic networks of the parasite and its hosts. 
The analysis of the combined parasite-host metabolic network should significantly improve 
understanding of the P. falciparum vulnerabilities. For example, several host cell enzymes are 
actively used by the parasite during its life cycle [276, 293]. Although we did not consider these 
human enzymes in our analysis, they can be easily included in future applications of the model. 
The available global flux-balanced metabolic human network [294], metabolic network 
specifically active in the liver [295], and well-curated models of human red blood cell 
metabolism [296-300] make such combined analyses possible. Third, it will be interesting to 
reconstruct stoichiometric metabolic networks for other clinically relevant Plasmodium species 
(e.g. P. vivax, P. malariae, P. ovale, and P. knowlesi) as well as the important model species P. 
berghei and P. yoelii. The comparative analysis of these networks may reveal important 
physiological and evolutionary differences between Plasmodium spp., and also help in the 
identification of common metabolic drug targets. 
 Taking into account the global health burden of malaria, it is essential to develop and 
implement new effective pharmaceuticals as quickly as possible. Systems biology approaches 
can be used to significantly facilitate drug identification and development [301, 302]. To date, 
we have only begun to see the application of such integrative methods in the context of malaria 
research (reviewed in [198]). We believe that the presented network represents an important step 




parasite nicotinate mononucleotide adenylyltransferase illustrates the ability of the model to 
speed up development of novel anti-malaria targets and pharmaceuticals. Importantly, although 
the identified compound is available, it has not been previously tested against Plasmodium spp. 
While 1_03 inhibited parasite growth only at relatively high concentrations (MIC50 = 50 μM), 
these were comparable to the inhibitory concentrations for the bacteria against which the drug 
was initially developed [282]. The incomplete growth inhibition at lower compound 
concentrations could be explained by the incomplete drug inhibition. Our model predicts linear 
decrease in the P. falciparum biomass production as the level of NMNAT inhibition increases; 
for example, 90% inhibition results in 90% growth decrease. Since Sorci et al. initially screened 
for compounds that could selectively inhibit pure NMNAT enzyme, these compounds have not 
been optimized for cellular permeability, accumulation or other pharmacokinetic parameters, and 
thus should primarily serve as a structural basis for further malaria drug development. 
Future improvements to the reconstructed P. falciparum metabolic network, including adding 
experimental details for missing activities and precise metabolic measurements necessary to 
describe the growth-related objective function, will lead to a better understanding of parasite 
physiology. Ultimately, such models should significantly accelerate the identification of 
desperately needed new drug leads against this devastating disease. 
5.4. Methods 
5.4.1. Genome-scale metabolic reconstruction 
 The reconstruction process started with the identification of enzyme coding genes in the 
P. falciparum genome. We considered a variety of resources, including PlasmoDB [303], the 




Encyclopedia of Genes and Genomes (KEGG) [131]. The identified enzymes were mapped to 
the corresponding metabolic reactions by consulting several well studied metabolic models, 
including the iAF1260 model for E. coli [304], the iND750 model for S. cerevisiae [218], the 
genome scale human metabolic network by Duarte et al. [294], and the KEGG database [131]. 
Based on this set of enzymatic activities and their stoichiometry, we used flux balance analysis to 
see if the network was able to produce a set of basic biomass components; e.g. aminoacids, 
lipids, nucleotides and cofactors. For each metabolite that the network was unable to synthesize 
we searched the literature for relevant publications concerning pathways and genes associated 
with the metabolite production or transport. Network enzymes were assigned to different cellular 
compartments based on experimental evidence, when available, and on computationally 
predicted localization information [217, 269, 305, 306]. Transport and exchange reactions 
reported in the literature or in databases such as PlasmoDB and MPMP were initially included in 
the model. We added additional transport reactions required for production of the biomass 
components. All metabolic and transport reactions were used to formulate a stoichiometric flux 
balance model [307]. The model was improved following an iterative procedure as previously 
described [51, 216]. 
The assembled network was manually inspected and compared to the Malaria Parasite 
Metabolic Pathway Database [210]. Metabolic network gaps [31] were identified and included in 
the assembled network model [308, 309]. The reactions for which no literature support is 
available and which are not essential for the biomass production were removed from the 
network. Additional adjustments related to reaction directionalities and metabolite availabilities 




Because the P. falciparum biomass objective function cannot be completely established based on 
the available literature, in our calculations we used a modified version of the yeast objective 
function reported in the iND750 model [218]. The objective function modifications included the 
lipid composition, which was adjusted as reported for Plasmodium [279], and amino acid and 
nucleotide compositions adjusted based on the proteome and genome sequences weighted by 
available expression data [204]. In particular, the percent prevalence of each ribonucleotide and 
aminoacid across all open reading frames (ORFs) was calculated as the relative frequency of 
each monomer; the counts at each ORF were multiplied by the ORF’s expression level (when 
available). The percent prevalence of the dNTPs was derived from the genome A+T content of 
80.6%. These percentages were converted to mmol/gDW as described [212]. Systems Biology 
Research Tool [310] was used to perform flux balance analysis [307] of the network, including 
single and double in silico deletions of network enzymes. The reconstructed network was able to 
either synthesize or import all the biomass components presented in Supplementary Table 5.1. 
The assembled metabolic model is available in the Systems Biology Markup Language format 
from the BioModels database [311] with accession number MODEL1007060000. 
5.4.2. Parasite culture, growth, and drug inhibition assays 
 The cultures of P. falciparum were maintained and synchronized by standard methods 
[312, 313]. Briefly, red blood cells (RBCs), infected by P. falciparum (3D7 strain), were grown 
in the RPMI 1640 culture medium supplemented with sodium carbonate (2 mg/mL), 
hypoxanthine (100 μM), Albumax II (0.25%) and gentamycin (50 μg/mL) in a humidified 
incubator at 5% CO2, 6% O2 and 37° C. The growth synchronizations were carried out by 




sorbitol for 5 minutes at room temperature, washing once with sorbitol-free PBS, and 
resuspending in culture medium. 
 The compounds 1_03 and 3_02 were acquired from ChemDiv 
(http://chemdiv.emolecules.com; ChemDiv IDs 8003-6329 and 5350-0029, respectively) and 
resuspended at 100 mM in DMSO. Growth inhibition studies were carried out using the SYBR 
Green I fluorescence assay [283]. Briefly, synchronized parasite cultures (early ring stage, 1% 
parasitemia, 1% hematocrit, 100 μL total volume) were suspended in nicotinamide-free RPMI 
1640 containing 0.1% DMSO and differing concentrations of drug in 96-well plates.  After 72 
hour incubation the plates were frozen at -80° C overnight, then thawed and mixed with 100 μL 
lysis buffer (20 mM Tris-HCl, pH 7.5; 5 mM EDTA; 0.008% w/v saponin; 0.08% v/v Triton X-
100; 1 × SYBR Green I) per well, incubated 1 hour at room temperature and quantified using a 
BioTek SynergyMX plate reader (excitation 488 nm, emission 522 nm). The concentrations 0, 
0.1, 1, 5, 10, 50, 100 and 250 μM were tested in triplicate in two independent growth assays. 
 
5.4.3. Using expression-constrained network to predict shifts in external metabolic 
concentrations 
 In the expression-constrained flux analysis we used P. falciparum expression data [208] 
as described previously in Coljin et al. [214]. Specifically, for genes with available mRNA 
expression data, the maximum flux through the associated metabolic reactions was constrained 
proportionally to their expression level; with the highest expression value corresponding to the 
maximum possible metabolic flux. In order to obtain absolute expression values, rather than the 




multiplied each ratio with the average sum of the median intensity across the full 
intraerythrocytic developmental cycle [204].  
The ring, throphozoite, and schizont developmental stages in cultures were defined for 
hours 1-18, 19-30, and 31-48 after synchronization with D-sorbitol, respectively. In the analysis 
we used intracellular RBC metabolite concentrations data obtained by Olszewski et al. [208]. We 
compared the changes in metabolite abundances between infected and uninfected red blood cells, 
from one development stage to the next. For each metabolite the predicted concentration changes 
were considered to agree with experimental data, if the metabolite consumption in the network 
increased (or the metabolite production decreased) when the experimentally measured metabolite 
concentration also decreased, or alternatively, if consumption of the metabolite decreased (or 
















5.5 Supplementary figures and tables 
 



































Supplementary figure 5.1. Distribution of sequence identities to human transcripts for 
Plasmodium proteins predicted as essential for growth. 
 
Supplementary figure 5.2. Growth inhibition profile of compound 1_03 in in vitro cultures of 
P. falciparum. See Methods for experimental details. Error bars represent the standard deviation 





































Supplementary figure 5.3. The accuracy of the metabolite exchange predictions made using 
2000 trials with randomized expression data (the distribution in grey), and prediction based on 
sampling of 2000 alternative FBA optimal solutions (the distribution in cyan). The single 
prediction discussed in the paper (70% accuracy) is shown using a vertical black arrow. In the 
randomized trials expression values were randomly shuffled between parasite metabolic genes. 
Only in about 2% of the randomized trials the prediction accuracy was higher than the average 
accuracy obtained using the true (non-shuffled) expression values. Alternative optima were 
obtained using the artificial centering hit-and-run algorithm [314], implemented in the COBRA 
toolbox [127], with biomass fluxes fixed to their maximum value. The difference in the 









Supplementary table 5.1. Biomass components and cofactors which can be synthesized or 
imported by the reconstructed metabolic network of P. falciparum. Coefficients indicate 
mmol/gDW 
Amino acids  dGTP 4.97E-04 
Alanine 0.0885 dTTP 2.12E-03 
Arginine 0.0876 Cofactors  
Asparagine 0.4053 10-Formyltetrahydrofolate 2.23E-04 
Aspartate 0.1943 2-Octaprenyl-6-hydroxyphenol 2.23E-04 
Cysteine 0.0438 Coenzyme A 5.76E-04 
Glutamine 0.0879 Flavin adenine dinucleotide 2.23E-04 
Glutamate 0.2275 5,10-Methylenetetrahydrofolate 2.23E-04 
Glycine 0.1186 Nicotinamide adenine dinucleotide 1.83E-03 
Histidine 0.0690 Nicotinamide adenine dinucleotide phosphate 4.47E-04 
Isoleucine 0.2314 Protoheme 2.23E-04 
Leucine 0.2210 Pyridoxal 5-phosphate 2.23E-04 
Lysine 0.3325 Riboflavin 2.23E-04 
Methionine 0.0662 5,6,7,8-Tetrahydrofolate 2.23E-04 
Phenylalanine 0.1183 Thiamine diphosphate 2.23E-04 
Proline 0.0704 Polyamines  
Serine 0.1982 Putrescine 0.0350 
Threonine 0.1327 Spermidine 0.0070 
Tryptophan 0.0136 Lipids  
Tyrosine 0.1440 Phosphatidylethanolamine 2.88E-04 
Valine 0.1318 Phosphatidylcholine 5.43E-04 
Ribonucleotides  Cholesterol 1.55E-02 
ATP 0.1475 Others  
CTP 0.0320 S-Adenosyl-L-methionine 2.23E-04 
GTP 0.0456 Fe2+ 7.11E-03 
UTP 0.1004 Fe3+ 7.11E-03 
Deoxyribonucleotides  Ammonium 1.18E-02 
dATP 2.12E-03 SO4 3.95E-03 














Supplementary table 5.2. Single deletions displaying a phenotype in the unconstrained 
metabolic network of P. falciparum. L: Lethal, GR: Growth Reducing, SGR: Slight Growth 
Reducing 
 
Gene  Enzyme name EC Number Pred. 
MAL13P1_186 1-deoxy-D-xylulose-5-phosphate synthase 2.2.1.7 L 
MAL13P1_221 1-deoxy-D-xylulose-5-phosphate synthase 2.1.3.2 L 
MAL13P1_292 FAD synthetase, riboflavin kinase 2.7.7.2, 2.7.1.26 L 
MAL13P1_326 Ferrochelatase 4.99.1.1 L 
MAL8P1_81 Phosphopantothenoylcysteine decarboxylase 4.1.1.36 L 




2.7.6.3, 2.5.1.15 L 
PF10_0121 Hypoxanthine phosphoribosyltransferase 2.4.2.8 L 
PF10_0155 Phosphopyruvate hydratase 4.2.1.11 L 
PF10_0221 (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase 1.17.7.1 L 
PF10_0225 Orotidine-5'-phosphate decarboxylase 4.1.1.23 L 
PF10_0275 Protoporphyrinogen oxidase 1.3.3.4 L 
PF10_0363 Pyruvate kinase 2.7.1.40 L 
PF11_0059 Pantothenate transporter -- L 
PF11_0169 Pyridoxine/pyridoxal 5-phosphate biosynthesis enzyme -- L 
PF11_0295 Geranyltranstransferase, dimethylallyltranstransferase 2.5.1.10, 2.5.1.1 L 
PF11_0410 Carbonate dehydratase 4.2.1.1 L 
PF11_0436 Coproporphyrinogen oxidase 1.3.3.3 L 
PF13_0044 
Carbamoyl-phosphate synthase (ammonia), carbamoyl-phosphate synthase 
(glutamine-hydrolysing) 
6.3.4.16, 6.3.5.5 L 
PF13_0140 Dihydrofolate synthase, tetrahydrofolate synthase 6.3.2.12, 6.3.2.17 L 
PF13_0159 Nicotinate-nucleotide adenylyltransferase 2.7.7.18 L 
PF13_0287 Adenylosuccinate synthase 6.3.4.4 L 
PF14_0415 Dephospho-CoA kinase 2.7.1.24 L 
PF14_0598 Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) 1.2.1.12 L 
PF14_0641 1-deoxy-D-xylulose-5-phosphate reductoisomerase 1.1.1.267 L 
PF14_0697 Dihydroorotase 3.5.2.3 L 
PFA0225w 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 1.17.1.2 L 
PFA0340w 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2.7.7.60 L 
PFB0200c 





PFB0280w Shikimate kinase, 3-phosphoshikimate 1-carboxyvinyltransferase 2.7.1.71, 2.5.1.19 L 
PFB0295w Adenylosuccinate lyase 4.3.2.2 L 
PFB0420w Adenylate cyclase, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase 4.6.1.1, 4.6.1.12 L 
PFC0831w Triose-phosphate isomerase 5.3.1.1 L 
PFD0830w Thymidylate synthase, dihydrofolate reductase 2.1.1.45, 1.5.1.3 L 




PFE0410w Dihydroxyacetone phosphate transporter (apicoplast) -- L 
PFE0630c Orotate phosphoribosyltransferase 2.4.2.10 L 
PFE1510c Phosphoenolpyruvate transporter (apicoplast) -- L 
PFF0160c Dihydroorotate oxidase 1.3.3.1 L 
PFF0360w Uroporphyrinogen decarboxylase 4.1.1.37 L 
PFF0370w 3-octaprenyl-4-hydroxybenzoate carboxy-lyase 4.1.1.- L 
PFF0450c Iron transporter -- L 
PFF0530w Transketolase 2.2.1.1 L 
PFF1105c Chorismate synthase 4.2.3.5 L 
PFF1410c Nicotinate phosphoribosyltransferase 2.4.2.11 L 
PFF1490w 
Methylenetetrahydrofolate dehydrogenase (NADP+), 
methenyltetrahydrofolate cyclohydrolase 
1.5.1.5, 3.5.4.9 L 
PFI1090w Methionine adenosyltransferase 2.5.1.6 L 
PFI1100w Aminodeoxychorismate synthase, aminodeoxychorismate lyase 2.6.1.85, 4.1.3.38 L 
PFI1105w Phosphoglycerate kinase 2.7.2.3 L 
PFI1170c Thioredoxin-disulfide reductase 1.8.1.9 L 
PFI1195c Thiamine diphosphokinase 2.7.6.2 L 
PFI1310w NAD+ synthase (glutamine-hydrolysing) 6.3.5.1 L 
PFI1420w Guanylate kinase 2.7.4.8 L 
PFL2210w 5-aminolevulinate synthase 2.3.1.37 L 
PFL2465c dTMP kinase 2.7.4.9 L 
PF14_0378 Triose-phosphate isomerase 5.3.1.1 GR 
PF14_0425 Fructose-bisphosphate aldolase 4.1.2.13 GR 
PFL0960w Ribulose-phosphate 3-epimerase 5.1.3.1 GR 
MAL13P1_206  Phosphate transporter (citoplasm) -- SGR 
MAL13P1_82 CDP-diacylglycerol-inositol 3-phosphatidyltransferase 2.7.8.11 SGR 
MAL13P1_86 Choline-phosphate cytidylyltransferase 2.7.7.15 SGR 
PF10_0122 Phosphoglucomutase 5.4.2.2 SGR 
PF13_0259 dCTP deaminase 3.5.4.13 SGR 
PF14_0097 phosphatidate cytidylyltransferase 2.7.7.41 SGR 
PF14_0341 Glucose-6-phosphate isomerase 5.3.1.9 SGR 
PF14_0511 6-phosphogluconolactonase, glucose-6-phosphate dehydrogenase 3.1.1.31, 1.1.1.49 SGR 
PF14_0520 phosphogluconate dehydrogenase (decarboxylating) 1.1.1.44 SGR 
PFE0660c Purine-nucleoside phosphorylase 2.4.2.1 SGR 
PFF1215w Sphingomyelin synthase 2.7.8.27 SGR 
PFF1375c Ethanolaminephosphotransferase, diacylglycerol cholinephosphotransferase 2.7.8.1, 2.7.8.2 SGR 







Suppelementary table 5.3. Single deletions of orphan metabolic activities predicted to be lethal 
in the unconstrained metabolic network of P. falciparum 
Reaction Name Enzyme EC Number Biological Process 
R_NADK NAD+ kinase 2.7.1.23 Nicotinate and nicotinamide metabolism 
R_UPP3S_ap Uroporphyrinogen-III synthase 4.2.1.75 Porphyrin metabolism 
R_DDPA 3-deoxy-7-phosphoheptulonate synthase 2.5.1.54 Shikimate biosynthesis 
R_DHQS 3-dehydroquinate synthase 4.2.3.4 Shikimate biosynthesis 
R_DHQTi 3-dehydroquinate dehydratase 4.2.1.10 Shikimate biosynthesis 
R_SHK3Dr Shikimate dehydrogenase 1.1.1.25 Shikimate biosynthesis 
R_CHRPL Chorismate lyase 4.1.3.40 Ubiquinone metabolism 
R_OPHBDC_mt  3-octaprenyl-4-hydroxybenzoate carboxy-lyase 4.1.1.- Ubiquinone metabolism 
R_OPHHX_mt  2-octaprenylphenol hydroxylase 1.14.13.- Ubiquinone metabolism 
 
 
Supplementary table 5.4. Double deletions predicted to be lethal in the unconstrained metabolic 
network of P. falciparum. *Isoenzyme pairs 





PF11_0036 Phosphopantothenate-cysteine ligase 6.3.2.5 CoA biosynthesis 
PFD0610w Phosphopantothenate-cysteine ligase 6.3.2.5 CoA biosynthesis 
2* 
PF11_0208 Phosphoglycerate mutase 5.4.2.1 Glycolysis 
PFD0660w Phosphoglycerate mutase 5.4.2.1 Glycolysis 
3 
PF14_0378 Triose-phosphate isomerase 5.3.1.1 
Glycolysis, isoprenoid 
metabolism 
PFL0960w Ribulose-phosphate 3-epimerase 5.1.3.1 Pentose phosphate cycle 
4 
PF10_0122 Phosphoglucomutase 5.4.2.2 
Glycolysis,  pentose 
phosphate cycle 
PFE0730c Ribose-5-phosphate isomerase 5.3.1.6 Pentose phosphate cycle 
5* 
PF13_0143 Ribose-phosphate diphosphokinase 2.7.6.1 Pentose phosphate cycle 
PF11_0157 Ribose-phosphate diphosphokinase 2.7.6.1 Pentose phosphate cycle 
6 
PFE0660c Purine-nucleoside phosphorylase 2.4.2.1 
Purine, methionine and 
polyamine metabolism 
PFE0730c Ribose-5-phosphate isomerase 5.3.1.6 Pentose phosphate cycle 
7* 
PF10_0086 Adenylate kinase 2.7.4.3 Purine metabolism 
PFD0755c Adenylate kinase 2.7.4.3 Purine metabolism 
8* 
PF14_0541  Inorganic diphosphatase 3.6.1.1 
Purine, terpenoid 
metabolism 
PFC0710w Inorganic diphosphatase 3.6.1.1 
Purine, terpenoid 
metabolism 




PFL0305c 5'-nucleotidase 3.1.3.5 Purine metabolism 
10* 
PF13_0349 Nucleoside-diphosphate kinase 2.7.4.6 
Pyrimidine, purine, 
dolichol metabolism 




MAL13P1_82 CDP-diacylglycerol-inositol 3-phosphatidyltransferase 2.7.8.11 
Inositol phosphate 
metabolism 
PF14_0100 CTP synthase 6.3.4.2 Pyrimidine metabolism 
12 
MAL13P1_82 CDP-diacylglycerol-inositol 3-phosphatidyltransferase 2.7.8.11 
Inositol phosphate 
metabolism 
MAL13P1_206 Phosphate transporter -- Transport 
13 




PF14_0100 CTP synthase 6.3.4.2 Pyrimidine metabolism 
14 
MAL13P1_206 Phosphate transporter -- Transport (Pi) 





PFC0725c NO2 transporter -- Transport  




PF10_0334 Succinate dehydrogenase (ubiquinone) 1.3.5.1 
Mitochondrial electron 
flow 
PFC0725c NO2 transporter -- Transport  
 
Supplementary table 5.5. Essentiality in S. cerevisiae of the orthologs for essential and non-
essential Plasmodium metabolic genes. While all of the orthologs for essential metabolic genes 
in yeast are also essential in Plasmodium, only about half of the orthologs for Plasmodium 
essential metabolic genes are essential in yeast. Fisher’s exact test P-value =0.04. 
 
 Yeast essential Yeast non-essential Total 
Plasmodium essential 6 4 10 
Plasmodium non-essential 0 5 5 









Chapter 6.  
 
THE RATE OF THE MOLECULAR CLOCK AND THE COST OF GRATUITOUS 
PROTEIN SYNTHESIS 
This chapter is based on “Plata, G., Gottesman, M., Vitkup, D. The Rate of the Molecular 
Clock and the Cost of Gratuitous Protein Synthesis. Genome Biol. (9):R98, (2010)”  
 
The nature of the protein molecular clock, the protein-specific rate of amino acid substitutions, is 
among the central questions of molecular evolution. Protein expression level is the dominant 
determinant of the clock rate in a number of organisms. It has been suggested that highly 
expressed proteins evolve slowly in all species mainly to maintain robustness to translation 
errors that generate toxic misfolded proteins. Here we investigate this hypothesis experimentally 
by comparing the growth rate of E. coli expressing wild type and misfolding-prone variants of 
the LacZ protein. We show that the cost of toxic protein misfolding is small compared to other 
costs associated with protein synthesis. Complementary computational analyses demonstrate that 
there is also a relatively weaker, but statistically significant, selection for increasing solubility 
and polarity in highly expressed E. coli proteins. Although we cannot rule out the possibility that 
selection against misfolding toxicity significantly affects the protein clock in species other than 
E. coli, our results suggest that it is unlikely to be the dominant and universal factor determining 
the clock rate in all organisms. We find that in this bacterium other costs associated with protein 
synthesis are likely to play an important role. Interestingly, our experiments also suggest 
significant costs associated with volume effects, such as jamming of the cellular environment 







Once the first protein sequences became available, their comparison led to the conclusion 
that the number of accumulated substitutions between orthologs was mainly a function of the 
evolutionary time elapsed since the last common ancestor of corresponding species [65, 315]. 
Consequently, orthologous proteins accumulate substitutions at approximately constant rate over 
long evolutionary intervals. This observation suggests that one can use available protein 
sequences as a molecular clock to estimate divergence times between different species [316]. 
Further studies revealed that while the pace of the molecular clock is similar for orthologous 
proteins in different lineages, it varies by several orders of magnitude across non-orthologous 
proteins [317, 318]. 
 For several decades the dominant hypothesis explaining the large variability of the 
molecular clock rate between non-orthologous proteins was based on the concept of functional 
protein density: the higher the fraction of protein residues directly involved in its function, the 
slower the protein molecular clock [319, 320]. It was not until high-throughput genomics data 
became widely available that multiple molecular and genetic variables were used to investigate 
the dominant factors influencing the molecular clock rates of different proteins. Surprisingly, 
such features as gene essentiality [321-324], the number of protein-protein interactions [72, 325], 
and specific functional roles [70, 326], have been shown to have, on average, either non-
significant, or significant but relatively weak correlations with protein evolutionary rates. On the 
other hand, quantities directly related to gene expression, such as codon bias, mRNA expression, 
and protein abundance, showed the strongest correlation with the rate of protein evolution [73, 
327]. For example, expression alone explains about a third of the variance in the substitution 




[329]. In these and many other organisms highly expressed genes accept significantly less 
synonymous and non-synonymous (amino acid changing) substitutions than genes with with low 
expression levels [330]. 
 Considering the major role played by expression in setting the rate of amino acid 
substitutions, it is important to understand the main molecular mechanisms of this effect [71]. A 
popular theory by Drummond et al. [328, 331, 332] suggests that highly expressed proteins may 
evolve slowly in all organisms, from microbes to human [331], due to the selection against 
toxicity associated with protein misfolding. The logic behind this interesting hypothesis is that a 
significant fraction (>10%) of cellular proteins may contain translation errors [333, 334] that 
could cause cytotoxic protein misfolding. If misfolded proteins indeed incur substantial toxicity 
costs, greater pressure to avoid misfolding will affect highly expressed genes since they generate 
relatively more misfolded proteins [328]. Consequently, adaptive pressure will maintain 
sequences of highly expressed proteins robust to translation errors, which will in turn slow the 
amino acid substitution rate, i.e. the protein molecular clock. The misfolding toxicity hypothesis 
was supported by the results of computer simulations [331], but to the best of our knowledge, it 
has never been tested experimentaly. 
 In this study we specifically investigated whether the toxicity of misfolded proteins or 
other costs associated with protein synthesis make a dominant contribution to cellular fitness 
(growth rate), and consequently constrain the molecular clock in E. coli. To test this, we used 
wild type (WT) and misfolding-prone variants of the E. coli -galactosidase gene, lacZ. We also 






The native biological function of the LacZ protein is to cleave lactose for use as a source 
of carbon and energy [335]; in the absence of lactose,  -galactosidase does not participate in the 
E. coli carbon metabolism. Therefore, we used lacZ expression in a lactose-free medium to 
measure the cost of gratuitous protein expression [336, 337]. To compare that expression cost to 
the cost of potentially toxic protein misfolding, we used site-directed mutagenesis to engineer 
several destabilizing single-residue substitutions into lacZ. Single amino acid substitutions 
should serve as a good model for translational errors because only rarely, in about 10% of the 
proteins that contain translation errors, two or more residues will be simultaneously 
mistranslated in the same protein. We expressed the misfolding-prone mutants at the same level 
as the wild type protein. Because the misfolded LacZ proteins are both potentially toxic and also 
devoid of biological function, the comparison of the growth rates of bacteria carrying the WT 
and each of the destabilized mutants allowed us to evaluate the additional fitness cost specifically 
arising from misfolding toxicity. 
6.2.1. Destabilizing mutations in lacZ yield aggregated and partialy soluble proteins 
Amino acid substitutions in protein cores are significantly more destabilizing than 
substitutions on protein surfaces [338, 339]. Therefore, we selected five buried residues encoding 
non-polar amino acids which could be mutated to polar residues with single nucleotide 
substitutions while maintaining a similar level of codon preference (Table 6.1). We used the 
DPX server [340] to identify buried residues of the LacZ protein based on its crystal structure 
(PDB code: 1dp0). We then applied the I-mutant_2.0 algorithm [341] to confirm that the selected 




substitutions were introduced separately into plasmids containing lacZ under transcriptional 
control of the IPTG-inducible lac promoter [342]. We then used a -galactosidase assay [343] to 
experimentally confirm reductions in the catalytic activity of LacZ in all of the generated 
mutants (see Table 6.1). 
Table 6.1. Characteristics of destabilizing mutations engineered into E. coli -galactosidase. 
In the table ∆∆G values represent destabilizing effects predicted by the I-mutant2.0 server [341]. 
The experimentally determined enzymatic activities of the mutants (in percentages) are shown in 
the table relative to WT. 
 
Mutant V567D F758S I141N G353D A880E 
Predicted ∆∆G  
kcal/mol 
-2.6 -2.9 -2.4 -1.6 -0.6 
Relative protein activity  
(%) 
31 4 17 2 61 
Codon Substitution 
(WT/Mutant) 
GTC/GAC TTT/TCT ATT/AAT GGC/GAC GCG/GAG 
Codon preference % 
 (WT/Mutant) 
13.5/53.9 29.0/32.4 33.5/17.3 42.8/53.9 32.3/24.7 
Found in inclusion bodies 
(see Figure 1A) 
No Yes Yes Yes No 
 
 To determine whether the destabilized proteins tended to aggregate, we separated soluble 
proteins and proteins in inclusion bodies (see Methods) and analyzed them by SDS-PAGE (Fig. 
6.1A). The three mutants with the lowest catalytic activity (F758S, I141N and G353D) were 
found in inclusion bodies (Table 6.1), the remaining two mutants (V567D and A880E) and WT 
proteins were found mainly in the soluble protein fraction. Next, by inspecting total cell extracts 
at different time points after IPTG induction, we confirmed that the total amount of protein 
synthesized in each mutant strain was similar to WT. As shown in Figure 6.1B similar amounts 




Quantitative analysis of the Coomasie stained bands also did not reveal any significant difference 
between the LacZ synthesis rates in WT and mutant strains (Fig. 6.1C). Finally, because 
expression of misfolded proteins is expected to generate a heat shock response [344, 345], we 
used western blots to monitor the amount of the GroEL heat shock protein in induced and un-
induced cells carrying WT and mutant lacZ (Fig. 6.1D). In cells carrying WT lacZ, the 
concentration of GroEL increased when IPTG was added. However, in both the V567D and 
F758S mutants, the levels of GroEL in either induced or uninduced cells were equal or higher 
than that in induced WT cells. 
 
Figure 6.1. Expression of destabilizing mutants and WT LacZ. (A) SDS-PAGE of soluble 
and insoluble fractions of cells expressing WT LacZ and five destabilizing mutants induced with 
10 M IPTG. (B) Total -galactosidase at different times after IPTG induction. The LacZ band 
is indicated by the black arrow. (C) Relative synthesis rate of -galactosidase. P-values were 
obtained using a t-test of the linear regression slopes based on quantification of the gel images. 
(D) GroEL western blots in cells exprerssing WT and LacZ mutants. S: Soluble fraction, I: 
Insoluble fraction.-: No IPTG, +: 20 M IPTG, ∆: Heat shock (1h shift from 37 to 42°C). 
Time after IPTG (min)                         60                                     90                                    180 
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 Overall, the results described in this section demonstrate that: 1) all engineered mutants 
have significantly reduced catalytic activities, 2) soluble and insoluble mutants are expressed at 
the same level as WT, and 3) the mutants induce a heat shock response, and in some cases 
aggregate in inclusion bodies. 
6.2.2. Misfolded proteins are no more toxic than WT proteins 
 The synthesis of WT or mutant -galactosidase was initially induced by adding 10 M 
IPTG. Using WT LacZ activity as a reference [346], we estimated that about 30,000 molecules 
of -galactosidase were present in each bacterial cell at this induction level. This approximately 
corresponds to half of the protein molecules expressed by a fully induced WT lacZ operon [343]. 
Cells expressing WT LacZ grew approximately 13% slower on glycerol as the sole carbon 
source compared to uninduced cells (Fig. 6.2A). If misfolded proteins indeed impose a 
significant extra cost on the bacterium, then similarly expressed mutant strains with destabilizing 
substitutions should lead to a more pronounced growth decrease compared to the one observed 
with WT LacZ. However, as shown in Fig. 6.2A, the mutant strains grew as well as cells 
expresing WT LacZ, and, despite inclusion body formation, two of the mutants even grew 
significantly faster (see Discussion).  
To further explore the potential toxicity of the destabilized proteins we focused on two 
mutants (F758S and V567D). These mutants are examples of a completely aggregated and a 
soluble but destabilized LacZ protein, respectively. By varying the concentration of IPTG we 
monitored the growth of cells with different levels of expressed LacZ proteins (Fig. 6.2B). 
Importantly, no additional growth decrease was observed in the mutant strains compared to the 




from the un-induced promoter, we also observed the same growth rate reduction in all constructs 
relative to cells carrying an empty pBR322 plasmid (Fig. 6.2B). 
 

















































































































Figure 6.2. Growth rate comparisons between WT and misfolding-prone LacZ. (A) Growth 
rates of cells expressing WT LacZ relative to uninduced cells and cells expressing each of the 
five destabilizing mutants (10 M IPTG). Mann-Whitney U P-value *:0.02,**:7.6*10
-4
. (B) 
Growth rates of cells expressing WT LacZ and two mutants at different induction (IPTG) levels, 
the growth rate of cells carrying an empty plasmid is also shown for comparison. (C) Growth 
rates of cells expressing LacZ and two destabilizing mutants on acetate and glycerol as the main 
carbon source (expression in both cases was induced with 10 M ITPG). Error bars represent the 





 We investigated the possibility that the toxicity of misfolded proteins was more 
pronounced on a relatively poor carbon source by measuring the growth of E. coli cells 
expressing V567D, F758S, and WT on acetate. Although the overall growth rate on acetate was 
only about 60% of that on glycerol, we again did not observe any additional fitness (growth) 
decrease due to the destabilizing mutations (Fig. 6.2C). This experiment confirmed that the 
observed results are not specific to a particular carbon source. 
6.2.3. Nucleotide level selection, protein solubility, and stability in E. coli 
 Nucleotide sequences of highly expressed genes are significantly constrained by selection 
for amino acid codons corresponding to abundant tRNAs [347-349]. A recent experimental 
analysis by Kudla et al. [350] suggests that non-optimal codons can directly influence E. coli 
growth (fitness). Using 154 variants of Green Fluorescent Protein (GFP) with multiple random 
synonymous substitutions, these authors found a significant positive correlation between codon 
optimality and bacterial growth rate. An important role played by the nucleotide-level selection 
in evolution of E. coli proteins is also supported by a high correlation between the rates of non-
synonymous (Ka) and synonymous (Ks) substitutions (Fig. 6.3B, Spearman’s rank correlation 
r=0.66, P-value<10
-10
). In addition, the partial correlation between Ka and mRNA expression, 
controlling for Ks, is small (r=-0.14, P-value=7*10
-9
), whereas the partial correlation between Ks 











































































Figure 6.3. Correlation of E. coli mRNA expression with Ka, protein solubility, and the 
fraction of charged residues. (A) Correlation between expression and the rate of non-
synonymous substitutions (Ka) (Spearman’s r=-0.45, P-value<10
-10
). (B) Correlation between Ka 
and the rate of synonymous substitutions (Ks) (r=0.66, P-value<10
-10
). (C) Correlation between 
expression and protein solubility measured in vitro [351] (r=0.27, P-value< 10
-10
). (D) 
Correlation between expression and the fraction of charged residues (r=0.28, P-value<10
-10
). The 
red lines on each panel represent a 200-point moving average of the data. 
 
Although selection for optimal codons at the nucleotide level should significantly affect 
the rates of both synonymous and non-synonymous substitutions [349], there are additional 
constraints specifically acting on non-synonymous sites (see [71, 352]). Many of these additional 




reported that highly expressed E. coli proteins are more soluble than proteins with lower 
expression [353-355]. It is likely that the observed increase in solubility is necessary to avoid 
protein aggregation and non-functional binding [356] mediated by non-specific hydrophobic 
interactions. Using the genome-wide protein solubility data for E. coli proteins obtained by Niwa 
et al [351] we indeed observed a significant correlation between solubility and expression (Fig. 
6.3C; Spearman’s r= 0.27, P-value<10
-10
). Importantly, the observed selection for solubility does 
not explain the correlation between the protein evolutionary rate and expression (Fig. 6.3A, r=-
0.45, P-value<10
-10
); the partial correlation between Ka and expression, controlling either for 




The positive correlation between solubility and expression is in agreement with an 
increase in the fraction of charged residues (Fig. 6.3D, r=0.28, P-value<10
-10
) and a 
simultaneous decrease in the fraction of hydrophobic residues (r=-0.16, P-value<10
-10
) in highly 
expressed E. coli proteins. We observed similar results by analyzing E. coli protein duplicates 
(paralogs) with different expression levels. By directly comparing duplicates expressed at 
different levels, many confounding factors, such as differences in folding topology or protein 
secondary structure, are removed. The analysis of 370 E. coli paralogs (see Methods) 
demonstrated a decrease in the fraction of hydrophobic residues (paired Wilcoxon signed rank 
test, P-value=7*10
-4
) and a simultaneous increase in the fraction of charged residues (P-
value=7*10
-6
) in the duplicates with higher expression levels.  
The analysis of 602 E. coli protein structures currently available in PDB (see Methods,) 
confirmed a significant increase in the fraction of solvent-exposed charged residues in highly 
expressed proteins (r=0.18, P-value=6*10
-6




stabilities [357], a proposed consequence of selection for translational robustness [331], we did 
not detect strong correlations between mRNA expression and other structural features usually 
associated with increased protein stability [328, 331]. For example, we did not observe a 
significant increase in the fraction of buried hydrophobic residues (r=0.06, P-value=0.13) [358-
360] or an increase in the average number of contacts per residue (contact density) in highly 
expressed E. coli proteins (r=0.02, P-value=0.96). Neither did we find a decrease in the fraction 
of residues in loops or unstructured protein regions (r=0.07, P-value=0.06) [361]. Our analysis of 
experimentally determined E. coli protein stabilities assembled in the ProTherm database [362] 
also failed to reveal any significant correlation between protein stability, measured either by 
protein melting temperature (r=-0.14, P-value=0.46) or folding free energy (∆G, r=-0.08 P-
value=0.70), and mRNA expression level (Fig. 6.4A, B). We also did not detect significant 
changes in the contact order, a structural measure strongly associated with folding speed [363, 
364], in highly expressed bacterial proteins (r=-0.01, P-value=0.8). 
Overall, the computational analysis described above suggests that, at least based on the 
currently available datasets, an increase in folding speed and/or protein stability for highly 
expressed bacterial proteins are unlikely to play a major role in constraining the protein 
























































Figure 6.4. Relationship between protein stability and mRNA expression. The 
experimentally measured stability data were obtained from the ProTherm database [362], the 
expression data for E. coli was obtained from the study of Lu et al. [365] (A) Correlation 
between mRNA expression and melting temperature for 28 proteins (r=-0.14, P-value=0.45). (B) 
Correlation between mRNA expression and folding free energy for 23 proteins (r=-0.08, P-
value=0.70). The dashed red line represents the linear regression line between each feature and 
the natural logarithm of the expression values. 
 
6.3. Discussion 
The results presented here demonstrate that, at least in E. coli, the cost associated with the 
gratuitous expression of a protein is significantly higher than the additional toxicity cost incurred 
by destabilization or misfolding of the same amount of protein; by “gratuitous” we imply here 
that the protein has no effect on fitness through its biological function. It is important to 
emphasize that our growth measurements are not sensitive enough to detect small fitness effects, 
for example decreases in the growth rate on the order of 1% or less, and consequently we cannot 




by Lindner et al. [367] using time-lapse microscopy, showed that the presence of protein 
aggregates in E. coli has an effect on growth rate at the level of individual cells. Nevertheless, 
our experiments do show that the misfolding toxicity cost is significantly smaller than other costs 
associated with protein expression. 
We believe that the main expression costs specifically in this bacterium are related to 
translational efficiency and jamming of the cell’s cytoplasm with useless proteins. Importantly, 
expression costs associated with amino acid waste, or the energy required for gratuitous 
expression were recently shown by Stoebel et al. [368] to play a relatively minor role. On the 
other hand both gratuitous protein expression and suboptimal codons can significantly slow 
bacterial growth, for instance, by reducing the pool of free ribosomes in the cell [342, 350]. This 
effect will preferentially affect highly expressed genes bound by a relatively larger number of 
ribosomes. A gene with non-optimal codons will slow the rate of translation (speed of ribosomal 
motion) and thus titrate more ribosomes. A reduced pool of free ribosomes will necessarily slow 
expression of all bacterial genes and thus decrease the rate of biomass synthesis [369]. 
Interestingly, we observed that bacteria expressing two of the mutants (F758S and 
G353D) grew significantly faster than cells expressing native LacZ protein (Figure 6.2A), 
although still not as fast as uninduced E. coli. This intriguing result demonstrates that titration of 
ribosomes cannot be the only explanation for the costs associated with gratuitous protein 
synthesis. The F758S and G353D proteins had the lowest catalytic activities of all constructs 
(Table 6.1) and both mutants, as well as I141N, were found mostly in inclusion bodies. It is 
likely that the localization of the LacZ proteins to inclusion bodies prevents jamming of the 
cytoplasm and relieves effects associated with non-functional binding. It was previously shown 




rejuvenation phenotype [367]. We would like to emphasize that this result does not support the 
misfolding toxicity hypothesis, as these mutants grew faster than the strain expressing WT LacZ. 
Based on the growth rates of mutants primarily localized to inclusion bodies (V567D, F758S, 
I141N; average growth decrease 6.7%) and the proteins remaining in the cytoplasm (WT, 
V567D, A880E; average growth decrease, 14%), one can conclude that effects of jamming and 
translational efficiency make approximately similar contributions to fitness. 
An important separate question in the context of the mistranslation-induced misfolding 
hypothesis is whether phenotypic (transcriptional or translational) mutations can cause enough 
protein misfolding to be significantly cytotoxic. Although suboptimal codons are expected to 
substantially increase the translational error rate [348], no correlation was observed between 
codon optimization and the fraction of properly folded GFP by Kudla et al.[350]. Even if 
relatively rare, phenotypic mutations can be still significantly damaging if they occur in 
functionally and structurally important sties. This may explain a well-established correlation 
between codon optimization and evolutionary conservation of corresponding protein sites [370-
372]. This correlation is not necessarily a consequence of selection against mistranslation 
induced toxicity, and again may be primarily related to the loss of functional proteins and the 
cost of additional protein synthesis necessary to compensate for the misfolding. In fact, it has 
been reported that essential bacterial proteins have lower aggregation propensities than those 
predicted for non-essential proteins [355]. 
 While our study demonstrates that misfolding toxicity is unlikely to be a universally 
dominant factor connecting expression and the protein molecular clock in all species, we cannot 
rule out the possibility that toxicity may play an important role in other species. We note, 




molecular clock are generally much weaker than in some microbes. For example, Liao et al. 
[373] demonstrated that expression plays a relatively minor role in constraining the molecular 
clock in mammalian species. Also, by comparing evolutionary rate of separate and fused protein 
domains in human and Arabidopsis, Wolf et al. [374] found a comparable contribution from 
expression and structural-functional constraints. 
 A number of elegant experimental studies have demonstrated cytotoxic effect of several 
misfolded or marginally stable proteins in higher organisms [375, 376]. For instance, several 
hundred mutations in the SOD1 protein were shown to result in aggregates associated with 
amyotrophic lateral sclerosis (ALS) in humans [377]; also, non-natural peptides have been used 
to induce cytotoxic aggregates of GFP in C. elegans [378]. Although these studies directly 
demonstrate the importance of misfolding and aggregation for some specific proteins, the extent 
to which these effects dominate the molecular clock for all proteins in these and other species 
needs to be investigated and again compared to other contributing factors. 
6.4. Conclusions 
 Our experimental results suggest that selection against toxic protein misfolding is 
unlikely to be the universal and dominant factor determining protein molecular clock in all 
species. We demonstrate that, at least in E. coli, other factors associated with gratuitous protein 
synthesis, such as translational efficiency and possibly jamming of the cytoplasm, are likely to be 
the primary constraints. Our computational analyses also suggest a relatively weaker, but 





6.6. Materials and methods 
6.6.1. Strains and mutant generation 
 Escherichia coli K12 strain GP4 (W3102,  XA 21Z, lacI
q
) was used in all experiments. 
lacZ was expressed from the IPTG inducible Lac promoter in plasmid PIV18 [342]; PIV18 is a 
pBR322 derivative that carries a mutation in the Shine Dalgarno sequence of the lacZ transcript 
which increases translation efficiency. Site directed mutagenesis was carried out using 
Stratagene's QuikChange Lightning kit (Stratagene, Cedar Creek, TX). pBR322 was used as the 
empty plasmid control. 
6.6.2. Growth Curve Analysis 
 For each construct, a sweep of colonies was grown overnight on LB liquid media 
supplemented with 100g/mL ampicillin. Overnight cultures were diluted by a 1:100 factor and 
grown on M9 minimal media suplemented with 0.5% casaminoacids, 0.25g/mL thiamine, 100 
g/mL ampicillin and either 0.4% glycerol or acetate as carbon sources. 300 L of cells with an 
OD600 of 0.5 were transfered to flasks containing 5.5 mL of prewarmed media suplemented 
with the appropiate amount of IPTG. Two hours after induction, OD600 was measured every 45 
minutes. Growth rate was determined as the regression line slope of time and the logarithm of 
OD600. 
6.6.3. SDS-PAGE and western blot 
 The equivalent of 200 L of cells at OD600 of 0.7 was collected by centrifugation and 




Merck, Darmstadt, Germany). Soluble proteins were retrieved after centrifugation of the lysed 
cells and aggregated proteins were then harvested following instructions for inclusion body 
purification described in the BugBuster reagent manual. Both fractions were saved in a 50 L 
volume including 10 L 4X SDS loading buffer, boiled, and electrophoresed on a 10% 
SDS  polyacrylamide gel. Gels were stained with coomassie blue and scanned for analysis. For 
the analysis of total protein, cells were lysed in BugBuster reagent containing rLysozyme and 
boiled after addition of 4X SDS loading buffer. Bands were quantified using the ImageJ program 
[379]. 
 Protein samples separated by SDS-PAGE as described above were blotted overnight onto 
a nitrocellulose membrane and incubated with Anti-GroEL antibody produced in rabbit 1:10 000 
(Sigma Aldrich, St. Louis, MO). Blots were blocked with 5 % non-fat dry milk, incubated with 
1:3000 anti-rabbit horseradish peroxidase conjugate antibody and visualized with Amersham's 
ECL Plus Western Blotting Reagent (GE Healthcare, Munich, Germany).  
6.6.4. Structural analysis of E. coli proteins 
 In the analysis we used 602 E. coli protein structures currently available in PDB [380]. 
To prevent sampling biases, we filtered available PDB entries so that no two protein structures 
used in the calculations, had sequence identity higher than 90%; similar results were obtained 
without filtering. We defined buried residues as those with a solvent accessible area smaller than 
16% [381, 382]. Solvent accessibility was calculated by the DSSP [383] program. The fraction 
of protein residues in loops was also calculated using DSSP. Two non-adjacent protein residues 
were considered to be in contact if any two of their non-hydrogen atoms were closer than 4.5 Å 




per residue. Contact order was calculated as (L·N)
-1
·Σ∆Sij; where N is the total number of 
contacts, L is the total number of residues in the protein and ∆Sij, which is summed over all 
contacts, is the number of aminoacids separating contacting residues[364]. In vitro solubility data 
for E. coli proteins was obtained directly from the study of Niwa et al. [351] 
6.6.5. Correlation of the synonymous (Ks) and non-synonymous (Ka) substitution rates with 
expression 
 Orthologous ORFs and protein sequences from E. coli and Salmonella enterica were used 
to calculate Ks and Ka values. The E. coli - Salmonella orthologs were determined as bi-
directional best hits using protein BLAST [18]. Ka and Ks values were calculated using the 
Maximum Likelihood method implemented in the PAML package [385]. The mRNA expression 
data reported by Lu et al. [365] was used to calculate the correlations. For the analysis of 
duplicated genes we defined duplicates as pairs of E. coli proteins having more than 40% 
sequence identity that could be aligned for at least 80% of their total length using BLAST. In the 
analysis of duplicates we used expression data from 466 experiments in the Many Microbes 
Microarrays Database [386]. We selected for the analysis only the pairs for which one paralog 























































GENETIC ROBUSTNESS AND FUNCTIONAL EVOLUTION OF GENE 
DUPLICATES 
 
Gene duplications are a major source of evolutionary innovations. Understanding the functional 
divergence of duplicates and their role in genetic robustness is an important challenge in biology. 
Previously, analyses of genetic robustness were primarily focused on duplicates essentiality and 
epistasis in several laboratory conditions. In this study we use several quantitative datasets to 
understand compensatory interactions between S. cerevisiae duplicates that are likely to be 
relevant in natural biological populations. Our study suggests that duplicates acquire new 
functional roles substantially faster than has been anticipated, possibly from the moment of 
duplication. Due to their high functional load, very close duplicates are unlikely to provide 
substantial backup in the context of long term evolution. Interestingly, for gene pairs that survive 
an initial period of high duplicate loss, the overall functional load is reduced. At intermediate 
divergence distances the quantitative decrease in fitness due to removal of one duplicate 
becomes smaller. At these distances, yeast duplicates display more balanced functional loads and 
their transcriptional control becomes significantly more complex. In the context of growth 
phenotypes relevant in natural populations, yeast duplicates diverged beyond 70% sequence 
identity are not likely to provide substantial compensation for their paralogs. 
7.1 Introduction 
Survival of biological systems crucially depends on robustness to harmful genetic 
mutations, i.e. genetic robustness, and to changes in environmental conditions [387-389]. Two 
distinct mechanisms of genetic robustness have been previously discussed. First, alternative 




molecular networks [390, 391]. Second, a major role in genetic robustness is attributed to gene 
duplicates [387, 392]. Gene duplications are frequent in evolution and range in size from small-
scale (SSD) to whole-genome events (WGD) [393, 394]. While in about 90% of the cases one 
duplicate is eventually lost in evolution [392], duplicated genes can, at least partially, back-up 
each other's function. Importantly, functional compensation by duplicates plays a significant role 
in buffering deleterious human mutations [395]. 
 Genetic robustness due to gene duplicates is inherently tied to their functional 
divergence. Duplicates that acquire distinct molecular functions are naturally unable to 
compensate for one another. In addition, even if molecular function is conserved, incomplete 
compensation between duplicates is possible due to different expression patterns or dosage 
effects. Gene duplications are the major source of new genes [396] and several conceptual 
models of duplicates’ evolution have been proposed [397, 398]. In the neofunctionalization 
model one duplicate gains new functions, i.e. functions not associated with the ancestral gene, 
while the other duplicate retains the ancestral functions [396, 399, 400]. In contrast, in the 
subfunctionalization model both duplicates become indispensable and are retained in evolution 
by partitioning the ancestral gene functions [401, 402]. Both these models imply an eventual loss 
of the ability of duplicates to fully substitute for each other. It is also likely that a significant 
fraction of duplicates are fixed and retained in genomes due to selective advantages, such as 
dosage effects or condition-specific expression patterns, present from the moment of duplication 
[403, 404]. In cases of fixation due to a selective advantage, full compensation between 
duplicates is unlikely. 
Even though full compensation between duplicates is not expected in the long term, the 




by several independent approaches. These include a lower than expected fraction of essential 
genes with close duplicates [387], a paucity of pairwise epistatic interactions involving 
duplicated genes [405], and an excess of aggravating genetic interactions between paralogs [406, 
407]. The contribution of duplicates to robustness has been primarily considered in the context of 
qualitative growth phenotypes either in nutrient rich or in a small number of laboratory 
conditions [387, 408, 409]. Although popular in experiments, these conditions are unlikely to 
approximate well a natural milieu of living systems which are constantly bombarded by a diverse 
array of environmental stresses and stimuli. Perhaps more importantly, even if there is a strong 
compensatory interaction between a pair of duplicates, an evolutionary relevant decrease in 
fitness can still persist – due to an incomplete buffering – after a damaging mutation in one of the 
duplicates [366]. In the context of long-term evolution, there may not be much difference 
between mutations leading to the lethal phenotype and mutations associated with a fitness 
decrease substantially larger than the inverse of the effective population size [410, 411]. Given 





even a small fitness decrease can be effectively lethal for these organisms. Consequently, 
quantitative analyses of growth phenotypes, preferably in multiple environmental conditions, are 
necessary to understand the extent to which compensation between duplicates plays an important 
role in natural biological populations. Here we perform such an analysis and show that in the 
context of natural populations, genetic buffering mediated by duplicates is likely to be rare and, 
surprisingly, it is not a monotonic function of duplicates’ divergence.  
7.2. Materials and methods 
 Gene and protein sequences for Saccharomyces cerevisiae, S. paradoxus, S. bayanus, S. 




Genome Database (SGD; http://downloads.yeastgenome.org/) and the study by Kellis et al. 
[413]. Pairs of gene duplicates were identified by sequence homology between proteins within 
each genome using BLASTP [18]. Only duplicates that were bi-directional best hits and could be 
aligned by more than 80% of each ORF’s sequence length were considered in our analysis [414]. 
Following previous studies [387], we excluded ribosomal genes from the analysis due to their 
high expression, dominant impact on growth, and strong codon adaptation bias. Evolutionary 
distances between duplicated genes were estimated using the method of Yang and Nielsen [415] 
implemented in the PAML package [385]; the use of other methods, such as maximum 
likelihood, to estimate Ka and Ks did not significantly change the observed patterns 
(Supplementary fig. 7.1A). 
We used the data obtained by Hillenmeyer et al. [416] to measure the fitness contribution 
of duplicates across multiple environmental conditions and chemical perturbations. Using a P-
value cutoff of 0.01, we obtained the number of experimental conditions for which a growth 
defect was observed for every single gene deletion mutant. We also analyzed quantitative growth 
measurements for double and single deletion yeast strains obtained from De Luna et al. [417] 
and Costanzo et al. [418]. Gene essentiality data was obtained from the study of Giaever et al. 
[289].  
To functionally characterize duplicated genes, Gene Ontology [419] annotations were 
collected from SGD and EC annotations from the Comprehensive Yeast Genome Database 
(CYGD)[420]. Transcription factor binding motifs used in our work were compiled from Kafri et 
al. [421] and the high-confidence predictions in Kellis et al. [413]. We used protein localization 
data from Huh et al. [422], Codon Adaptation Index (CAI) calculations based on the dataset by 





 Hillenmeyer et al. [416] quantified growth phenotypes of single-gene yeast deletion 
strains in a large collection of environmental conditions. The assembled dataset contains 
approximately 5.5 million phenotypes of heterozygous and homozygous mutants in about 400 
conditions. The sampled conditions represent 27 different environmental stresses and hundreds 
of perturbations with diverse chemical compounds. Environmental stresses comprised different 
growth media, media lacking specific vitamins or amino acids, as well as different pH and 
temperature regimes. This comprehensive collection of phenotypes allowed us to investigate in 
detail the diversification of duplicates’ functions and their contribution to genetic robustness in 
multiple conditions.  
7.3.1. Compensation patterns based on quantitative fitness data 
We first investigated how the average number of sensitive conditions, i.e. conditions with 
a significant growth decrease due to deletion of one duplicate, depends on sequence divergence 
(Ka) between the duplicated genes (Fig. 7.1A, B). We considered the fraction of different 
conditions with a growth phenotype as a quantitative measure of compensation capacity for 
duplicates at various divergence distances. For very close duplicates the average number of 
sensitive conditions is not significantly different from that of a random pair of yeast singletons 
(Fig. 7.1B red line). Importantly, this result does not suggest that random gene pairs and close 
duplicates are equivalent in terms of similarity of their molecular function. As we demonstrate 
below, the observed pattern is likely due to a higher overall functional load of close duplicates; 
here and throughout the paper we use the term functional load of a gene to characterize the 




Interestingly, the number of sensitive conditions initially drops as duplicates diverge, 
decreasing about 30% at the distances corresponding to Ka ≈ 0.1 (Ks ≈ 1, see Supplementary 
fig. 7.2A, B). As duplicates diverge further, the average number of sensitive conditions increases 
again, reaching the average for a random pair of yeast singletons at Ka ≈ 0.25. The trend shown 
in Figure 7.1B is not sensitive to the P-value cutoff used to determine the significance of the 
growth decrease observed in mutant strains (Supplementary fig. 7.3). A similar trend was also 
observed for the average growth decrease, measured either by log-ratios or Z-scores across all 
tested conditions (Supplementary fig. 7.4A, B). Bin-free analyses of the data (Supplementary 
fig. 7.1B, C, 7.2B) also revealed a smaller fitness cost due to the loss of duplicates at 
intermediate distances (Ka ≈ 0.1). 
Because most actively growing wild-type yeast populations are diploid [423], we mainly 
focused our analysis on heterozygous mutant strains. The patterns of functional compensation for 
heterozygous and homozygous mutants are similar when multiple-drug resistance genes, as 
defined by Hillenmeyer et al. [416], are not considered (Supplementary fig. 7.4C). The trends 
also remain similar when only environmental perturbations are analyzed in the homozygous 
experiments (Supplementary fig. 7.4D). We also checked that the observed compensation 
patterns due to closest duplicates are not significantly influenced by additional, i.e. more 
diverged, paralogs (Supplementary fig. 7.4E). This lack of significant compensation by 
diverged duplicates results in an approximately linear relationship between the number of 
sensitive conditions per yeast protein family and the family size (Supplementary fig. 7.5). 
Finally, the observed compensation patterns were not affected by removal of gene pairs with a 




trend cannot be explained by expression-based constraints on the rate of duplicate sequence 
evolution (Ka) [73]. 























































































































































































Figure 7.1. Compensation patterns between yeast duplicates as a function of their 
evolutionary divergence, Ka, the number of non-synonymous substitutions per site. A. Scatter 
plot of the fraction of sensitive conditions, i.e. conditions with detectable growth phenotypes 
resulting from deletion of one duplicate gene, versus Ka. Each dot in the figure represents a pair 
of yeast duplicates. B. The average fraction of sensitive conditions per duplicate pair. The P-
value was calculated using the Mann Whitney U test. The red lines in A and B indicate the 
average fraction of sensitive conditions for a random pair of yeast singletons. C. The average 
fraction of essential duplicates, i.e. duplicates with a lethal phenotype upon deletion, as a 
function of Ka. The red line indicates the fraction of essential yeast singletons. Gene essentiality 
data were obtained from the Saccharomyces Genome Deletion Project [289]. D. Fraction of 
conditions with a significant growth decrease for deletion of yeast duplicates arising from small-




as SSD or WGD based on the study by Kellis et al. [394] The red line shows the average fraction 
of sensitive conditions for a random pair of yeast singletons. In the figures, error bars represent 
the standard error of the mean (SEM). 
 
It is interesting to compare the ability of duplicates to buffer mutations leading to any 
detectable growth decrease beyond a given fitness threshold (Fig. 7.1B) and their role in 
protecting against the no-growth phenotype, i.e. the likelihood to observe essential genes in 
duplicate pairs. In Figure 7.1C, using data from the study by Giaever et al. [289], we show the 
fraction of essential duplicates as a function of their divergence. In agreement with previous 
studies [387, 408, 409] we found that the fraction of essential genes remains low and 
approximately constant for close duplicates, and increases substantially only at divergence 
distances corresponding to Ka > 0.4. Notably, this pattern is qualitatively different from the 
compensation for quantitative growth phenotypes (Fig. 7.1B), demonstrating the aforementioned 
impact of using quantitative phenotypes to assess the evolutionarily relevant consequences of 
mutations. Also in contrast to patterns obtained in studies based on essential genes [408], we 
observed similar compensation profiles for gene pairs originating from small-scale and genome-
wide duplications (Fig. 7.1D). Because all WGD duplicates have the same age, this result 
suggests that the ability of duplicates to buffer each-other’s function across multiple conditions 
depends more strongly on their sequence divergence than on the time since duplication. 
7.3.2. Correlates of functional compensation  
It is likely that the observed decrease in the number of sensitive conditions at 
intermediate divergence distances (Ka ≈ 0.1) is due to a decrease of the functional load carried at 
these distances by the union of duplicate genes. To explore this possibility we considered the 




from Costanzo et al. [418]. In these studies the authors performed quantitative growth 
measurements of yeast strains with individual and simultaneous deletions of duplicates. Using 
the single deletion phenotypes from the DeLuna et al. (Fig. 7.2A) and Costanzo et al. studies 
(Fig. 7.2B), we observed fitness profiles similar to the one obtained based on the data from 
Hillenmeyer et al. (Fig. 7.1B) as a function of Ka, with smaller phenotypic effects at 
intermediate distances. Interestingly, the overall functional importance of duplicate pairs, 
measured by the phenotype of double deletions, indeed substantially decreases with their 
divergence (Fig. 7.2C, D). This result suggests that while close duplicates are more likely to 
have similar functions, their higher functional load makes complete compensation less likely. 
Because the overall functional load of duplicates remains approximately constant for Ka > 0.1, 
the higher fraction of detectable growth phenotypes at these distances is likely due to a decreased 
ability for functional compensation as duplicates diverge. Indeed, compensation between 
duplicates quantified by the presence of aggravating interactions between duplicate pairs 

























































































































































Figure 7.2. Growth phenotypes for individual and simultaneous deletion of duplicates as a 
function of their sequence divergence (Ka). The results in the first column (A, C, E) are based 
on the competition experiments by DeLuna et al. [417], and in the second column (B, D, F) on 
the synthetic genetic arrays (SGA) by Costanzo et al. [418]. A, B. Fractions of single duplicate 
deletions with a significant growth decrease. C, D. Fractions of simultaneous (double) duplicate 
deletions with a significant growth decrease. Due to different measurement sensitivities of the 




DeLuna et al. (A, C) and 10% for Costanzo et al. (B, D); the presented results are not sensitive to 
the exact cutoff values (see Supplementary fig.7.6). P-values were obtained using Fisher’s exact 
test. E, F. Fraction of paralogs with a significant negative epistatic interaction from the studies of 
DeLuna et al. and Costanzo et al., respectively. In the figures error bars represent the SEM. 
 
Besides a smaller overall functional load, it is possible that duplicates at intermediate 
distances have other properties that favor genetic robustness. To explore this possibility, for each 
duplicate pair we looked at the gene with the largest and the gene with the smallest number of 
sensitive conditions (Fig. 7.3A). Notably, while the duplicate with more conditions (Fig. 7.3A, 
black) follows the average trend for all duplicates (Figure 7.1B), the duplicate with fewer 
conditions (Fig. 7.3A, red) shows a steady gain in the number of conditions as a function of Ka. 
Consequently, the functional load of close duplicates, measured by the number of sensitive 
conditions, is very different, and this difference becomes significantly smaller as the genes 
diverge (Fig. 3B. Pearson’s r=-0.64, P-value=7*10
-4
, see also Supplementary Fig. 72C). Close 
duplicates with the larger number of sensitive conditions also show a higher evolutionary 
constraint, evaluated by the normalized ratio of non-synonymous to synonymous substitutions 
per nucleotide site, Ka/Ks (Wilcoxon Signed Rank test P-value=7*10
-3
, Fig. 7.2C). This result 
agrees with previous reports of asymmetric evolution of duplicates in the context of co-
expression, genetic interaction and protein-protein interaction networks [405, 424, 425]. The 
observed asymmetry in the functional load between close duplicates can make buffering 
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Figure 7.3. Differences in the number of sensitive conditions between duplicates. A. The 
average fraction of sensitive conditions for the duplicates with the higher and lower number of 
sensitive conditions in each pair; Ka values represent sequence divergence between duplicates. 
The P-value is for the Mann Whitney U test. B. The relative difference in the number of sensitive 
conditions between duplicates as a function of their initial divergence; Ka values represent 
sequence divergence between duplicates. The relative difference was calculated as the absolute 
difference in the number of sensitive conditions between duplicates normalized to the total 





). C. The average Ka/Ks ratio for the paralogs with the largest (more 
sensitive) and smallest (less sensitive) number of conditions with a significant growth decrease. 
Ka/Ks ratios were calculated relative to orthologous sequences in S. bayanus. Only duplicates 




 To further explore the mechanism behind the observed back-up patterns, we analyzed the 
functional diversification of yeast duplicates as a function of their sequence divergence (Ka). 
First, for genes encoding metabolic enzymes we calculated the fraction of gene pairs with 
conserved Enzyme Commission (EC) numbers (Fig. 7.4A); the conservation of EC numbers 
indicates that corresponding proteins catalyze identical biochemical reactions. Second, we 
calculated the fraction of shared Gene Ontology (GO) terms describing protein molecular 
function (MF) for all duplicates (Fig. 7.4B). Both measures showed that the molecular function 
of yeast duplicates typically starts to substantially diverge only at about Ka > 0.4. The timing of 
this divergence approximately coincides with a significant increase in the fraction of essential 
duplicates (Fig. 7.1C). On the other hand, the significant changes in the number of quantitative 
growth phenotypes are observed when the molecular function of duplicates is usually still 
conserved. 
 A complementary analysis of transcription factor binding sites suggests that gene 
regulation plays an important role in establishing the observed compensation patterns. It was 
previously demonstrated that duplicated yeast genes have, on average, a higher number of cis-
regulatory motifs than singleton genes [426]. Using a comprehensive dataset of about 150 known 
and predicted DNA binding motifs in yeast [413, 421], we found that the average number of 
different motifs regulating a duplicate pair increases significantly at Ka ≈ 0.1 (Fig. 7.4D, red, 
Mann-Whitney U test, P-value=0.06). At this divergence distance, the average number of 
different motifs per duplicate pair is more than twice the number of motifs for a pair of yeast 
singletons (Fig. 7.4D, red line). The number of regulatory motifs increases both for the duplicate 
with the highest and the duplicate with the smallest number of sensitive conditions 




0.1 is also confirmed by a significant increase (Mann-Whitney U test, P-value=1*10
-3
) at these 
distances of the number of transcription factor mutants [427] affecting duplicate gene expression 
(Fig. 7.4D, black). 
 While the total number of DNA motifs regulating duplicates initially increases with 
divergence, the fraction of shared motifs (Supplementary fig. 7.9A, se also [428]), the overlap 
in GO terms describing biological processes (Fig. 7.4C), and the overlap in cellular localization 
observed in fluorescence-tagging experiments [422] decrease (Supplementary fig. 7.8B). Such a 
pattern suggests that the increase in regulatory complexity allows duplicates to specialize for 
different biological processes while mostly preserving common molecular functions. The ability 
of duplicates with partially diverged regulatory regions to compensate for each other through 
expression changes of the intact gene was previously described by Kafri et al [421, 429]. Also, 
the recent study by DeLuna et al. [430] showed that upon deletion of one duplicate, expression 
changes of the remaining paralog are often need-based, i.e. they happen primarily when the 
corresponding function is required. Such regulatory back-up circuits should, at least in some 
cases, enable functional compensation between homologs with different expression patterns in 
wild type. Notably, based on the data from recent study by Springer et al. [431], who measured 
the expression changes of yeast genes when one of two genomic copies was deleted in diploid 
cells, we observed a significant dosage response only for genes forming recently duplicated pairs 
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Figure 7.4. Diversification of duplicates function and regulation. A. Fraction of metabolic 
duplicates sharing the same Enzyme Commission (EC) numbers; conservation of EC numbers 
indicates catalysis of identical biochemical reactions. B. Fraction of Gene Ontology (GO) 




Process (BP) terms shared between duplicates. In figures B and C we considered only GO terms 
with a distance of 3 or more to the corresponding GO root hierarchy term. D. In red, the average 
number of different transcription factor binding motifs per duplicate pair. Transcription factor 
(TF) binding motifs were compiled from the studies of Kafri et al. [421] and Kellis et al. [413]. 
In black, the average number of transcription factor deletions in S. cerevisiae that significantly 
affect the expression of duplicate genes. The data were obtained from the study by Hu et al. 
(2007). For comparison we also show the average number of motifs and TF mutants affecting 
expression for random pairs of yeast singletons (horizontal red and black lines); the P-values 
were calculated using the Mann Whitney U test. E. The average dosage compensation 
(responsiveness) of duplicates as a function of sequence divergence (Ka). The data for the 
average expression responsiveness was obtained from the work of Springer et al. [431]. In that 
study responsiveness was measured in diploid yeast strains as the Log2 ratio (perturbed vs. 
normal) of expression changes for the remaining gene copy following deletion of the equivalent 
gene copy on a sister chromosome. The P-value was calculated using the Mann-Whitney U test. 
In all figures error bars represent the SEM. 
 
  Finally, the patterns of diversification and functional compensation described above 
should correlate with the process of duplicate loss in evolution. We investigated the retention of 
yeast duplicates using the complete genomic sequences of seven species: S. cerevisiae, S. 
paradoxus, S. bayanus, S. castelli, S. mikatae, S. kudriavzevii and S. kluyveri. We calculated the 
number of remaining duplicates as a function of their evolutionary divergence (Fig. 7.5, see also 
Supplementary fig. 7.10A for the corresponding relationships in individual yeast species). This 
analysis suggests that a relatively brief initial period of high duplicate loss [392] is followed by a 
long evolutionary period (Ka > 0.1) during which the average loss rate decreases more than 
tenfold (red in Fig. 7.5). Interestingly, the loss rate significantly decreases approximately at the 
divergence distance when duplicates become more similar in terms of their functional load (Fig. 
7.2B) and when their regulatory complexity significantly increases (Fig. 7.5D). It is likely that 
the duplicates surviving the initial loss stage develop independent functionalities and are 
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Figure 7.5. The average number of duplicates retained in the genomes of yeast species as a 
function of the duplicates divergence Ka, the number of non-synonymous substitutions per 
site. The number of remaining duplicates was averaged over the genomes of seven yeast species: 
S. cerevisiae, S. paradoxus, S. bayanus, S. castelli, S. mikatae, S. kudriavzevii and S. kluyveri. 
See also Supplementary figure 7.10 for the number of remaining duplicates in the individual 
species, and for the number of remaining duplicates as a function of Ks. The rate of duplicate 
loss in evolution is more than 10 times lower for the distances shown in red (Ka>0.1) compared 
to the distances in black (Ka<0.1). In the figure error bars represent the SEM. 
 
7.4. Discussion 
 In the present study we analyzed genetic robustness due to duplicates in the context of 
quantitative growth phenotypes and sensitivities to gene deletions in multiple environmental 
conditions. Such robustness is important for understanding the buffering of deleterious mutations 
in large natural biological populations. Our results demonstrate that, contrary to commonly held 
view, close gene duplicates are unlikely to provide a high level of back-up in the context of long 
term evolution. Consequently, it is unlikely that many duplicates are fixed in natural populations 




 Our analysis also suggests that duplicate redundancies described in genomics databases, 
and frequently observed in laboratory experiments, should be considered with caution, at least 
with respect to their functions in natural biological populations. To investigate this point further, 
we analyzed a set, compiled by Kafri et al. [432], of 112 yeast duplicates reported to be at least 
partially redundant in research publications. These duplicates have been described as redundant 
based on their functional overlap and compensatory interactions observed in small-scale 
experimental studies. Interestingly, based on the number of conditions with quantitative growth 
phenotypes from the study by Hillenmeyer et al. [416], and the quantitative growth 
measurements by Costanzo et al. [418], the duplicates annotated as redundant are not 
significantly different from all other yeast duplicates (Mann Whitney U P=0.13 and 0.35 
respectively, Supplementary fig. 7.11). This demonstrates that, although many yeast duplicates 
indeed may show functional overlap in some laboratory conditions, their compensation 
properties will probably be significantly less important in long term evolution due to the ability 
of purifying selection to efficiently prune mutations causing even a small fitness decrease. 
It is likely that several different factors contribute to the relative paucity of functional 
compensation between paralogs at small divergence distances. A significant fraction of 
duplications are likely to be fixed due to dosage effects [403], and functional compensation 
between such duplicates in the context of long term evolution is unlikely. For example, the lack 
of significant compensation between histone pairs, HTA1-HTA2 and HHT1-HHT2, is likely to 
be a consequence of their role in maintaining proper histone levels in yeast cells. Gene dosage 
may explain the inability of some duplicates to backup each other, but it is unlikely to be the 




(Supplementary fig. 7.6A) or forming known protein complexes (Supplementary fig. 7.6B) 
were removed from the analysis, the pattern of functional compensation remained similar. 
Close duplicates are also less likely to compensate for each other probably due to the 
aforementioned dichotomy in their functional loads (Fig. 7.3A, B). Indeed, many close 
duplicates can be classified, based on their activity and breadth of expression, into a major and a 
minor functional isoforms. For example, glyceraldehyde-3-phosphate dehydrogenase TDH1 is 
active under various stress conditions, while its isoenzyme TDH2 is used primarily during 
exponential growth [433]. Similarly, the ubiquitin conjugating enzyme UBC4 is expressed 
during exponential growth, while its duplicate UBC5 is active during stationary phase [434]. The 
difference in functional load for close yeast duplicates is also consistent with the asymmetric 
partition of functions, interactions, and gene expression, observed between close duplicates in 
other organisms, for example Arabidopsis and Human [425, 435, 436]. This suggests that 
duplicate-dependent compensation in the context of long term evolution may be limited in other 
species as well. 
 Our analysis suggests that a typical lifecycle of gene duplicates in yeast consists of 
several distinct evolutionary stages [397, 398]. In the first stage (at duplicate distances 
corresponding to Ka < 0.05), duplicates tend to have high overall functional loads and significant 
asymmetry in the number of sensitive conditions; both of these factors make complete 
compensation unlikely. The high functional load of close duplicates suggests that adaptive 
selection plays an important role in their fixation. In the second stage (0.05 < Ka < 0.25), as 
duplicates diverge further, their overall functional load usually decreases. This may happen, for 
example, due to relaxation of the environmental conditions which facilitated the original 




functional loads (Fig. 7.2C), are lost at this stage (Fig. 7.5). Gene pairs which survive the period 
of high duplicate loss display more balanced functional loads and complex regulation; these gene 
pairs are usually retained for long evolutionary times in yeast genomes (Fig. 7.5). Surviving 
duplicates can provide at least partial compensation at intermediate divergence distances and also 
serve as an important source of new protein functions. In the third stage (Ka > 0.3 or ~70% 
sequence identity), the lifecycle of duplicates is completed when their functional roles diverge, 
and their quantitative compensation properties become indistinguishable from those of random 















7.5 Supplementary figures 


























































































































































Supplementary figure 7.1. Fraction of conditions with a significant growth decrease for yeast 
duplicate deletions as a function of their divergence; Ka. A. The number of non-synonymous 
substitutions per site, was calculated using the Maximum Likelihood method implemented in the 
PAML package [385]. The error bars represent the standard error of the mean (SEM). P-value is 
for the Mann Whitney U test. B. The moving average of the data in Fig. 1A using a window size 
of Ka=0.05. The red line in panels A-C shows the average fraction of sensitive conditions for a 
random pair of yeast singletons. C. Linear versus quadratic polynomial model comparison for a 
bin-free fit of the number of sensitive conditions as a function of Ka. The quadratic model is 
































































































































































Supplementary figure 7.2. A. Fraction of conditions with a significant growth decrease as a 
function of Ks, the number of synonymous substitutions per site between duplicates. The error 
bars represent the SEM. B. The sliding window average of the Ks data, using a window size of 
Ks=0.5. The red line in A and B shows the average fraction of sensitive conditions for a random 
pair of yeast singletons. C. The relative difference in the number of sensitive conditions between 
duplicates as a function of their initial divergence (Ks). The relative difference was calculated as 
the absolute difference in the number of sensitive conditions between duplicates normalized to 
the total number of sensitive conditions for the pair (Spearman’s r=-0.71, P-value=0.002; 






























































































































































































Supplementary figure 7.3. Fraction of conditions with a significant growth decrease for yeast 
duplicate deletions. In the figures different P-value cutoffs were used to determine whether 
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Supplementary figure 7.4. A. The average Log2-ratios across multiple environmental 
conditions of the wild type growth rates relative to the growth rates of duplicate deletion strains. 
In the figure larger Log2-ratios correspond to lower growth rates of duplicate deletions compared 
to the wild type. B. The average Z-scores across multiple environmental conditions of the wild 
type growth rates relative to the growth rates of duplicate deletion strains. C. Fraction of 
conditions with a significant growth decrease for homozygous and heterozygous diploid yeast 
strains, when multi-drug resistance (MDR) genes, as defined by Hillenmeyer et al. [416], are 
removed from the analysis. D. Fraction of conditions with a significant growth decrease for 
homozygous yeast deletion strains when only 27 environmental perturbations were considered, 
i.e. perturbations with chemical compounds were not used in the analysis. E. Fraction of 
conditions with a significant growth decrease when only duplicates without additional (i.e. more 
diverged) paralogs in the yeast genome are considered (Left) or when only duplicates with 
several paralogs are considered (Right).The error bars represent the SEM. 
 























































Number of genes in the family
  
Supplementary figure 7.5. The average fraction of unique conditions with a significant growth 
decrease, based on Hillenmeyer et al. [416], per yeast protein family as a function of the family 
size, i.e. the number of genes in the family. The error bars represent the SEM, the straight lines 

















































































































Supplementary figure 7.6. The fraction of conditions with a significant growth phenotype for 
duplicate deletions. A. Excluding pairs with a high Codon Adaptation Index (CAI). High CAI 
values usually indicate high expression levels of the corresponding genes. In the figure, yeast 
duplicate pairs for which at least one gene has CAI>0.3 were removed from the analysis. The 
CAI values for yeast duplicates were obtained from the study by Lu et al. [365]. B. Excluding 
gene pairs that participate in known protein complexes. The information about protein 
complexes was obtained from the Comprehensive Yeast Genome database [420]. The error bars 
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Supplementary figure 7.7. The fraction of single duplicate deletions with a growth decrease 
below different thresholds. The presented results are based (A) on the competition experiments 
by DeLuna et al. [417], and (B) on the synthetic genetic arrays by Costanzo et al. [418].  























































Supplementary figure 7.8. The average number of known and predicted transcription factor 
binding motifs for yeast duplicates with the largest (A) the smallest (B) number of sensitive 
conditions in each pair. The transcription factor binding motifs (150 in total) were obtained from 

















































































Supplementary figure 7.9. A. The fraction of DNA binding motifs shared between yeast 
duplicates. The number of shared motifs between each duplicate pair was normalized by the total 
number of unique motifs for the pair. The DNA binding motifs (150 in total) were obtained from 
the studies by Kafri et al. [421] and Kellis et al. [413]. The red line shows the fraction of motifs 
shared by a random pair of yeast singletons. B. The overlap in cellular localization between yeast 
duplicates. The fraction of shared cellular locations was calculated for each pair as the number of 
shared locations normalized by the total number of different locations for the pair. The figure is 
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Supplementary figure 7.10. A. The number of duplicates retained in the genomes of seven 
yeast species (S. cerevisiae, S. paradoxus, S. bayanus, S. castelli, S. mikatae, S. kudriavzevii and 
S. kluyveri.) as a function of the duplicate divergence Ka, the number of non-synonymous 
substitutions per site. B. The average number of duplicates retained in the genomes of seven 
yeast species as a function of the divergence between duplicates (Ks). The number of the 
remaining duplicates was averaged over the genomes of seven yeast species: S. cerevisiae, S. 
paradoxus, S. bayanus, S. castelli, S. mikatae, S. kudriavzevii and S. kluyveri. The error bars 
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Supplementary figure 7.11. Compensation patterns for yeast duplicates described in research 
literature as redundant, at least partially, and all other yeast duplicates (red). The set of 112 
redundant duplicates was compiled by Kafri et al. [432] based on literature analysis. The error 


























In this dissertation we have introduced comparative systems biology as a means to 
explore the long term patterns of phenotypic evolution of bacteria. Flux analysis of hundreds of 
microbial metabolic networks shows that different phenotypes change at different rates but 
following a well-defined exponential decay-like trend. Our results are in excellent agreement 
with experimental data and provide a framework to explore several ecological and evolutionary 
questions. Comparison of species’ predicted phenotypic properties can complement gene and 
genome-based bacterial taxonomy pointing out potential interesting associations between 
microorganisms. These tools can also be used to measure and understand phenotypic diversity 
and evolutionary processes of different subsets of bacteria. 
Our comparative analysis is good at identifying global trends, but specific phenotypic 
predictions are limited by the accuracy of the underlying network models. We presented a 
flexible probabilistic framework (GLOBUS) for metabolic annotations and demonstrated its 
potential use as an aid in stoichiometric model reconstructions. GLOBUS can integrate multiple 
sources of evidence including sequence, structure, and context based functional descriptors; 
moreover, we showed that flux information from a universal mass-balanced metabolic network 
can provide a global context that significantly improves annotation accuracy. The probabilistic 
approach allows a direct ranking of annotations based on their quality, and tracing of GLOBUS 
results to specific sources of evidence. 
The significance of building high-quality metabolic reconstructions is demonstrated by 




literature and reconciliation of model predictions with experimental evidence, allowed us to 
reproduce many known features of malarial metabolism, including most known gene-knockout 
phenotypes. This effort led to the identification and further validation of a novel candidate drug 
target for this important pathogen. We also demonstrated the ability of the network to integrate 
several sources of high-throughput data –including transcriptomics and metabolomics– which 
will be important features of metabolic reconstructions as these datasets continue to expand. 
Going back to the level of sequence evolution, we experimentally demonstrated that the 
cost associated with the expression of misfolded proteins in E. coli is mainly a consequence of 
gratuitous protein synthesis and not misfolded protein toxicity. This result calls into question the 
universality of a recent hypothesis about why highly expressed proteins evolve slowly [331] 
Complementary computational analyses showed that translational efficiency, or the selection for 
optimal codons in E. coli, is one important determinant of the lower evolutionary rate of 
abundant proteins.  
The above result highlights the importance of even mild fitness differences for sequence 
evolution in species with large population sizes. On the same vein, we found that the ability of 
duplicated yeast genes to compensate for the loss of their paralogs is very limited in the context 
of natural populations. Our results show a tradeoff between the functional load of duplicated 
gene pairs and their sequence similarity. This way, functional compensation between paralogs 
was only observed at intermediate divergence distances, with close duplicates being as likely as 
random singletons to fully buffer for mutations of their paralogs. Our work points out important 
differences in the patterns of duplicated gene buffering when it is considered from the point of 
view of genetic interactions, as has typically been the case, and when it is looked at from the 






1. Plata G, Fuhrer T, Hsiao TL, Sauer U, Vitkup D: Global probabilistic annotation of 
metabolic networks enables enzyme discovery. Nat Chem Biol 2012, 8:848-854. 
2. Plata G, Hsiao TL, Olszewski KL, Llinas M, Vitkup D: Reconstruction and flux-
balance analysis of the Plasmodium falciparum metabolic network. Mol Syst Biol 
2010, 6:408. 
3. Plata G, Gottesman ME, Vitkup D: The rate of the molecular clock and the cost of 
gratuitous protein synthesis. Genome Biol 2010, 11:R98. 
4. Ward BB: How many species of prokaryotes are there? Proc Natl Acad Sci USA 2002, 
99:10234-10236. 
5. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R: The microbial pan-genome. 
Curr Opin Genet Dev 2005, 15:589-594. 
6. Lukjancenko O, Wassenaar TM, Ussery DW: Comparison of 61 sequenced Escherichia 
coli genomes. Microb Ecol 2010, 60:708-720. 
7. Gripp E, Hlahla D, Didelot X, Kops F, Maurischat S, Tedin K, Alter T, Ellerbroek L, 
Schreiber K, Schomburg D, et al: Closely related Campylobacter jejuni strains from 
different sources reveal a generalist rather than a specialist lifestyle. BMC Genomics 
2011, 12:584. 
8. Koonin EV, Wolf YI: Genomics of bacteria and archaea: the emerging dynamic view 
of the prokaryotic world. Nucleic Acids Res 2008, 36:6688-6719. 
9. Pagani I, Liolios K, Jansson J, Chen IM, Smirnova T, Nosrat B, Markowitz VM, 
Kyrpides NC: The Genomes OnLine Database (GOLD) v.4: status of genomic and 
metagenomic projects and their associated metadata. Nucleic Acids Res 2012, 
40:D571-579. 
10. Rinke C, Schwientek P, Sczyrba A, Ivanova NN, Anderson IJ, Cheng JF, Darling A, 
Malfatti S, Swan BK, Gies EA, et al: Insights into the phylogeny and coding potential 
of microbial dark matter. Nature 2013. 
11. Mason OU, Hazen TC, Borglin S, Chain PS, Dubinsky EA, Fortney JL, Han J, Holman 
HY, Hultman J, Lamendella R, et al: Metagenome, metatranscriptome and single-cell 
sequencing reveal microbial response to Deepwater Horizon oil spill. ISME J 2012, 
6:1715-1727. 
12. Wu D, Hugenholtz P, Mavromatis K, Pukall R, Dalin E, Ivanova NN, Kunin V, Goodwin 
L, Wu M, Tindall BJ, et al: A phylogeny-driven genomic encyclopaedia of Bacteria 




13. Sheppard SK, Didelot X, Meric G, Torralbo A, Jolley KA, Kelly DJ, Bentley SD, Maiden 
MC, Parkhill J, Falush D: Genome-wide association study identifies vitamin B5 
biosynthesis as a host specificity factor in Campylobacter. Proc Natl Acad Sci USA 
2013. 
14. Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers 
EW: GenBank. Nucleic Acids Res 2013, 41:D36-42. 
15. Siggins A, Gunnigle E, Abram F: Exploring mixed microbial community functioning: 
recent advances in metaproteomics. FEMS Microbiol Ecol 2012, 80:265-280. 
16. Madupu R, Richter A, Dodson RJ, Brinkac L, Harkins D, Durkin S, Shrivastava S, Sutton 
G, Haft D: CharProtDB: a database of experimentally characterized protein 
annotations. Nucleic Acids Res 2012, 40:D237-241. 
17. UniProt C: Reorganizing the protein space at the Universal Protein Resource 
(UniProt). Nucleic Acids Res 2012, 40:D71-75. 
18. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: 
Gapped BLAST and PSI-BLAST: a new generation of protein database search 
programs. Nucleic Acids Res 1997, 25:3389-3402. 
19. Lipman DJ, Pearson WR: Rapid and sensitive protein similarity searches. Science 
1985, 227:1435-1441. 
20. Tian W, Skolnick J: How well is enzyme function conserved as a function of pairwise 
sequence identity? J Mol Biol 2003, 333:863-882. 
21. Dini-Andreote F, Andreote FD, Araujo WL, Trevors JT, van Elsas JD: Bacterial 
genomes: habitat specificity and uncharted organisms. Microb Ecol 2012, 64:1-7. 
22. Gilks WR, Audit B, De Angelis D, Tsoka S, Ouzounis CA: Modeling the percolation of 
annotation errors in a database of protein sequences. Bioinformatics 2002, 18:1641-
1649. 
23. Karp PD: What we do not know about sequence analysis and sequence databases. 
Bioinformatics 1998, 14:753-754. 
24. Schnoes AM, Brown SD, Dodevski I, Babbitt PC: Annotation error in public 
databases: misannotation of molecular function in enzyme superfamilies. PLoS 
Comput Biol 2009, 5:e1000605. 
25. Sigrist CJ, de Castro E, Cerutti L, Cuche BA, Hulo N, Bridge A, Bougueleret L, Xenarios 
I: New and continuing developments at PROSITE. Nucleic Acids Res 2013, 41:D344-
347. 
26. Furnham N, de Beer TA, Thornton JM: Current challenges in genome annotation 





27. Dale JM, Popescu L, Karp PD: Machine learning methods for metabolic pathway 
prediction. BMC Bioinformatics 2010, 11:15. 
28. Karp PD, Paley SM, Krummenacker M, Latendresse M, Dale JM, Lee TJ, Kaipa P, 
Gilham F, Spaulding A, Popescu L, et al: Pathway Tools version 13.0: integrated 
software for pathway/genome informatics and systems biology. Brief Bioinform 2010, 
11:40-79. 
29. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and 
interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40:D109-
114. 
30. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, de Crecy-
Lagard V, Diaz N, Disz T, Edwards R, et al: The subsystems approach to genome 
annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res 
2005, 33:5691-5702. 
31. Kharchenko P, Chen L, Freund Y, Vitkup D, Church GM: Identifying metabolic 
enzymes with multiple types of association evidence. BMC Bioinformatics 2006, 
7:177. 
32. Yamada T, Waller AS, Raes J, Zelezniak A, Perchat N, Perret A, Salanoubat M, Patil 
KR, Weissenbach J, Bork P: Prediction and identification of sequences coding for 
orphan enzymes using genomic and metagenomic neighbours. Mol Syst Biol 2012, 
8:581. 
33. Chen L, Vitkup D: Predicting genes for orphan metabolic activities using 
phylogenetic profiles. Genome Biol 2006, 7:R17. 
34. Overbeek R, Fonstein M, D'Souza M, Pusch GD, Maltsev N: The use of gene clusters to 
infer functional coupling. Proc Natl Acad Sci USA 1999, 96:2896-2901. 
35. Yanai I, Derti A, DeLisi C: Genes linked by fusion events are generally of the same 
functional category: a systematic analysis of 30 microbial genomes. Proc Natl Acad 
Sci USA 2001, 98:7940-7945. 
36. Hsiao TL, Revelles O, Chen L, Sauer U, Vitkup D: Automatic policing of biochemical 
annotations using genomic correlations. Nat Chem Biol 2010, 6:34-40. 
37. Tian W, Dong X, Zhou Y, Ren R: Predicting Gene Function Using Omics Data: From 
Data Preparation to Data Integration. In Protein function prediction for omics era. 1st 
edition. Edited by Daisuke K. New York: Springer; 2011: 215-242 
38. Kharchenko P, Church GM, Vitkup D: Expression dynamics of a cellular metabolic 
network. Mol Syst Biol 2005, 1:2005 0016. 
39. Jiao D, Ye Y, Tang H: Probabilistic inference of biochemical reactions in microbial 




40. Peregrin-Alvarez JM, Sanford C, Parkinson J: The conservation and evolutionary 
modularity of metabolism. Genome Biol 2009, 10:R63. 
41. Pah AR, Guimera R, Mustoe AM, Amaral LA: Use of a global metabolic network to 
curate organismal metabolic networks. Sci Rep 2013, 3:1695. 
42. Galperin MY, Koonin EV: Sources of systematic error in functional annotation of 
genomes: domain rearrangement, non-orthologous gene displacement and operon 
disruption. In Silico Biol 1998, 1:55-67. 
43. Levy ED, Ouzounis CA, Gilks WR, Audit B: Probabilistic annotation of protein 
sequences based on functional classifications. BMC Bioinformatics 2005, 6:302. 
44. Tomar N, De RK: Comparing methods for metabolic network analysis and an 
application to metabolic engineering. Gene 2013, 521:1-14. 
45. Orth JD, Thiele I, Palsson BO: What is flux balance analysis? Nat Biotechnol 2010, 
28:245-248. 
46. Joyce AR, Palsson B: Predicting Gene Essentiality Using Genome-Scale in Silico 
Models In Microbial Gene Essentiality: Protocols and Bioinformatics Volume 416. 
Edited by Osterman AL, Gerdes SY. Totowa: Humana Press Inc.; 2008: 433-457: 
Methods in Molecular Biology. 
47. Lee DS, Burd H, Liu J, Almaas E, Wiest O, Barabasi AL, Oltvai ZN, Kapatral V: 
Comparative genome-scale metabolic reconstruction and flux balance analysis of 
multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets. J 
Bacteriol 2009, 191:4015-4024. 
48. Burgard AP, Pharkya P, Maranas CD: Optknock: a bilevel programming framework 
for identifying gene knockout strategies for microbial strain optimization. Biotechnol 
Bioeng 2003, 84:647-657. 
49. Klitgord N, Segre D: Environments that induce synthetic microbial ecosystems. PLoS 
Comput Biol 2010, 6:e1001002. 
50. Lewis NE, Nagarajan H, Palsson BO: Constraining the metabolic genotype-phenotype 
relationship using a phylogeny of in silico methods. Nat Rev Microbiol 2012, 10:291-
305. 
51. Thiele I, Palsson BO: A protocol for generating a high-quality genome-scale 
metabolic reconstruction. Nat Protoc 2010, 5:93-121. 
52. Satish Kumar V, Dasika MS, Maranas CD: Optimization based automated curation of 
metabolic reconstructions. BMC Bioinformatics 2007, 8:212. 
53. Vitkin E, Shlomi T: MIRAGE: a functional genomics-based approach for metabolic 
network model reconstruction and its application to cyanobacteria networks. 




54. Henry CS, DeJongh M, Best AA, Frybarger PM, Linsay B, Stevens RL: High-
throughput generation, optimization and analysis of genome-scale metabolic models. 
Nat Biotechnol 2010, 28:977-982. 
55. Latendresse M, Krummenacker M, Trupp M, Karp PD: Construction and completion of 
flux balance models from pathway databases. Bioinformatics 2012, 28:388-396. 
56. Oberhardt MA, Puchałka J, Martins dos Santos VAP, Papin JA: Reconciliation of 
Genome-Scale Metabolic Reconstructions for Comparative Systems Analysis. PLoS 
Comput Biol 2011, 7:e1001116. 
57. Alam MT, Medema MH, Takano E, Breitling R: Comparative genome-scale metabolic 
modeling of actinomycetes: the topology of essential core metabolism. FEBS Lett 
2011, 585:2389-2394. 
58. Barona-Gomez F, Cruz-Morales P, Noda-Garcia L: What can genome-scale metabolic 
network reconstructions do for prokaryotic systematics? Antonie Van Leeuwenhoek 
2012, 101:35-43. 
59. Mithani A, Hein J, Preston GM: Comparative analysis of metabolic networks provides 
insight into the evolution of plant pathogenic and nonpathogenic lifestyles in 
Pseudomonas. Mol Biol Evol 2011, 28:483-499. 
60. Chavali AK, D'Auria KM, Hewlett EL, Pearson RD, Papin JA: A metabolic network 
approach for the identification and prioritization of antimicrobial drug targets. 
Trends Microbiol 2012, 20:113-123. 
61. Hamilton JJ, Reed JL: Identification of functional differences in metabolic networks 
using comparative genomics and constraint-based models. PLoS One 2012, 7:e34670. 
62. Zakrzewski P, Medema MH, Gevorgyan A, Kierzek AM, Breitling R, Takano E: 
MultiMetEval: comparative and multi-objective analysis of genome-scale metabolic 
models. PLoS One 2012, 7:e51511. 
63. Stolyar S, Van Dien S, Hillesland KL, Pinel N, Lie TJ, Leigh JA, Stahl DA: Metabolic 
modeling of a mutualistic microbial community. Mol Syst Biol 2007, 3:92. 
64. Zomorrodi AR, Maranas CD: OptCom: a multi-level optimization framework for the 
metabolic modeling and analysis of microbial communities. PLoS Comput Biol 2012, 
8:e1002363. 
65. Zuckerkandl E, Pauling L: Evolutionary divergence and convergence in proteins. In 
Evolving Genes and Proteins. Edited by Bryson V, Vogel H. New York: Academic Press; 
1965: 97-166 
66. Kimura M: Evolutionary rate at the molecular level. Nature 1968, 217:624-626. 
67. Chothia C, Lesk AM: The relation between the divergence of sequence and structure 




68. Whitman WB, Coleman DC, Wiebe WJ: Prokaryotes: the unseen majority. Proc Natl 
Acad Sci U S A 1998, 95:6578-6583. 
69. Philippot L, Andersson SG, Battin TJ, Prosser JI, Schimel JP, Whitman WB, Hallin S: 
The ecological coherence of high bacterial taxonomic ranks. Nat Rev Microbiol 2010, 
8:523-529. 
70. Koonin EV: Systemic determinants of gene evolution and function. Mol Syst Biol 
2005, 1:2005 0021. 
71. Pal C, Papp B, Lercher MJ: An integrated view of protein evolution. Nat Rev Genet 
2006, 7:337-348. 
72. Fraser HB, Hirsh AE, Steinmetz LM, Scharfe C, Feldman MW: Evolutionary rate in 
the protein interaction network. Science 2002, 296:750-752. 
73. Pal C, Papp B, Hurst LD: Highly expressed genes in yeast evolve slowly. Genetics 
2001, 158:927-931. 
74. Tamames J: Evolution of gene order conservation in prokaryotes. Genome Biol 2001, 
2:RESEARCH0020. 
75. Snir S, Wolf YI, Koonin EV: Universal pacemaker of genome evolution. PLoS Comput 
Biol 2012, 8:e1002785. 
76. Oberhardt MA, Palsson BO, Papin JA: Applications of genome-scale metabolic 
reconstructions. Mol Syst Biol 2009, 5:320. 
77. Feist AM, Palsson BO: The growing scope of applications of genome-scale metabolic 
reconstructions using Escherichia coli. Nat Biotechnol 2008, 26:659-667. 
78. Varma A, Palsson BO: Stoichiometric flux balance models quantitatively predict 
growth and metabolic by-product secretion in wild-type Escherichia coli W3110. 
Appl Environ Microbiol 1994, 60:3724-3731. 
79. Shlomi T, Berkman O, Ruppin E: Regulatory on/off minimization of metabolic flux 
changes after genetic perturbations. Proc Natl Acad Sci USA 2005, 102:7695-7700. 
80. Segre D, Vitkup D, Church GM: Analysis of optimality in natural and perturbed 
metabolic networks. Proc Natl Acad Sci USA 2002, 99:15112-15117. 
81. Lewis NE, Hixson KK, Conrad TM, Lerman JA, Charusanti P, Polpitiya AD, Adkins JN, 
Schramm G, Purvine SO, Lopez-Ferrer D, et al: Omic data from evolved E. coli are 
consistent with computed optimal growth from genome-scale models. Mol Syst Biol 
2010, 6:390. 
82. Ibarra RU, Edwards JS, Palsson BO: Escherichia coli K-12 undergoes adaptive 
evolution to achieve in silico predicted optimal growth. Nature 2002, 420:186-189. 
83. Fong SS, Palsson BO: Metabolic gene-deletion strains of Escherichia coli evolve to 




84. Kim TY, Sohn SB, Kim YB, Kim WJ, Lee SY: Recent advances in reconstruction and 
applications of genome-scale metabolic models. Curr Opin Biotechnol 2011. 
85. Notebaart RA, van Enckevort FH, Francke C, Siezen RJ, Teusink B: Accelerating the 
reconstruction of genome-scale metabolic networks. BMC Bioinformatics 2006, 7:296. 
86. DeJongh M, Formsma K, Boillot P, Gould J, Rycenga M, Best A: Toward the 
automated generation of genome-scale metabolic networks in the SEED. BMC 
Bioinformatics 2007, 8:139. 
87. Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing 
phylogenetic trees. Mol Biol Evol 1987, 4:406-425. 
88. Kuo CH, Ochman H: Inferring clocks when lacking rocks: the variable rates of 
molecular evolution in bacteria. Biol Direct 2009, 4:35. 
89. Moran NA, Munson MA, Baumann P, Ishikawa H: A Molecular Clock in 
Endosymbiotic Bacteria Is Calibrated Using the Insect Hosts. Proceedings of the 
Royal Society of London Series B-Biological Sciences 1993, 253:167-171. 
90. Bochner BR: Global phenotypic characterization of bacteria. FEMS Microbiol Rev 
2009, 33:191-205. 
91. Schuetz R, Zamboni N, Zampieri M, Heinemann M, Sauer U: Multidimensional 
optimality of microbial metabolism. Science 2012, 336:601-604. 
92. Koeppel AF, Wertheim JO, Barone L, Gentile N, Krizanc D, Cohan FM: Speedy 
speciation in a bacterial microcosm: new species can arise as frequently as 
adaptations within a species. ISME J 2013, 7:1080-1091. 
93. Doolittle WF, Zhaxybayeva O: On the origin of prokaryotic species. Genome Res 
2009, 19:744-756. 
94. Koonin EV: The Biological Big Bang model for the major transitions in evolution. 
Biol Direct 2007, 2:21. 
95. Lawrence JG, Retchless AC: The interplay of homologous recombination and 
horizontal gene transfer in bacterial speciation. Methods Mol Biol 2009, 532:29-53. 
96. Riley MA, Lizotte-Waniewski M: Population genomics and the bacterial species 
concept. Methods Mol Biol 2009, 532:367-377. 
97. Bochner BR, Gadzinski P, Panomitros E: Phenotype microarrays for high-throughput 
phenotypic testing and assay of gene function. Genome Res 2001, 11:1246-1255. 
98. Shea A, Wolcott M, Daefler S, Rozak DA: Biolog phenotype microarrays. Methods 
Mol Biol 2012, 881:331-373. 
99. Borglin S, Joyner D, DeAngelis KM, Khudyakov J, D'Haeseleer P, Joachimiak MP, 
Hazen T: Application of phenotypic microarrays to environmental microbiology. 




100. Dufresne A, Garczarek L, Partensky F: Accelerated evolution associated with genome 
reduction in a free-living prokaryote. Genome Biol 2005, 6:R14. 
101. Koskiniemi S, Sun S, Berg OG, Andersson DI: Selection-driven gene loss in bacteria. 
PLoS Genet 2012, 8:e1002787. 
102. van Ham RC, Kamerbeek J, Palacios C, Rausell C, Abascal F, Bastolla U, Fernandez JM, 
Jimenez L, Postigo M, Silva FJ, et al: Reductive genome evolution in Buchnera 
aphidicola. Proc Natl Acad Sci USA 2003, 100:581-586. 
103. Mendonca AG, Alves RJ, Pereira-Leal JB: Loss of genetic redundancy in reductive 
genome evolution. PLoS Comput Biol 2011, 7:e1001082. 
104. Rosinski-Chupin I, Sauvage E, Mairey B, Mangenot S, Ma L, Da Cunha V, Rusniok C, 
Bouchier C, Barbe V, Glaser P: Reductive evolution in Streptococcus agalactiae and 
the emergence of a host adapted lineage. BMC Genomics 2013, 14:252. 
105. Pal C, Papp B, Lercher MJ: Adaptive evolution of bacterial metabolic networks by 
horizontal gene transfer. Nat Genet 2005, 37:1372-1375. 
106. Stackebrandt E, Frederiksen W, Garrity GM, Grimont PA, Kampfer P, Maiden MC, 
Nesme X, Rossello-Mora R, Swings J, Truper HG, et al: Report of the ad hoc 
committee for the re-evaluation of the species definition in bacteriology. Int J Syst 
Evol Microbiol 2002, 52:1043-1047. 
107. Konstantinidis KT, Ramette A, Tiedje JM: The bacterial species definition in the 
genomic era. Philos Trans R Soc Lond B Biol Sci 2006, 361:1929-1940. 
108. Snel B, Huynen MA, Dutilh BE: Genome trees and the nature of genome evolution. 
Annu Rev Microbiol 2005, 59:191-209. 
109. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, Ezaki T, Arakawa M: 
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus 
Pseudomonas homology group II to the new genus, with the type species 
Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 
1992, 36:1251-1275. 
110. Coenye T, Vandamme P, Govan JR, LiPuma JJ: Taxonomy and identification of the 
Burkholderia cepacia complex. J Clin Microbiol 2001, 39:3427-3436. 
111. Bordiec S, Paquis S, Lacroix H, Dhondt S, Ait Barka E, Kauffmann S, Jeandet P, 
Mazeyrat-Gourbeyre F, Clement C, Baillieul F, Dorey S: Comparative analysis of 
defence responses induced by the endophytic plant growth-promoting 
rhizobacterium Burkholderia phytofirmans strain PsJN and the non-host bacterium 
Pseudomonas syringae pv. pisi in grapevine cell suspensions. J Exp Bot 2011, 62:595-
603. 
112. Deng L, Ren Y, Wei C: Pyrene degradation by Pseudomonas sp. and Burkholderia 
sp. enriched from coking wastewater sludge. J Environ Sci Health A Tox Hazard Subst 




113. Dixon SJ, Fedyshyn Y, Koh JL, Prasad TS, Chahwan C, Chua G, Toufighi K, 
Baryshnikova A, Hayles J, Hoe KL, et al: Significant conservation of synthetic lethal 
genetic interaction networks between distantly related eukaryotes. Proc Natl Acad 
Sci USA 2008, 105:16653-16658. 
114. Tischler J, Lehner B, Fraser AG: Evolutionary plasticity of genetic interaction 
networks. Nat Genet 2008, 40:390-391. 
115. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, 
Wanner BL, Mori H: Construction of Escherichia coli K-12 in-frame, single-gene 
knockout mutants: the Keio collection. Mol Syst Biol 2006, 2:2006 0008. 
116. Kobayashi K, Ehrlich SD, Albertini A, Amati G, Andersen KK, Arnaud M, Asai K, 
Ashikaga S, Aymerich S, Bessieres P, et al: Essential Bacillus subtilis genes. Proc Natl 
Acad Sci U S A 2003, 100:4678-4683. 
117. Xu P, Ge X, Chen L, Wang X, Dou Y, Xu JZ, Patel JR, Stone V, Trinh M, Evans K, et al: 
Genome-wide essential gene identification in Streptococcus sanguinis. Sci Rep 2011, 
1:125. 
118. Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L, Haase J, Charles I, Maskell 
DJ, Peters SE, Dougan G, et al: Simultaneous assay of every Salmonella Typhi gene 
using one million transposon mutants. Genome Res 2009, 19:2308-2316. 
119. Christen B, Abeliuk E, Collier JM, Kalogeraki VS, Passarelli B, Coller JA, Fero MJ, 
McAdams HH, Shapiro L: The essential genome of a bacterium. Mol Syst Biol 2011, 
7:528. 
120. Darwin C: The origin of species. New York, NY: Barnes & Noble Classics; 2008. 
121. Wagner A: The molecular origins of evolutionary innovations. Trends Genet 2011, 
27:397-410. 
122. Hindre T, Knibbe C, Beslon G, Schneider D: New insights into bacterial adaptation 
through in vivo and in silico experimental evolution. Nat Rev Microbiol 2012, 10:352-
365. 
123. Pommerenke C, Musken M, Becker T, Dotsch A, Klawonn F, Haussler S: Global 
genotype-phenotype correlations in Pseudomonas aeruginosa. PLoS Pathog 2010, 
6:e1001074. 
124. Lobkovsky AE, Wolf YI, Koonin EV: Gene frequency distributions reject a neutral 
model of genome evolution. Genome Biol Evol 2013, 5:233-242. 
125. Haegeman B, Weitz JS: A neutral theory of genome evolution and the frequency 
distribution of genes. BMC Genomics 2012, 13:196. 
126. Barve A, Wagner A: A latent capacity for evolutionary innovation through 




127. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ: Quantitative 
prediction of cellular metabolism with constraint-based models: the COBRA 
Toolbox. Nat Protoc 2007, 2:727-738. 
128. Real R, Vargas JM: The probabilistic basis of Jaccard's index of similarity. Systematic 
Biology 1996, 45:380-385. 
129. Almaas E, Kovacs B, Vicsek T, Oltvai ZN, Barabasi AL: Global organization of 
metabolic fluxes in the bacterium Escherichia coli. Nature 2004, 427:839-843. 
130. Almaas E, Oltvai ZN, Barabasi AL: The activity reaction core and plasticity of 
metabolic networks. PLoS Comput Biol 2005, 1:e68. 
131. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima 
S, Okuda S, Tokimatsu T, Yamanishi Y: KEGG for linking genomes to life and the 
environment. Nucleic Acids Res 2008, 36:D480-484. 
132. Karp PD, Paley S, Romero P: The Pathway Tools software. Bioinformatics 2002, 18 
Suppl 1:S225-232. 
133. Lee D, Redfern O, Orengo C: Predicting protein function from sequence and 
structure. Nat Rev Mol Cell Biol 2007, 8:995-1005. 
134. Iliopoulos I, Tsoka S, Andrade MA, Janssen P, Audit B, Tramontano A, Valencia A, 
Leroy C, Sander C, Ouzounis CA: Genome sequences and great expectations. Genome 
Biol 2001, 2:interactions0001-interactions0001.0003. 
135. Devos D, Valencia A: Intrinsic errors in genome annotation. Trends Genet 2001, 
17:429-431. 
136. Chang A, Scheer M, Grote A, Schomburg I, Schomburg D: BRENDA, AMENDA and 
FRENDA the enzyme information system: new content and tools in 2009. Nucleic 
Acids Res 2009, 37:D588-592. 
137. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D: GeneCards: a novel functional 
genomics compendium with automated data mining and query reformulation 
support. Bioinformatics 1998, 14:656-664. 
138. Caspi R, Foerster H, Fulcher CA, Kaipa P, Krummenacker M, Latendresse M, Paley S, 
Rhee SY, Shearer AG, Tissier C, et al: The MetaCyc Database of metabolic pathways 
and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic 
Acids Res 2008, 36:D623-631. 
139. Bairoch A, Apweiler R: The SWISS-PROT protein sequence data bank and its new 
supplement TREMBL. Nucleic Acids Res 1996, 24:21-25. 
140. Pellegrini M, Marcotte EM, Thompson MJ, Eisenberg D, Yeates TO: Assigning protein 
functions by comparative genome analysis: protein phylogenetic profiles. Proc Natl 




141. Wu LF, Hughes TR, Davierwala AP, Robinson MD, Stoughton R, Altschuler SJ: Large-
scale prediction of Saccharomyces cerevisiae gene function using overlapping 
transcriptional clusters. Nat Genet 2002, 31:255-265. 
142. Dandekar T, Snel B, Huynen M, Bork P: Conservation of gene order: a fingerprint of 
proteins that physically interact. Trends Biochem Sci 1998, 23:324-328. 
143. Eisenberg D, Marcotte EM, Xenarios I, Yeates TO: Protein function in the post-
genomic era. Nature 2000, 405:823-826. 
144. Korbel JO, Jensen LJ, von Mering C, Bork P: Analysis of genomic context: prediction 
of functional associations from conserved bidirectionally transcribed gene pairs. Nat 
Biotechnol 2004, 22:911-917. 
145. von Mering C, Zdobnov EM, Tsoka S, Ciccarelli FD, Pereira-Leal JB, Ouzounis CA, 
Bork P: Genome evolution reveals biochemical networks and functional modules. 
Proc Natl Acad Sci USA 2003, 100:15428-15433. 
146. Green ML, Karp PD: A Bayesian method for identifying missing enzymes in 
predicted metabolic pathway databases. BMC Bioinformatics 2004, 5:76. 
147. Koller D, Friedman N: Probabilistic graphical models : principles and techniques. 
Cambridge, MA: MIT Press; 2009. 
148. Price ND, Shmulevich I: Biochemical and statistical network models for systems 
biology. Curr Opin Biotechnol 2007, 18:365-370. 
149. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin 
MJ, Michoud K, O'Donovan C, Phan I, et al: The SWISS-PROT protein 
knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 2003, 
31:365-370. 
150. Li SZ: Markov random field modeling in image analysis. Tokyo: Springer; 2001. 
151. Casella G, George EI: Explaining the Gibbs sampler. Am Stat 1992, 46:167-174. 
152. Hastings WK: Monte Carlo sampling methods using Markov chains and their 
applications. Biometrika 1970, 57:97-109. 
153. Lawrence CE, Altschul SF, Boguski MS, Liu JS, Neuwald AF, Wootton JC: Detecting 
subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science 
1993, 262:208-214. 
154. Kuepfer L, Sauer U, Blank LM: Metabolic functions of duplicate genes in 
Saccharomyces cerevisiae. Genome Res 2005, 15:1421-1430. 
155. Kirkpatrick S, Gelatt CD, Jr., Vecchi MP: Optimization by Simulated Annealing. 
Science 1983, 220:671-680. 
156. Mo ML, Palsson BO, Herrgard MJ: Connecting extracellular metabolomic 




157. Henry CS, Zinner JF, Cohoon MP, Stevens RL: iBsu1103: a new genome-scale 
metabolic model of Bacillus subtilis based on SEED annotations. Genome Biol 2009, 
10:R69. 
158. Oh YK, Palsson BO, Park SM, Schilling CH, Mahadevan R: Genome-scale 
reconstruction of metabolic network in Bacillus subtilis based on high-throughput 
phenotyping and gene essentiality data. J Biol Chem 2007, 282:28791-28799. 
159. Becker SA, Palsson BO: Genome-scale reconstruction of the metabolic network in 
Staphylococcus aureus N315: an initial draft to the two-dimensional annotation. 
BMC Microbiol 2005, 5:8. 
160. Stamford NP, Capretta A, Battersby AR: Expression, purification and characterisation 
of the product from the Bacillus subtilis hemD gene, uroporphyrinogen III synthase. 
Eur J Biochem 1995, 231:236-241. 
161. Bower S, Perkins JB, Yocum RR, Howitt CL, Rahaim P, Pero J: Cloning, sequencing, 
and characterization of the Bacillus subtilis biotin biosynthetic operon. J Bacteriol 
1996, 178:4122-4130. 
162. Faille C, Lequette Y, Ronse A, Slomianny C, Garenaux E, Guerardel Y: Morphology 
and physico-chemical properties of Bacillus spores surrounded or not with an 
exosporium: consequences on their ability to adhere to stainless steel. Int J Food 
Microbiol 2010, 143:125-135. 
163. Eichenberger P, Fujita M, Jensen ST, Conlon EM, Rudner DZ, Wang ST, Ferguson C, 
Haga K, Sato T, Liu JS, Losick R: The program of gene transcription for a single 
differentiating cell type during sporulation in Bacillus subtilis. PLoS Biol 2004, 
2:e328. 
164. Timmons SC, Mosher RH, Knowles SA, Jakeman DL: Exploiting 
nucleotidylyltransferases to prepare sugar nucleotides. Org Lett 2007, 9:857-860. 
165. Ishihama Y, Schmidt T, Rappsilber J, Mann M, Hartl FU, Kerner MJ, Frishman D: 
Protein abundance profiling of the Escherichia coli cytosol. BMC Genomics 2008, 
9:102. 
166. Hecker M, Reder A, Fuchs S, Pagels M, Engelmann S: Physiological proteomics and 
stress/starvation responses in Bacillus subtilis and Staphylococcus aureus. Res 
Microbiol 2009, 160:245-258. 
167. Tam le T, Antelmann H, Eymann C, Albrecht D, Bernhardt J, Hecker M: Proteome 
signatures for stress and starvation in Bacillus subtilis as revealed by a 2-D gel 
image color coding approach. Proteomics 2006, 6:4565-4585. 
168. Galperin MY, Moroz OV, Wilson KS, Murzin AG: House cleaning, a part of good 
housekeeping. Mol Microbiol 2006, 59:5-19. 




170. Yamada T, Letunic I, Okuda S, Kanehisa M, Bork P: iPath2.0: interactive pathway 
explorer. Nucleic Acids Res 2011, 39:W412-415. 
171. Breitling R, Vitkup D, Barrett MP: New surveyor tools for charting microbial 
metabolic maps. Nat Rev Microbiol 2008, 6:156-161. 
172. Zamboni N, Sauer U: Novel biological insights through metabolomics and 13C-flux 
analysis. Curr Opin Microbiol 2009, 12:553-558. 
173. Rost B: Enzyme function less conserved than anticipated. J Mol Biol 2002, 318:595-
608. 
174. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc 
Natl Acad Sci USA 1988, 85:2444-2448. 
175. Bork P, Jensen LJ, von Mering C, Ramani AK, Lee I, Marcotte EM: Protein interaction 
networks from yeast to human. Curr Opin Struct Biol 2004, 14:292-299. 
176. Spirin V, Gelfand MS, Mironov AA, Mirny LA: A metabolic network in the 
evolutionary context: multiscale structure and modularity. Proc Natl Acad Sci USA 
2006, 103:8774-8779. 
177. Kharchenko P, Vitkup D, Church GM: Filling gaps in a metabolic network using 
expression information. Bioinformatics 2004, 20 Suppl 1:i178-185. 
178. Faith JJ, Hayete B, Thaden JT, Mogno I, Wierzbowski J, Cottarel G, Kasif S, Collins JJ, 
Gardner TS: Large-scale mapping and validation of Escherichia coli transcriptional 
regulation from a compendium of expression profiles. PLoS Biol 2007, 5:e8. 
179. Huynen MA, Bork P: Measuring genome evolution. Proc Natl Acad Sci USA 1998, 
95:5849-5856. 
180. Lee JM, Sonnhammer EL: Genomic gene clustering analysis of pathways in 
eukaryotes. Genome Res 2003, 13:875-882. 
181. DeRisi JL, Iyer VR, Brown PO: Exploring the metabolic and genetic control of gene 
expression on a genomic scale. Science 1997, 278:680-686. 
182. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, 
Coffey E, Dai H, He YD, et al: Functional discovery via a compendium of expression 
profiles. Cell 2000, 102:109-126. 
183. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE, 
Fujibuchi W, Edgar R: NCBI GEO: mining millions of expression profiles--database 
and tools. Nucleic Acids Res 2005, 33:D562-566. 
184. Geman S, Geman D: Stochastic relaxation, Gibbs distributions, and the Bayesian 
restoration of images. IEEE T Pattern Anal 1984, 6:721-741. 
185. Gelfand AE, Smith AFM: Sampling-based approches to calculating marginal 




186. Metropolis N, Rosenbluth AW, Rosenbluth MN, H. TA, E. T: Equations of state 
calculations by fast computing machines. J Chem Phys 1953, 21:1087-1091. 
187. Fuhrer T, Heer D, Begemann B, Zamboni N: High-throughput, accurate mass 
metabolome profiling of cellular extracts by flow injection-time-of-flight mass 
spectrometry. Anal Chem 2011, 83:7074-7080. 
188. Gudmundsson S, Thiele I: Computationally efficient flux variability analysis. BMC 
Bioinformatics 2010, 11:489. 
189. Nerlich AG, Schraut B, Dittrich S, Jelinek T, Zink AR: Plasmodium falciparum in 
ancient Egypt. Emerg Infect Dis 2008, 14:1317-1319. 
190. W.H.O.: World malaria report 2008. Geneva: World Health Organization; 2008. 
191. Baird JK: Effectiveness of antimalarial drugs. N Engl J Med 2005, 352:1565-1577. 
192. Aly AS, Vaughan AM, Kappe SH: Malaria parasite development in the mosquito and 
infection of the mammalian host. Annu Rev Microbiol 2009, 63:195-221. 
193. Haldar K, Mohandas N: Malaria, erythrocytic infection, and anemia. Hematology Am 
Soc Hematol Educ Program 2009:87-93. 
194. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR: Epidemiology of 
drug-resistant malaria. Lancet Infect Dis 2002, 2:209-218. 
195. Mackinnon MJ, Marsh K: The selection landscape of malaria parasites. Science 2010, 
328:866-871. 
196. Hyde JE: Drug-resistant malaria - an insight. FEBS J 2007, 274:4688-4698. 
197. Liu S, Mu J, Jiang H, Su XZ: Effects of Plasmodium falciparum mixed infections on 
in vitro antimalarial drug tests and genotyping. Am J Trop Med Hyg 2008, 79:178-
184. 
198. Dharia NV, Chatterjee A, Winzeler EA: Genomics and systems biology in malaria 
drug discovery. Curr Opin Investig Drugs 2010, 11:131-138. 
199. Carvalho TG, Menard R: Manipulating the Plasmodium genome. Curr Issues Mol Biol 
2005, 7:39-55. 
200. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, 
Nelson KE, Bowman S, et al: Genome sequence of the human malaria parasite 
Plasmodium falciparum. Nature 2002, 419:498-511. 
201. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL: The transcriptome of 





202. Hu G, Cabrera A, Kono M, Mok S, Chaal BK, Haase S, Engelberg K, Cheemadan S, 
Spielmann T, Preiser PR, et al: Transcriptional profiling of growth perturbations of 
the human malaria parasite Plasmodium falciparum. Nat Biotechnol 2010, 28:91-98. 
203. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De La Vega P, 
Holder AA, Batalov S, Carucci DJ, Winzeler EA: Discovery of gene function by 
expression profiling of the malaria parasite life cycle. Science 2003, 301:1503-1508. 
204. Llinas M, Bozdech Z, Wong ED, Adai AT, DeRisi JL: Comparative whole genome 
transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res 
2006, 34:1166-1173. 
205. Lasonder E, Ishihama Y, Andersen JS, Vermunt AM, Pain A, Sauerwein RW, Eling WM, 
Hall N, Waters AP, Stunnenberg HG, Mann M: Analysis of the Plasmodium 
falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-
542. 
206. Lasonder E, Janse CJ, van Gemert GJ, Mair GR, Vermunt AM, Douradinha BG, van 
Noort V, Huynen MA, Luty AJ, Kroeze H, et al: Proteomic profiling of Plasmodium 
sporozoite maturation identifies new proteins essential for parasite development and 
infectivity. PLoS Pathog 2008, 4:e1000195. 
207. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, 
Muster N, Sacci JB, Tabb DL, et al: A proteomic view of the Plasmodium falciparum 
life cycle. Nature 2002, 419:520-526. 
208. Olszewski KL, Morrisey JM, Wilinski D, Burns JM, Vaidya AB, Rabinowitz JD, Llinas 
M: Host-parasite interactions revealed by Plasmodium falciparum metabolomics. 
Cell Host Microbe 2009, 5:191-199. 
209. Yeh I, Hanekamp T, Tsoka S, Karp PD, Altman RB: Computational analysis of 
Plasmodium falciparum metabolism: organizing genomic information to facilitate 
drug discovery. Genome Res 2004, 14:917-924. 
210. Malaria Parasite Metabolic Pathways [http://sites.huji.ac.il/malaria/] 
211. Price ND, Reed JL, Palsson BO: Genome-scale models of microbial cells: evaluating 
the consequences of constraints. Nat Rev Microbiol 2004, 2:886-897. 
212. Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA: Systems analysis of 
metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 
2008, 4:177. 
213. Navid A, Almaas E: Genome-scale reconstruction of the metabolic network in 
Yersinia pestis, strain 91001. Mol Biosyst 2009, 5:368-375. 
214. Colijn C, Brandes A, Zucker J, Lun DS, Weiner B, Farhat MR, Cheng TY, Moody DB, 
Murray M, Galagan JE: Interpreting expression data with metabolic flux models: 





215. Schuetz R, Kuepfer L, Sauer U: Systematic evaluation of objective functions for 
predicting intracellular fluxes in Escherichia coli. Mol Syst Biol 2007, 3:119. 
216. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO: Reconstruction of biochemical 
networks in microorganisms. Nat Rev Microbiol 2009, 7:129-143. 
217. Ralph SA, van Dooren GG, Waller RF, Crawford MJ, Fraunholz MJ, Foth BJ, Tonkin 
CJ, Roos DS, McFadden GI: Tropical infectious diseases: metabolic maps and 
functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2004, 2:203-
216. 
218. Duarte NC, Herrgard MJ, Palsson BO: Reconstruction and validation of 
Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale 
metabolic model. Genome Res 2004, 14:1298-1309. 
219. Kirk K, Staines HM, Martin RE, Saliba KJ: Transport properties of the host cell 
membrane. Novartis Found Symp 1999, 226:55-66; discussion 66-73. 
220. Martin RE, Henry RI, Abbey JL, Clements JD, Kirk K: The 'permeome' of the malaria 
parasite: an overview of the membrane transport proteins of Plasmodium 
falciparum. Genome Biol 2005, 6:R26. 
221. Koncarevic S, Rohrbach P, Deponte M, Krohne G, Prieto JH, Yates J, 3rd, Rahlfs S, 
Becker K: The malarial parasite Plasmodium falciparum imports the human protein 
peroxiredoxin 2 for peroxide detoxification. Proc Natl Acad Sci USA 2009, 
106:13323-13328. 
222. Bonday ZQ, Taketani S, Gupta PD, Padmanaban G: Heme biosynthesis by the malarial 
parasite. Import of delta-aminolevulinate dehydrase from the host red cell. J Biol 
Chem 1997, 272:21839-21846. 
223. Francis SE, Sullivan DJ, Jr., Goldberg DE: Hemoglobin metabolism in the malaria 
parasite Plasmodium falciparum. Annu Rev Microbiol 1997, 51:97-123. 
224. Saito T, Maeda T, Nakazawa M, Takeuchi T, Nozaki T, Asai T: Characterisation of 
hexokinase in Toxoplasma gondii tachyzoites. Int J Parasitol 2002, 32:961-967. 
225. LeRoux M, Lakshmanan V, Daily JP: Plasmodium falciparum biology: analysis of in 
vitro versus in vivo growth conditions. Trends Parasitol 2009, 25:474-481. 
226. Janse CJ, Ramesar J, Waters AP: High-efficiency transfection and drug selection of 
genetically transformed blood stages of the rodent malaria parasite Plasmodium 
berghei. Nat Protoc 2006, 1:346-356. 
227. Janse CJ, Waters AP: Plasmodium berghei: the application of cultivation and 
purification techniques to molecular studies of malaria parasites. Parasitol Today 
1995, 11:138-143. 
228. Hanada K, Palacpac NM, Magistrado PA, Kurokawa K, Rai G, Sakata D, Hara T, Horii 




sphingomyelin and lysocholinephospholipids is a possible target for malaria 
chemotherapy. J Exp Med 2002, 195:23-34. 
229. Yu M, Kumar TR, Nkrumah LJ, Coppi A, Retzlaff S, Li CD, Kelly BJ, Moura PA, 
Lakshmanan V, Freundlich JS, et al: The fatty acid biosynthesis enzyme FabI plays a 
key role in the development of liver-stage malarial parasites. Cell Host Microbe 2008, 
4:567-578. 
230. Surolia N, Surolia A: Triclosan offers protection against blood stages of malaria by 
inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med 2001, 7:167-
173. 
231. Vaughan AM, O'Neill MT, Tarun AS, Camargo N, Phuong TM, Aly AS, Cowman AF, 
Kappe SH: Type II fatty acid synthesis is essential only for malaria parasite late liver 
stage development. Cell Microbiol 2009, 11:506-520. 
232. Dessens JT, Mendoza J, Claudianos C, Vinetz JM, Khater E, Hassard S, Ranawaka GR, 
Sinden RE: Knockout of the rodent malaria parasite chitinase pbCHT1 reduces 
infectivity to mosquitoes. Infect Immun 2001, 69:4041-4047. 
233. Spry C, Chai CL, Kirk K, Saliba KJ: A class of pantothenic acid analogs inhibits 
Plasmodium falciparum pantothenate kinase and represses the proliferation of 
malaria parasites. Antimicrob Agents Chemother 2005, 49:4649-4657. 
234. Zhang Y, Meshnick SR: Inhibition of Plasmodium falciparum dihydropteroate 
synthetase and growth in vitro by sulfa drugs. Antimicrob Agents Chemother 1991, 
35:267-271. 
235. Jiang L, Lee PC, White J, Rathod PK: Potent and selective activity of a combination of 
thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against 
Plasmodium falciparum. Antimicrob Agents Chemother 2000, 44:1047-1050. 
236. Schnick C, Polley SD, Fivelman QL, Ranford-Cartwright LC, Wilkinson SR, Brannigan 
JA, Wilkinson AJ, Baker DA: Structure and non-essential function of glycerol kinase 
in Plasmodium falciparum blood stages. Mol Microbiol 2009, 71:533-545. 
237. Wanidworanun C, Nagel RL, Shear HL: Antisense oligonucleotides targeting malarial 
aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum. Mol 
Biochem Parasitol 1999, 102:91-101. 
238. Razakantoanina V, Nguyen Kim PP, Jaureguiberry G: Antimalarial activity of new 
gossypol derivatives. Parasitol Res 2000, 86:665-668. 
239. Cassera MB, Merino EF, Peres VJ, Kimura EA, Wunderlich G, Katzin AM: Effect of 
fosmidomycin on metabolic and transcript profiles of the methylerythritol 
phosphate pathway in Plasmodium falciparum. Mem Inst Oswaldo Cruz 2007, 
102:377-383. 
240. Ono T, Cabrita-Santos L, Leitao R, Bettiol E, Purcell LA, Diaz-Pulido O, Andrews LB, 




signaling mediate Plasmodium sporozoite apical regulated exocytosis and 
hepatocyte infection. PLoS Pathog 2008, 4:e1000008. 
241. Das Gupta R, Krause-Ihle T, Bergmann B, Muller IB, Khomutov AR, Muller S, Walter 
RD, Luersen K: 3-Aminooxy-1-aminopropane and derivatives have an 
antiproliferative effect on cultured Plasmodium falciparum by decreasing 
intracellular polyamine concentrations. Antimicrob Agents Chemother 2005, 49:2857-
2864. 
242. Muller IB, Das Gupta R, Luersen K, Wrenger C, Walter RD: Assessing the polyamine 
metabolism of Plasmodium falciparum as chemotherapeutic target. Mol Biochem 
Parasitol 2008, 160:1-7. 
243. Ramya TN, Surolia N, Surolia A: Polyamine synthesis and salvage pathways in the 
malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun 2006, 
348:579-584. 
244. Haider N, Eschbach ML, Dias Sde S, Gilberger TW, Walter RD, Luersen K: The 
spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and 
biochemical characterisation of the polyamine synthesis enzyme. Mol Biochem 
Parasitol 2005, 142:224-236. 
245. Ramya TN, Mishra S, Karmodiya K, Surolia N, Surolia A: Inhibitors of 
nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium 
falciparum. Antimicrob Agents Chemother 2007, 51:307-316. 
246. Dawson PA, Cochran DA, Emmerson BT, Gordon RB: Inhibition of Plasmodium 
falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense 
oligodeoxynucleotide sequence. Mol Biochem Parasitol 1993, 60:153-156. 
247. Webster HK, Whaun JM, Walker MD, Bean TL: Synthesis of adenosine nucleotides 
from hypoxanthine by human malaria parasites (Plasmodium falciparum) in 
continuous erythrocyte culture: inhibition by hadacidin but not alanosine. Biochem 
Pharmacol 1984, 33:1555-1557. 
248. Bulusu V, Srinivasan B, Bopanna MP, Balaram H: Elucidation of the substrate 
specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from 
Plasmodium falciparum. Biochim Biophys Acta 2009, 1794:642-654. 
249. Hirai M, Arai M, Kawai S, Matsuoka H: PbGCbeta is essential for Plasmodium 
ookinete motility to invade midgut cell and for successful completion of parasite life 
cycle in mosquitoes. J Biochem 2006, 140:747-757. 
250. Deng X, Gujjar R, El Mazouni F, Kaminsky W, Malmquist NA, Goldsmith EJ, Rathod 
PK, Phillips MA: Structural plasticity of malaria dihydroorotate dehydrogenase 





251. Ho MC, Cassera MB, Madrid DC, Ting LM, Tyler PC, Kim K, Almo SC, Schramm VL: 
Structural and metabolic specificity of methylthiocoformycin for malarial adenosine 
deaminases. Biochemistry 2009, 48:9618-9626. 
252. Kicska GA, Tyler PC, Evans GB, Furneaux RH, Schramm VL, Kim K: Purine-less 
death in Plasmodium falciparum induced by immucillin-H, a transition state 
analogue of purine nucleoside phosphorylase. J Biol Chem 2002, 277:3226-3231. 
253. Chakrabarti D, Schuster SM, Chakrabarti R: Cloning and characterization of subunit 
genes of ribonucleotide reductase, a cell-cycle-regulated enzyme, from Plasmodium 
falciparum. Proc Natl Acad Sci U S A 1993, 90:12020-12024. 
254. Krungkrai J, Krungkrai SR, Supuran CT: Carbonic anhydrase inhibitors: inhibition of 
Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic 
sulfonamides-in vitro and in vivo studies. Bioorg Med Chem Lett 2008, 18:5466-5471. 
255. Flores MV, Atkins D, Wade D, O'Sullivan WJ, Stewart TS: Inhibition of Plasmodium 
falciparum proliferation in vitro by ribozymes. J Biol Chem 1997, 272:16940-16945. 
256. Nguyen C, Kasinathan G, Leal-Cortijo I, Musso-Buendia A, Kaiser M, Brun R, Ruiz-
Perez LM, Johansson NG, Gonzalez-Pacanowska D, Gilbert IH: Deoxyuridine 
triphosphate nucleotidohydrolase as a potential antiparasitic drug target. J Med 
Chem 2005, 48:5942-5954. 
257. Thornalley PJ, Strath M, Wilson RJ: Antimalarial activity in vitro of the glyoxalase I 
inhibitor diester, S-p-bromobenzylglutathione diethyl ester. Biochem Pharmacol 
1994, 47:418-420. 
258. Yano K, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S, Kawazu S: 2-Cys 
Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. 
Mol Biochem Parasitol 2006, 148:44-51. 
259. Yano K, Otsuki H, Arai M, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S, Kawazu S: 
Disruption of the Plasmodium berghei 2-Cys peroxiredoxin TPx-1 gene hinders the 
sporozoite development in the vector mosquito. Mol Biochem Parasitol 2008, 
159:142-145. 
260. Vega-Rodriguez J, Franke-Fayard B, Dinglasan RR, Janse CJ, Pastrana-Mena R, Waters 
AP, Coppens I, Rodriguez-Orengo JF, Srinivasan P, Jacobs-Lorena M, Serrano AE: The 
glutathione biosynthetic pathway of Plasmodium is essential for mosquito 
transmission. PLoS Pathog 2009, 5:e1000302. 
261. Krnajski Z, Gilberger TW, Walter RD, Cowman AF, Muller S: Thioredoxin reductase 
is essential for the survival of Plasmodium falciparum erythrocytic stages. J Biol 
Chem 2002, 277:25970-25975. 
262. Roberts F, Roberts CW, Johnson JJ, Kyle DE, Krell T, Coggins JR, Coombs GH, 
Milhous WK, Tzipori S, Ferguson DJ, et al: Evidence for the shikimate pathway in 




263. McRobert L, McConkey GA: RNA interference (RNAi) inhibits growth of 
Plasmodium falciparum. Mol Biochem Parasitol 2002, 119:273-278. 
264. Mukkamala D, No JH, Cass LM, Chang TK, Oldfield E: Bisphosphonate inhibition of a 
Plasmodium farnesyl diphosphate synthase and a general method for predicting 
cell-based activity from enzyme data. J Med Chem 2008, 51:7827-7833. 
265. Promeneur D, Liu Y, Maciel J, Agre P, King LS, Kumar N: Aquaglyceroporin PbAQP 
during intraerythrocytic development of the malaria parasite Plasmodium berghei. 
Proc Natl Acad Sci USA 2007, 104:2211-2216. 
266. Bhanot P, Schauer K, Coppens I, Nussenzweig V: A surface phospholipase is involved 
in the migration of plasmodium sporozoites through cells. J Biol Chem 2005, 
280:6752-6760. 
267. Lim L, McFadden GI: The evolution, metabolism and functions of the apicoplast. 
Philos Trans R Soc Lond B Biol Sci 2010, 365:749-763. 
268. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD: Computational 
prediction of human metabolic pathways from the complete human genome. 
Genome Biol 2005, 6:R2. 
269. van Dooren GG, Stimmler LM, McFadden GI: Metabolic maps and functions of the 
Plasmodium mitochondrion. FEMS Microbiol Rev 2006, 30:596-630. 
270. Foth BJ, Stimmler LM, Handman E, Crabb BS, Hodder AN, McFadden GI: The malaria 
parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, 
which is located in the apicoplast. Mol Microbiol 2005, 55:39-53. 
271. Dixon SJ, Costanzo M, Baryshnikova A, Andrews B, Boone C: Systematic mapping of 
genetic interaction networks. Annu Rev Genet 2009, 43:601-625. 
272. Wagner A: Robustness, evolvability, and neutrality. FEBS Lett 2005, 579:1772-1778. 
273. Vaidya AB, Mather MW: Mitochondrial evolution and functions in malaria parasites. 
Annu Rev Microbiol 2009, 63:249-267. 
274. Berwal R, Gopalan N, Chandel K, Prasad GB, Prakash S: Plasmodium falciparum: 
enhanced soluble expression, purification and biochemical characterization of 
lactate dehydrogenase. Exp Parasitol 2008, 120:135-141. 
275. Reed JL, Vo TD, Schilling CH, Palsson BO: An expanded genome-scale model of 
Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 2003, 4:R54. 
276. Ting LM, Shi W, Lewandowicz A, Singh V, Mwakingwe A, Birck MR, Ringia EA, 
Bench G, Madrid DC, Tyler PC, et al: Targeting a novel Plasmodium falciparum 





277. Hyde JE, Dittrich S, Wang P, Sims PF, de Crecy-Lagard V, Hanson AD: Plasmodium 
falciparum: a paradigm for alternative folate biosynthesis in diverse 
microorganisms? Trends Parasitol 2008, 24:502-508. 
278. Mi-Ichi F, Kita K, Mitamura T: Intraerythrocytic Plasmodium falciparum utilize a 
broad range of serum-derived fatty acids with limited modification for their growth. 
Parasitology 2006, 133:399-410. 
279. Hsiao LL, Howard RJ, Aikawa M, Taraschi TF: Modification of host cell membrane 
lipid composition by the intra-erythrocytic human malaria parasite Plasmodium 
falciparum. Biochem J 1991, 274 ( Pt 1):121-132. 
280. Magni G, Di Stefano M, Orsomando G, Raffaelli N, Ruggieri S: NAD(P) biosynthesis 
enzymes as potential targets for selective drug design. Curr Med Chem 2009, 
16:1372-1390. 
281. Merrick CJ, Duraisingh MT: Plasmodium falciparum Sir2: an unusual sirtuin with 
dual histone deacetylase and ADP-ribosyltransferase activity. Eukaryot Cell 2007, 
6:2081-2091. 
282. Sorci L, Pan Y, Eyobo Y, Rodionova I, Huang N, Kurnasov O, Zhong S, MacKerell AD, 
Jr., Zhang H, Osterman AL: Targeting NAD biosynthesis in bacterial pathogens: 
Structure-based development of inhibitors of nicotinate mononucleotide 
adenylyltransferase NadD. Chem Biol 2009, 16:849-861. 
283. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and 
inexpensive fluorescence-based technique for high-throughput antimalarial drug 
screening. Antimicrob Agents Chemother 2004, 48:1803-1806. 
284. Divo AA, Geary TG, Davis NL, Jensen JB: Nutritional requirements of Plasmodium 
falciparum in culture. I. Exogenously supplied dialyzable components necessary for 
continuous growth. J Protozool 1985, 32:59-64. 
285. Daran-Lapujade P, Jansen ML, Daran JM, van Gulik W, de Winde JH, Pronk JT: Role of 
transcriptional regulation in controlling fluxes in central carbon metabolism of 
Saccharomyces cerevisiae. A chemostat culture study. J Biol Chem 2004, 279:9125-
9138. 
286. Shlomi T, Cabili MN, Herrgard MJ, Palsson BO, Ruppin E: Network-based prediction 
of human tissue-specific metabolism. Nat Biotechnol 2008, 26:1003-1010. 
287. Ginsburg H: Progress in in silico functional genomics: the malaria Metabolic 
Pathways database. Trends Parasitol 2006, 22:238-240. 
288. Ginsburg H: Caveat emptor: limitations of the automated reconstruction of 
metabolic pathways in Plasmodium. Trends Parasitol 2009, 25:37-43. 
289. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, 
Anderson K, Andre B, et al: Functional profiling of the Saccharomyces cerevisiae 




290. Covert MW, Palsson BO: Transcriptional regulation in constraints-based metabolic 
models of Escherichia coli. J Biol Chem 2002, 277:28058-28064. 
291. De Silva EK, Gehrke AR, Olszewski K, Leon I, Chahal JS, Bulyk ML, Llinas M: 
Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad 
Sci U S A 2008, 105:8393-8398. 
292. Chung DW, Ponts N, Cervantes S, Le Roch KG: Post-translational modifications in 
Plasmodium: more than you think! Mol Biochem Parasitol 2009, 168:123-134. 
293. Dhanasekaran S, Chandra NR, Chandrasekhar Sagar BK, Rangarajan PN, Padmanaban 
G: Delta-aminolevulinic acid dehydratase from Plasmodium falciparum: indigenous 
versus imported. J Biol Chem 2004, 279:6934-6942. 
294. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO: 
Global reconstruction of the human metabolic network based on genomic and 
bibliomic data. Proc Natl Acad Sci USA 2007, 104:1777-1782. 
295. Zhao J, Geng C, Tao L, Zhang D, Jiang Y, Tang K, Zhu R, Yu H, Zhang WD, He F, et al: 
Reconstruction and analysis of human liver-specific metabolic network based on 
CNHLPP data. J Proteome Res 2010. 
296. Jamshidi N, Edwards JS, Fahland T, Church GM, Palsson BO: Dynamic simulation of 
the human red blood cell metabolic network. Bioinformatics 2001, 17:286-287. 
297. Joshi A, Palsson BO: Metabolic dynamics in the human red cell. Part III--Metabolic 
reaction rates. J Theor Biol 1990, 142:41-68. 
298. Joshi A, Palsson BO: Metabolic dynamics in the human red cell. Part IV--Data 
prediction and some model computations. J Theor Biol 1990, 142:69-85. 
299. Joshi A, Palsson BO: Metabolic dynamics in the human red cell. Part I--A 
comprehensive kinetic model. J Theor Biol 1989, 141:515-528. 
300. Joshi A, Palsson BO: Metabolic dynamics in the human red cell. Part II--Interactions 
with the environment. J Theor Biol 1989, 141:529-545. 
301. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P: A side effect resource to capture 
phenotypic effects of drugs. Mol Syst Biol 2010, 6:343. 
302. Yao L, Rzhetsky A: Quantitative systems-level determinants of human genes 
targeted by successful drugs. Genome Res 2008, 18:206-213. 
303. Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, 
Grant G, Harb OS, et al: PlasmoDB: a functional genomic database for malaria 
parasites. Nucleic Acids Res 2009, 37:D539-543. 
304. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, Broadbelt LJ, 




Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic 
information. Mol Syst Biol 2007, 3:121. 
305. Chan M, Tan DS, Wong SH, Sim TS: A relevant in vitro eukaryotic live-cell system 
for the evaluation of plasmodial protein localization. Biochimie 2006, 88:1367-1375. 
306. Waller RF, Keeling PJ, Donald RG, Striepen B, Handman E, Lang-Unnasch N, Cowman 
AF, Besra GS, Roos DS, McFadden GI: Nuclear-encoded proteins target to the plastid 
in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci USA 1998, 
95:12352-12357. 
307. Edwards JS, Ramakrishna R, Schilling CH, B.O. P: Metabolic flux balance analysis. In 
Metabolic engineering. Edited by Lee SYPET. New York, NY: Marcel Dekker Inc.; 
1999: pp. 13-57 
308. Mullin KA, Lim L, Ralph SA, Spurck TP, Handman E, McFadden GI: Membrane 
transporters in the relict plastid of malaria parasites. Proc Natl Acad Sci USA 2006, 
103:9572-9577. 
309. Quashie NB, Dorin-Semblat D, Bray PG, Biagini GA, Doerig C, Ranford-Cartwright LC, 
De Koning HP: A comprehensive model of purine uptake by the malaria parasite 
Plasmodium falciparum: identification of four purine transport activities in 
intraerythrocytic parasites. Biochem J 2008, 411:287-295. 
310. Wright J, Wagner A: The Systems Biology Research Tool: evolvable open-source 
software. BMC Syst Biol 2008, 2:55. 
311. Le Novere N, Bornstein B, Broicher A, Courtot M, Donizelli M, Dharuri H, Li L, Sauro 
H, Schilstra M, Shapiro B, et al: BioModels Database: a free, centralized database of 
curated, published, quantitative kinetic models of biochemical and cellular systems. 
Nucleic Acids Res 2006, 34:D689-691. 
312. Trager W, Jensen JB: Human malaria parasites in continuous culture. 1976. J 
Parasitol 2005, 91:484-486. 
313. Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic 
stages in culture. J Parasitol 1979, 65:418-420. 
314. Kaufman DE, Smith RL: Direction choice for accelerated convergence in hit-and-run 
sampling. Operations Research 1998, 46:84-95. 
315. Margoliash E: Primary structure and evolution of cytochrome C. Proc Natl Acad Sci 
USA 1963, 50:672-679. 
316. Benton MJ, Donoghue PC: Paleontological evidence to date the tree of life. Mol Biol 
Evol 2007, 24:26-53. 





318. Ayala FJ: Molecular clock mirages. Bioessays 1999, 21:71-75. 
319. Zuckerkandl E: Evolutionary processes and evolutionary noise at the molecular level. 
I. Functional density in proteins. J Mol Evol 1976, 7:167-183. 
320. Wilson AC, Carlson SS, White TJ: Biochemical evolution. Annu Rev Biochem 1977, 
46:573-639. 
321. Wang Z, Zhang JZ: Why Is the correlation between gene importance and gene 
evolutionary rate so weak? PLoS Genet 2009, 5:e1000329. 
322. Vitkup D, Kharchenko P, Wagner A: Influence of metabolic network structure and 
function on enzyme evolution. Genome Biol 2006, 7:R39. 
323. Jordan IK, Rogozin IB, Wolf YI, Koonin EV: Essential genes are more evolutionarily 
conserved than are nonessential genes in bacteria. Genome Res 2002, 12:962-968. 
324. Hirsh AE, Fraser HB: Protein dispensability and rate of evolution. Nature 2001, 
411:1046-1049. 
325. Jordan IK, Wolf YI, Koonin EV: No simple dependence between protein evolution 
rate and the number of protein-protein interactions: only the most prolific 
interactors tend to evolve slowly. BMC Evol Biol 2003, 3:5. 
326. Rocha EP, Danchin A: An analysis of determinants of amino acids substitution rates 
in bacterial proteins. Mol Biol Evol 2004, 21:108-116. 
327. Xia Y, Franzosa EA, Gerstein MB: Integrated assessment of genomic correlates of 
protein evolutionary rate. PLoS Comput Biol 2009, 5:e1000413. 
328. Drummond DA, Bloom JD, Adami C, Wilke CO, Arnold FH: Why highly expressed 
proteins evolve slowly. Proc Natl Acad Sci USA 2005, 102:14338-14343. 
329. Marais G, Duret L: Synonymous codon usage, accuracy of translation, and gene 
length in Caenorhabditis elegans. J Mol Evol 2001, 52:275-280. 
330. Rocha EP: The quest for the universals of protein evolution. Trends Genet 2006, 
22:412-416. 
331. Drummond DA, Wilke CO: Mistranslation-induced protein misfolding as a dominant 
constraint on coding-sequence evolution. Cell 2008, 134:341-352. 
332. Drummond DA, Wilke CO: The evolutionary consequences of erroneous protein 
synthesis. Nat Rev Genet 2009, 10:715-724. 
333. Kramer EB, Farabaugh PJ: The frequency of translational misreading errors in E. coli 
is largely determined by tRNA competition. RNA 2007, 13:87-96. 
334. Stansfield I, Jones KM, Herbert P, Lewendon A, Shaw WV, Tuite MF: Missense 




335. Müller-Hill B: The lac Operon: A Short History of a Genetic Paradigm. New York: 
Walter de Gruyter; 1996. 
336. Dong HJ, Nilsson L, Kurland CG: Gratuitous overexpression of genes in Escherichia 
coli leads to growth inhibition and ribosome destruction. J Bacteriol 1997, 179:2096-
2096. 
337. Dekel E, Alon U: Optimality and evolutionary tuning of the expression level of a 
protein. Nature 2005, 436:588-592. 
338. Pakula AA, Sauer RT: Genetic analysis of protein stability and function. Annu Rev 
Genet 1989, 23:289-310. 
339. Matthews BW: Structural and genetic analysis of the folding and function of T4 
lysozyme. FASEB J 1996, 10:35-41. 
340. Vlahovicek K, Pintar A, Parthasarathi L, Carugo O, Pongor S: CX, DPX and PRIDE: 
WWW servers for the analysis and comparison of protein 3D structures. Nucleic 
Acids Res 2005, 33:W252-W254. 
341. Capriotti E, Fariselli P, Casadio R: I-Mutant2.0: predicting stability changes upon 
mutation from the protein sequence or structure. Nucleic Acids Res 2005, 33:W306-
W310. 
342. Vind J, Sorensen MA, Rasmussen MD, Pedersen S: Synthesis of proteins in 
Escherichia coli is limited by the concentration of free ribosomes. Expression from 
reporter genes does not always reflect functional mRNA levels. J Mol Biol 1993, 
231:678-688. 
343. Sambrook J, Russell DW: Molecular Cloning: A laboratory manual. CSHL Press; 2001. 
344. Lesley SA, Graziano J, Cho CY, Knuth MW, Klock HE: Gene expression response to 
misfolded protein as a screen for soluble recombinant protein. Protein Eng 2002, 
15:153-160. 
345. Parsell DA, Sauer RT: Induction of a heat shock-like response by unfolded protein in 
Escherichia Coli: Dependence on protein level not protein degradation. Genes Dev 
1989, 3:1226-1232. 
346. Wang IN, Deaton J, Young R: Sizing the holin lesion with an endolysin-beta-
galactosidase fusion. J Bacteriol 2003, 185:779-787. 
347. Andersson SG, Kurland CG: Codon preferences in free-living microorganisms. 
Microbiol Rev 1990, 54:198-210. 
348. Bulmer M: The selection-mutation-drift theory of synonymous codon usage. Genetics 
1991, 129:897-907. 





350. Kudla G, Murray AW, Tollervey D, Plotkin JB: Coding-sequence determinants of gene 
expression in Escherichia coli. Science 2009, 324:255-258. 
351. Niwa T, Ying BW, Saito K, Jin W, Takada S, Ueda T, Taguchi H: Bimodal protein 
solubility distribution revealed by an aggregation analysis of the entire ensemble of 
Escherichia coli proteins. Proc Natl Acad Sci USA 2009, 106:4201-4206. 
352. Koonin EV, Wolf YI: Constraints and plasticity in genome and molecular-phenome 
evolution. Nat Rev Genet 2010, 11:487-498. 
353. Dobson CM: Protein misfolding, evolution and disease. Trends Biochem Sci 1999, 
24:329-332. 
354. Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M: A relationship between 
mRNA expression levels and protein solubility in E. coli. J Mol Biol 2009, 388:381-
389. 
355. de Groot NS, Ventura S: Protein aggregation profile of the bacterial cytosol. PLoS 
One 2010, 5:e9383. 
356. Zhang J, Maslov S, Shakhnovich EI: Constraints imposed by non-functional protein-
protein interactions on gene expression and proteome size. Mol Syst Biol 2008, 4:210. 
357. Strub C, Alies C, Lougarre A, Ladurantie C, Czaplicki J, Fournier D: Mutation of 
exposed hydrophobic amino acids to arginine to increase protein stability. BMC 
Biochem 2004, 5:9. 
358. Baldwin RL: Energetics of protein folding. J Mol Biol 2007, 371:283-301. 
359. Dill KA: Dominant forces in protein folding. Biochemistry 1990, 29:7133-7155. 
360. Honig B, Yang AS: Free energy balance in protein folding. Adv Protein Chem 1995, 
46:27-58. 
361. Thompson MJ, Eisenberg D: Transproteomic evidence of a loop-deletion mechanism 
for enhancing protein thermostability. J Mol Biol 1999, 290:595-604. 
362. Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A: ProTherm, version 4.0: 
thermodynamic database for proteins and mutants. Nucleic Acids Res 2004, 
32:D120-121. 
363. Ivankov DN, Garbuzynskiy SO, Alm E, Plaxco KW, Baker D, Finkelstein AV: Contact 
order revisited: influence of protein size on the folding rate. Protein Sci 2003, 
12:2057-2062. 
364. Plaxco KW, Simons KT, Baker D: Contact order, transition state placement and the 
refolding rates of single domain proteins. J Mol Biol 1998, 277:985-994. 
365. Lu P, Vogel C, Wang R, Yao X, Marcotte EM: Absolute protein expression profiling 
estimates the relative contributions of transcriptional and translational regulation. 




366. Thatcher JW, Shaw JM, Dickinson WJ: Marginal fitness contributions of nonessential 
genes in yeast. Proc Natl Acad Sci USA 1998, 95:253-257. 
367. Lindner AB, Madden R, Demarez A, Stewart EJ, Taddei F: Asymmetric segregation of 
protein aggregates is associated with cellular aging and rejuvenation. Proc Natl Acad 
Sci USA 2008, 105:3076-3081. 
368. Stoebel DM, Dean AM, Dykhuizen DE: The cost of expression of Escherichia coli lac 
operon proteins is in the process, not in the products. Genetics 2008, 178:1653-1660. 
369. Tuller T, Waldman YY, Kupiec M, Ruppin E: Translation efficiency is determined by 
both codon bias and folding energy. Proc Natl Acad Sci USA 2010, 107:3645-3650. 
370. Akashi H: Synonymous codon usage in Drosophila melanogaster: natural selection 
and translational accuracy. Genetics 1994, 136:927-935. 
371. Huang Y, Koonin EV, Lipman DJ, Przytycka TM: Selection for minimization of 
translational frameshifting errors as a factor in the evolution of codon usage. 
Nucleic Acids Res 2009, 37:6799-6810. 
372. Stoletzki N, Eyre-Walker A: Synonymous codon usage in Escherichia coli: selection 
for translational accuracy. Mol Biol Evol 2007, 24:374-381. 
373. Liao BY, Scott NM, Zhang J: Impacts of gene essentiality, expression pattern, and 
gene compactness on the evolutionary rate of mammalian proteins. Mol Biol Evol 
2006, 23:2072-2080. 
374. Wolf MY, Wolf YI, Koonin EV: Comparable contributions of structural-functional 
constraints and expression level to the rate of protein sequence evolution. Biol Direct 
2008, 3:40. 
375. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi 
G, Dobson CM, Stefani M: Inherent toxicity of aggregates implies a common 
mechanism for protein misfolding diseases. Nature 2002, 416:507-511. 
376. Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI: Progressive disruption of 
cellular protein folding in models of polyglutamine diseases. Science 2006, 311:1471-
1474. 
377. Munch C, Bertolotti A: Exposure of Hydrophobic Surfaces Initiates Aggregation of 
Diverse ALS-Causing Superoxide Dismutase-1 Mutants. J Mol Biol 2010. 
378. Link CD, Fonte V, Hiester B, Yerg J, Ferguson J, Csontos S, Silverman MA, Stein GH: 
Conversion of green fluorescent protein into a toxic, aggregation-prone protein by 
C-terminal addition of a short peptide. Journal of Biological Chemistry 2006, 
281:1808-1816. 
379. Abramoff MD, Magelhaes PJ, Ram SJ: Image Processing with ImageJ. Biophotonics 




380. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, 
Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242. 
381. Momen-Roknabadi A, Sadeghi M, Pezeshk H, Marashi SA: Impact of residue 
accessible surface area on the prediction of protein secondary structures. BMC 
Bioinformatics 2008, 9:357. 
382. Rost B, Sander C: Conservation and prediction of solvent accessibility in protein 
families. Proteins 1994, 20:216-226. 
383. Kabsch W, Sander C: Dictionary of protein secondary structure: pattern recognition 
of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637. 
384. Bloom JD, Drummond DA, Arnold FH, Wilke CO: Structural determinants of the rate 
of protein evolution in yeast. Mol Biol Evol 2006, 23:1751-1761. 
385. Yang ZH: PAML: a program package for phylogenetic analysis by maximum 
likelihood. Comput Appl Biosci 1997, 13:555-556. 
386. Faith JJ, Driscoll ME, Fusaro VA, Cosgrove EJ, Hayete B, Juhn FS, Schneider SJ, 
Gardner TS: Many Microbe Microarrays Database: uniformly normalized 
Affymetrix compendia with structured experimental metadata. Nucleic Acids Res 
2008, 36:D866-870. 
387. Gu Z, Steinmetz LM, Gu X, Scharfe C, Davis RW, Li WH: Role of duplicate genes in 
genetic robustness against null mutations. Nature 2003, 421:63-66. 
388. Stelling J, Sauer U, Szallasi Z, Doyle FJ, 3rd, Doyle J: Robustness of cellular functions. 
Cell 2004, 118:675-685. 
389. Wagner A: Robustness and Evolvability in Living Systems. Princeton: Princeton Univ. 
Press; 2005. 
390. Wagner A: Robustness against mutations in genetic networks of yeast. Nat Genet 
2000, 24:355-361. 
391. Papp B, Pal C, Hurst LD: Metabolic network analysis of the causes and evolution of 
enzyme dispensability in yeast. Nature 2004, 429:661-664. 
392. Lynch M, Conery JS: The evolutionary fate and consequences of duplicate genes. 
Science 2000, 290:1151-1155. 
393. Wapinski I, Pfeffer A, Friedman N, Regev A: Natural history and evolutionary 
principles of gene duplication in fungi. Nature 2007, 449:54-61. 
394. Kellis M, Birren BW, Lander ES: Proof and evolutionary analysis of ancient genome 
duplication in the yeast Saccharomyces cerevisiae. Nature 2004, 428:617-624. 
395. Hsiao TL, Vitkup D: Role of duplicate genes in robustness against deleterious human 




396. Ohno S: Evolution by gene duplication. Berlin, New York: Springer-Verlag; 1970. 
397. Conant GC, Wolfe KH: Turning a hobby into a job: how duplicated genes find new 
functions. Nat Rev Genet 2008, 9:938-950. 
398. Innan H, Kondrashov F: The evolution of gene duplications: classifying and 
distinguishing between models. Nat Rev Genet 2010, 11:97-108. 
399. Nadeau JH, Sankoff D: Comparable rates of gene loss and functional divergence after 
genome duplications early in vertebrate evolution. Genetics 1997, 147:1259-1266. 
400. Sidow A: Genome duplications in the evolution of early vertebrates. Curr Opin Genet 
Dev 1996, 6:715-722. 
401. Force A, Lynch M, Pickett FB, Amores A, Yan YL, Postlethwait J: Preservation of 
duplicate genes by complementary, degenerative mutations. Genetics 1999, 
151:1531-1545. 
402. Lynch M, Force A: The probability of duplicate gene preservation by 
subfunctionalization. Genetics 2000, 154:459-473. 
403. Kondrashov FA, Rogozin IB, Wolf YI, Koonin EV: Selection in the evolution of gene 
duplications. Genome Biol 2002, 3:RESEARCH0008. 
404. Bergthorsson U, Andersson DI, Roth JR: Ohno's dilemma: evolution of new genes 
under continuous selection. Proc Natl Acad Sci U S A 2007, 104:17004-17009. 
405. VanderSluis B, Bellay J, Musso G, Costanzo M, Papp B, Vizeacoumar FJ, Baryshnikova 
A, Andrews B, Boone C, Myers CL: Genetic interactions reveal the evolutionary 
trajectories of duplicate genes. Mol Syst Biol 2010, 6:429. 
406. Ihmels J, Collins SR, Schuldiner M, Krogan NJ, Weissman JS: Backup without 
redundancy: genetic interactions reveal the cost of duplicate gene loss. Mol Syst Biol 
2007, 3:86. 
407. Li J, Yuan Z, Zhang Z: The cellular robustness by genetic redundancy in budding 
yeast. PLoS Genet 2010, 6:e1001187. 
408. Guan Y, Dunham MJ, Troyanskaya OG: Functional analysis of gene duplications in 
Saccharomyces cerevisiae. Genetics 2007, 175:933-943. 
409. Conant GC, Wagner A: Duplicate genes and robustness to transient gene knock-
downs in Caenorhabditis elegans. Proc Biol Sci 2004, 271:89-96. 
410. Gillespie JH: Population Genetics, A Concise Guide. Baltimore: Johns Hopkins Univ. 
Press; 1998. 





412. Lynch M: Streamlining and simplification of microbial genome architecture. Annu 
Rev Microbiol 2006, 60:327-349. 
413. Kellis M, Patterson N, Endrizzi M, Birren B, Lander ES: Sequencing and comparison 
of yeast species to identify genes and regulatory elements. Nature 2003, 423:241-254. 
414. Gu Z, Cavalcanti A, Chen FC, Bouman P, Li WH: Extent of gene duplication in the 
genomes of Drosophila, nematode, and yeast. Mol Biol Evol 2002, 19:256-262. 
415. Yang Z, Nielsen R: Estimating synonymous and nonsynonymous substitution rates 
under realistic evolutionary models. Mol Biol Evol 2000, 17:32-43. 
416. Hillenmeyer ME, Fung E, Wildenhain J, Pierce SE, Hoon S, Lee W, Proctor M, St Onge 
RP, Tyers M, Koller D, et al: The chemical genomic portrait of yeast: uncovering a 
phenotype for all genes. Science 2008, 320:362-365. 
417. DeLuna A, Vetsigian K, Shoresh N, Hegreness M, Colon-Gonzalez M, Chao S, Kishony 
R: Exposing the fitness contribution of duplicated genes. Nat Genet 2008, 40:676-681. 
418. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, 
Toufighi K, Mostafavi S, et al: The genetic landscape of a cell. Science 2010, 327:425-
431. 
419. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski 
K, Dwight SS, Eppig JT, et al: Gene ontology: tool for the unification of biology. The 
Gene Ontology Consortium. Nat Genet 2000, 25:25-29. 
420. Guldener U, Munsterkotter M, Kastenmuller G, Strack N, van Helden J, Lemer C, 
Richelles J, Wodak SJ, Garcia-Martinez J, Perez-Ortin JE, et al: CYGD: the 
Comprehensive Yeast Genome Database. Nucleic Acids Res 2005, 33:D364-368. 
421. Kafri R, Bar-Even A, Pilpel Y: Transcription control reprogramming in genetic 
backup circuits. Nat Genet 2005, 37:295-299. 
422. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, O'Shea EK: 
Global analysis of protein localization in budding yeast. Nature 2003, 425:686-691. 
423. Gimeno CJ, Fink GR: The logic of cell division in the life cycle of yeast. Science 1992, 
257:626. 
424. Conant GC, Wolfe KH: Functional partitioning of yeast co-expression networks after 
genome duplication. PLoS Biol 2006, 4:e109. 
425. Wagner A: Asymmetric functional divergence of duplicate genes in yeast. Mol Biol 
Evol 2002, 19:1760-1768. 
426. He X, Zhang J: Gene complexity and gene duplicability. Curr Biol 2005, 15:1016-
1021. 
427. Hu Z, Killion PJ, Iyer VR: Genetic reconstruction of a functional transcriptional 




428. Papp B, Pal C, Hurst LD: Evolution of cis-regulatory elements in duplicated genes of 
yeast. Trends Genet 2003, 19:417-422. 
429. Kafri R, Levy M, Pilpel Y: The regulatory utilization of genetic redundancy through 
responsive backup circuits. Proc Natl Acad Sci USA 2006, 103:11653-11658. 
430. DeLuna A, Springer M, Kirschner MW, Kishony R: Need-based up-regulation of 
protein levels in response to deletion of their duplicate genes. PLoS Biol 2010, 
8:e1000347. 
431. Springer M, Weissman JS, Kirschner MW: A general lack of compensation for gene 
dosage in yeast. Mol Syst Biol 2010, 6:368. 
432. Kafri R, Dahan O, Levy J, Pilpel Y: Preferential protection of protein interaction 
network hubs in yeast: evolved functionality of genetic redundancy. Proc Natl Acad 
Sci USA 2008, 105:1243-1248. 
433. Boucherie H, Bataille N, Fitch IT, Perrot M, Tuite MF: Differential synthesis of 
glyceraldehyde-3-phosphate dehydrogenase polypeptides in stressed yeast cells. 
FEMS Microbiol Lett 1995, 125:127-133. 
434. Seufert W, Jentsch S: Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate 
selective degradation of short-lived and abnormal proteins. EMBO J 1990, 9:543-
550. 
435. Zou C, Lehti-Shiu MD, Thomashow M, Shiu SH: Evolution of stress-regulated gene 
expression in duplicate genes of Arabidopsis thaliana. PLoS Genet 2009, 5:e1000581. 
436. Chung WY, Albert R, Albert I, Nekrutenko A, Makova KD: Rapid and asymmetric 
divergence of duplicate genes in the human gene coexpression network. BMC 
Bioinformatics 2006, 7:46. 
 
 
